[
  {
    "chunk_id": "PFIZER_135315170_001_2024_FORM_5500",
    "schedule_type": "FORM_5500",
    "page_range": "1-3",
    "page_count": 3,
    "raw_text": "Form5500 Annual Return/Report of Employee Benefit Plan OMB Nos. 1210-0110\n1210-0089\nThis form is required to be filed for employee benefit plans under sections 104\nand 4065 of the Employee Retirement Income Security Act of 1974 (ERISA) and\nDepartment of the Treasury\nInternal Revenue Service sections 6057(b) and 6058(a) of the Internal Revenue Code (the Code). 2024\nDepartment of Labor \uf034 Complete all entries in accordance with\nEmployee Benefits Security the instructions to the Form 5500.\nAdministration\nPension Benefit Guaranty Corporation This Form is Open to Public\nInspection\nPart I Annual Report Identification Information\nFor calendar plan year 2024 or fiscal plan year beginning 01/01/2024 and ending 12/31/2024\nA This return/report is for: X a multiemployer plan X a multiple-employer plan (Filers checking this box must provide participating\nemployer information in accordance with the form instructions.)\nXX a single-employer plan X a DFE (specify) _C_\nB This return/report is: X the first return/report X the final return/report\nX an amended return/report X a short plan year return/report (less than 12 months)\nC If the plan is a collectively-bargained plan, check here. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . ..\uf034 X\nD Check box if filing under: XX Form 5558 X automatic extension X the DFVC program\nX special extension (enter description) ABCDEFGHI ABCDE\nE If this is a retroactively adopted plan permitted by SECURE Act section 201, check here. . . . . . . . . . . . . . . . . . . . . . . . . ..\uf034 X\nPart II Basic Plan Information\u2014enter all requested information\n1a Name of plan 1b Three-digit plan\nAPBFCIDZEERF GCHOIN SOALBICDDATEEFDG PHEIN SAIOBNC DPELAFNGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI number (PN) \uf034 000011\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI 1c Effective date of plan\nY0Y1/Y01Y/1-9M4M3-DD\n2a Plan sponsor\u2019s name (employer, if for a single-employer plan) 2b Employer Identification\nMailing address (include room, apt., suite no. and street, or P.O. Box) Number (EIN)\nCity or town, state or province, country, and ZIP or foreign postal code (if foreign, see instructions) 0113-25331455176078\nAPBFCIZDEERF INGCHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI 2c Plan Sponsor\u2019s telephone\nD/B/A ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI number\nABCDEFGHI 01223142-576337-28392 3\ncA/ToT ENATBICODNE UFSG BHEIN EAFBITCSD EFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI 2d Business code (see\n16263 H4U5D6S7O8N9 B OAUBLCEDVAERFDG HEIAS TA BCDEFGHI ABCDE instructions)\n1\nN\n2\nE\n3\nW\n4 5\nYO\n6\nR\n7\nK\n8\n,\n9\nN Y\nA\n1\nB\n0\nC\n0\nD\n01\nE\n-2\nF\n1\nG\n9\nH\n2\nI ABCDEFGHI ABCDE\n031252431045\nCITYEFGHI ABCDEFGHI AB, ST 012345678901\nUK\nCaution: A penalty for the late or incomplete filing of this return/report will be assessed unless reasonable cause is established.\nUnder penalties of perjury and other penalties set forth in the instructions, I declare that I have examined this return/report, including accompanying schedules,\nstatements and attachments, as well as the electronic version of this return/report, and to the best of my knowledge and belief, it is true, correct, and complete.\nSIGN Filed with authorized/valid electronic signature. Y1Y0/Y02Y/-20M2M5-DD ASTBECPDHEEFNG PHEIN NAABCCCDHEIOFGHI ABCDEFGHI ABCDE\nHERE\nSignature of plan administrator Date Enter name of individual signing as plan administrator\nSIGN YYYY-MM-DD ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDE\nHERE\nSignature of employer/plan sponsor Date Enter name of individual signing as employer or plan sponsor\nSIGN YYYY-MM-DD ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDE\nHERE\nSignature of DFE Date Enter name of individual signing as DFE\nFor Paperwork Reduction Act Notice, see the Instructions for Form 5500. Form 5500 (2024)\nv.240311\n\nForm 5500 (2024) Page 2\n3a Plan administrator\u2019s name and address X Same as Plan Sponsor 3b Administrator\u2019s EIN\n012133-425876572585\nABTHCED ERFETGIHRIEM AENBTC DCEOFMGMHITIT EAEB CDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI 3c Administrator\u2019s telephone\nPFIZER INC\nc/o ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI number\n66 HUDSON BOULEVARD EAST\n12N3EW45 Y6O7R8K9, NAY B1C00D0E1-F2G19H2I ABCDEFGHI ABCDE 01223142-573637-28392 3\n123456789 ABCDEFGHI ABCDEFGHI ABCDE\nCITYEFGHI ABCDEFGHI AB, ST 012345678901\nUK\n4 If the name and/or EIN of the plan sponsor or the plan name has changed since the last return/report filed for this plan, 4b EIN012345678\nenter the plan sponsor\u2019s name, EIN, the plan name and the plan number from the last return/report:\na Sponsor\u2019s name 4d PN\nc Plan Name 012\n5 Total number of participants at the beginning of the plan year 5 12345678596071162\n6 Number of participants as of the end of the plan year unless otherwise stated (welfare plans complete only lines 6a(1),\n6a(2), 6b, 6c, and 6d).\na(1) Total number of active participants at the beginning of the plan year ............................................................................ 6a(1) 8876\na(2) Total number of active participants at the end of the plan year ..................................................................................... 6a(2) 7790\nb Retired or separated participants receiving benefits ....................................................................................................... 6b 12345678195061572\nc Other retired or separated participants entitled to future benefits ................................................................................... 6c 12345678295081782\nd Subtotal. Add lines 6a(2), 6b, and 6c. ............................................................................................................................ 6d 12345678499031252\ne Deceased participants whose beneficiaries are receiving or are entitled to receive benefits. ......................................... 6e 1234567893031412\nf Total. Add lines 6d and 6e. ........................................................................................................................................... 6f 12345678592061662\ng(1) Number of participants with account balances as of the beginning of the plan year (only defined contribution plans 6g(1)\ncomplete this item) .........................................................................................................................................................\ng(2) N\nco\nu\nm\nm\np\nb\nl\ne\net\nr\ne\no\nt\nf\nh\np\nis\na r\nit\nti\ne\nc\nm\nip\n)\na\n.\nn\n..\nt\n.\ns\n. .\nw\n...\ni\n.\nt\n.\nh\n.. .\na\n..\nc\n.\nc\n..\no\n..\nu\n..\nn\n..\nt\n. .\nb\n..\na\n..\nl\n.\na\n..\nn\n.\nc\n..\ne\n..\ns\n.. .\na\n..\ns\n.. .\no\n..\nf\n.\nt\n.\nh\n..\ne\n.. .\ne\n..\nn\n..\nd\n.. .\no\n..\nf\n. .\nt\n.\nh\n..\ne\n.. .\np\n..\nl\n.\na\n..\nn\n. .\ny\n..\ne\n..\na\n..\nr\n. .\n(\n.\no\n..\nn\n..\nl\n.\ny\n.. .\nd\n..\ne\n..\nf\n.\ni\n.\nn\n.\ne\n..\nd\n.. .\nc\n..\no\n..\nn\n..\nt\n.\nr\n.\ni\n.\nb\n..\nu\n..\nt\n.\ni\n.\no\n..\nn\n. .\np\n..\nl\n.\na\n..\nn\n..\ns\n.. . ............... 6g(2) 123456789012\nh N le u s m s t b h e a r n o 1 f 0 p 0 a % rti c v ip es a t n e t d s . w ... h .. o .. . t . e .. r . m ... i . n .. a .. t . e . d .. . e .. m ... p .. l . o .. y .. m ... e .. n . t . . d .. u .. r .. in .. g .. . t . h .. e .. . p .. l . a .. n .. . y . e .. a .. r . . w ... i . t . h .. . a .. c . c .. r . u .. e .. d .. . b .. e .. n .. e .. f . i . t . s . . t . h .. a .. t . . w ... e .. r . e .. . .................... 6h 1234567890152\n7 Enter the total number of employers obligated to contribute to the plan (only multiemployer plans complete this item) ........ 7\n8a If the plan provides pension benefits, enter the applicable pension feature codes from the List of Plan Characteristics Codes in the instructions:\n1A 3F\nb If the plan provides welfare benefits, enter the applicable welfare feature codes from the List of Plan Characteristics Codes in the instructions:\n9a Plan funding arrangement (check all that apply) 9b Plan benefit arrangement (check all that apply)\n(1) XX Insurance (1) XX Insurance\n(2) X Code section 412(e)(3) insurance contracts (2) X Code section 412(e)(3) insurance contracts\n(3) XX Trust (3) XX Trust\n(4) X General assets of the sponsor (4) X General assets of the sponsor\n10 Check all applicable boxes in 10a and 10b to indicate which schedules are attached, and, where indicated, enter the number attached. (See instructions)\na Pension Schedules b General Schedules\n(1) XX R (Retirement Plan Information) (1) XX H (Financial Information)\n(2) X I (Financial Information \u2013 Small Plan)\n(2) X MB (Multiemployer Defined Benefit Plan and Certain Money\nPurchase Plan Actuarial Information) - signed by the plan (3) X A (Insurance Information) \u2013 Number Attached ___ 0 ___\nactuary (4) XX C (Service Provider Information)\n(3) XX SB (Single-Employer Defined Benefit Plan Actuarial (5) XX D (DFE/Participating Plan Information)\nInformation) - signed by the plan actuary\n(4) X DCG (Individual Plan Information) \u2013 Number Attached ______ (6) XX G (Financial Transaction Schedules)\n(5) X MEP (Multiple-Employer Retirement Plan Information)\n\nForm 5500 (2024) Page 3\nPart III Form M-1 Compliance Information (to be completed by welfare benefit plans)\n11a If the plan provides welfare benefits, was the plan subject to the Form M-1 filing requirements during the plan year? (See instructions and 29 CFR\n2520.101-2.) ........................\u2026\u2026\u2026..\u2026. X Yes X No\nIf \u201cYes\u201d is checked, complete lines 11b and 11c.\n11b Is the plan currently in compliance with the Form M-1 filing requirements? (See instructions and 29 CFR 2520.101-2.) \u2026\u2026..... X Yes X No\n11c Enter the Receipt Confirmation Code for the 2024 Form M-1 annual report. If the plan was not required to file the 2024 Form M-1 annual report, enter the\nReceipt Confirmation Code for the most recent Form M-1 that was required to be filed under the Form M-1 filing requirements. (Failure to enter a valid\nReceipt Confirmation Code will subject the Form 5500 filing to rejection as incomplete.)\nReceipt Confirmation Code______________________",
    "char_count": 9892
  },
  {
    "chunk_id": "PFIZER_135315170_001_2024_SCHEDULE_SB",
    "schedule_type": "SCHEDULE_SB",
    "page_range": "4-6",
    "page_count": 3,
    "raw_text": "SCHEDULE SB Single-Employer Defined Benefit Plan OMB No. 1210-0110\n(Form 5500) Actuarial Information\n2024\nDepartment of the Treasury\nInternal Revenue Service\nThis schedule is required to be filed under section 104 of the Employee\nDepartment of Labor Retirement Income Security Act of 1974 (ERISA) and section 6059 of the This Form is Open to Public\nEmployee Benefits Security Administration\nInternal Revenue Code (the Code). Inspection\nPension Benefit Guaranty Corporation\n\uf034 File as an attachment to Form 5500 or 5500-SF.\nFor calendar plan year 2024 or fiscal plan year beginning 0 1 / 0 1 / 2 0 2 4 and ending 1 2 / 3 1 / 2 0 2 4\n\uf034\nRound off amounts to nearest dollar.\n\uf034\nCaution: A penalty of $1,000 will be assessed for late filing of this report unless reasonable cause is established.\nA Name of plan B Three-digit\nABC P D F E IZ F E G R H C I O N A S B O C L D ID E A F T G E H D I P E A N B S C IO D N E P F L G A H N I ABCDEFGHI ABCDEFGHI plan number (PN) \uf034 001 001\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\nC Plan sponsor\u2019s name as shown on line 2a of Form 5500 or 5500-SF D Employer Identification Number (EIN)\nP\nA\nF\nB\nIZ\nC\nE\nD\nR\nE\nIN\nF\nC\nGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI 0123456\n1\n7\n3\n8\n-5 315170\nABCDEFGHI ABCDEFGHI\nE Type of plan: XX Single X Multiple-A X Multiple-B F Prior year plan size: X 100 or fewer X 101-500 XX More than 500\nPart I Basic Information\n1 Enter the valuation date: Month ___0_1_____ Day __0_1______ Year _2_0_2_4_____\n2 Assets:\na Market value ..................................................................................................................................................... 2a -12345610798595206122613845\nb Actuarial value .................................................................................................................................................. 2b -12345612708590708182873945\n3 Funding target/participant count breakdown (1) Number of (2) Vested Funding (3) Total Funding\nparticipants Target Target\na For retired participants and beneficiaries receiving payment .................................... . 20331 4023825707 4023825707\nb For terminated vested participants............................................................................ 28932 3511103183 3511103183\nc For active participants .............................................................................................. 8930 2342923284 2530634025\nd Total ......................................................................................................................... 58193 9877852174 10065562915\n4 If the plan is in at-risk status, check the box and complete lines (a) and (b)............................. X\na Funding target disregarding prescribed at-risk assumptions ............................................................................... 4a -123456789012345\nb Funding target reflecting at-risk assumptions, but disregarding transition rule for plans that have been in\n4b -123456789012345\nat-risk status for fewer than five consecutive years and disregarding loading factor ............................................\n5 Effective interest rate ............................................................................................................................................. 5 1235..1132%\n6 Target normal cost\na Present value of current plan year accruals ........................................................................................................ 6a 0\nb Expected plan-related expenses ........................................................................................................................ 6b 17150000\nc Target normal cost.............................................................................................................................................. 6c 17150000\nStatement by Enrolled Actuary\nTo the best of my knowledge, the information supplied in this schedule and accompanying schedules, statements and attachments, if any, is complete and accurate. Each prescribed assumption was applied in\naccordance with applicable law and regulations. In my opinion, each other assumption is reasonable (taking into account the experience of the plan and reasonable expectations) and such other assumptions, in\ncombination, offer my best estimate of anticipated experience under the plan.\nSIGN\nHERE 07/31/2025\nSignature of actuary Date\nABCMDAETFTHGEHWI FAISBHCEDLEFGHI ABCDEFGHI ABCDE 23-08172 YYYY-MM-DD\nType or print name of actuary Most recent enrollment number\nABCMDEERFCGEHRI ABCDEFGHI ABCDEFGHI ABCDE 215-982-4212 1234567\nFirm name Telephone number (including area code)\n12330 4S5O6U7T8H9 1 7TAHB CSTDREEFEGTH, I19 TAHB FCLDOEOFRG HI ABCDE 1234567890\n12P3H4IL5A6D7E8LP9H IAAB, PCAD 1E9F1G03HI ABCDEFGHI ABCDE\nUK\nAddress of the firm\nIf the actuary has not fully reflected any regulation or ruling promulgated under the statute in completing this schedule, check the box and see instructions X\nFor Paperwork Reduction Act Notice, see the Instructions for Form 5500 or 5500-SF. Schedule SB (Form 5500) 2024\nv. 240311\n\nSchedule SB (Form 5500) 2024 Page 2 - 1-1 x\nPart II Beginning of Year Carryover and Prefunding Balances\n(a) Carryover balance (b) Prefunding balance\n7 Balance at beginning of prior year after applicable adjustments (line 13 from prior -123456789012345 -123456789012345\nyear) ............................................................................................................................ 0 2198763802\n8 Portion elected for use to offset prior year\u2019s funding requirement (line 35 from prior\nyear) ..........................................................................................................................\n-123456789012345 -123456710889403513273945\n9 Amount remaining (line 7 minus line 8) ........................................................................ -1234567890120345 -1234562709809302814223345\n10 Interest on line 9 using prior year\u2019s actual return of 1 1 . 0 7 % ................................. -1234567890120345 -123456723819309913253645\n11 Prior year\u2019s excess contributions to be added to prefunding balance:\na Present value of excess contributions (line 38a from prior year) ............................... -1234567890123045\nb(1) Interest on the excess, if any, of line 38a over line 38b from prior year\nSchedule SB, using prior year's effective interest rate of 5 . 0 5 % .............\n-1234567890123045\nb(2) Interest on line 38b from prior year Schedule SB, using prior year's actual\nreturn ................................................................................................................. 0\nc Total available at beginning of current plan year to add to prefunding balance ................ 0\nd Portion of (c) to be added to prefunding balance ...................................................... -1234567890123 0 45\n-123456789012345\n12 Other reductions in balances due to elections or deemed elections ............................. -1234567890120345 -1234567890123045\n13 Balance at beginning of current year (line 9 + line 10 + line 11d \u2013 line 12) ................... -1234567890120345 -1234562732819702717273945\nPart III Funding Percentages\n14 Funding target attainment percentage ..................................................................................................................................................................... 14 12396..1652%\n15 Adjusted funding target attainment percentage ...................................................................................................................................... 15 121318..1632%\n16 Prior year\u2019s funding percentage for purposes of determining whether carryover/prefunding balances may be used to reduce current\nyear\u2019s funding requirement .....................................................................................................................................................................\n16 12391..1282%\n17 If the current value of the assets of the plan is less than 70 percent of the funding target, enter such percentage. ................................. 17 123.12%\nPart IV Contributions and Liquidity Shortfalls\n18 Contributions made to the plan for the plan year by employer(s) and employees:\n(a) Date (b) Amount paid by (c) Amount paid by (a) Date (b) Amount paid by (c) Amount paid by\n(MM-DD-YYYY) employer(s) employees (MM-DD-YYYY) employer(s) employees\nYYYY-MM-DD 12345678901234 12345678901234 YYYY-MM-DD 12345678901234 123456789012345-\n5 5 5- 123456789012345\nYYYY-MM-DD 12345678901234 12345678901234 YYYY-MM-DD 12345678901234 123456789012345-\nYYYY-MM-DD 1234567\n5\n8 901234 1234567\n5\n8 901234 YYYY- MM-DD\n1\n1\n2\n2\n3\n3\n4\n4\n5\n5\n6\n6\n7\n7\n8\n8\n9\n9\n0\n0\n1\n1\n2\n2\n3\n3\n54\n4\n5\n- -\n-\n1\n1\n1\n1\n2\n2\n2\n2\n3\n3\n3\n3\n4\n4\n4\n4\n5\n5\n5\n5\n6\n6\n6\n6\n7\n7\n7\n7\n8\n8\n8\n8\n9\n9\n9\n9\n0\n0\n0\n0\n1\n1\n1\n1\n2\n2\n2\n2\n3\n3\n3\n3\n4\n4\n4\n4\n5\n5\n5\n5\n-\nYYYY-MM-DD 1234567\n5\n8 901234 1234567\n5\n8 901234 YYYY- MM-DD\n1\n1\n2\n2\n3\n3\n4\n4\n5\n5\n6\n6\n7\n7\n8\n8\n9\n9\n0\n0\n1\n1\n2\n2\n3\n3\n54\n4-5\n-\n-\n-\n- 11\n1\n1\n1\n22\n2\n2\n2\n33\n3\n3\n3\n44\n4\n4\n4\n55\n5\n5\n5\n66\n6\n6\n6\n77\n7\n7\n7\n88\n8\n8\n8\n99\n9\n9\n9\n00\n0\n0\n0\n11\n1\n1\n1\n22\n2\n2\n2\n33\n3\n3\n3\n44\n4\n4\n4\n55\n5\n5\n5\n-\nYYYY-MM-DD 1234567 5 8 901234 1234567 5 8 901234 1 1 2 2 3 3 4 4 5 5 6 6 7 7 8 8 9 9 0 0 1 1 2 2 3 354 4 -5 - - - - - 1 1 1 1 12 2 2 2 23 3 3 3 34 4 4 4 45 5 5 5 56 6 6 6 67 7 7 7 7 8 8 8 8 89 9 9 9 90 0 0 0 01 1 1 1 12 2 2 2 23 3 3 3 34 4 4 4 45 5 5 5 5\n5 5\nTotals \u25ba 18(b)\n1 1 2 2 3 3 4 4 5 5 6 6 7 7 8 8 9 9 0 0 1 1 2 2 3 3 4 45\n-5 -5 0\n1--\n-\n- -8(11\n1\n1 1c22\n2\n2\n2)\n33\n3\n3\n3\n44\n4\n4\n4\n55\n5\n5\n5\n66\n6\n6\n6\n77\n7\n7\n7\n88\n8\n8\n8\n99\n9\n9\n9\n00\n0\n0\n0\n11\n1\n1\n1\n22\n2\n2\n2\n33\n3\n3\n3\n44\n4\n4\n4\n55\n5\n5\n50\n19 Discounted employer contributio ns \u2013 see instructions for small plan with a valuation date after the be1\n1\ng2\n2\nin3\n3\nn4\n4\nin5\n5\ng 6\n6\nof7\n7\nt8\n8\nhe9\n9\ny0\n0\ne1\n1\na2\n2\nr: 3\n3\n4\n4\n-5 -\n-- -11 122 233 344 455 566\n6\n77 788 899 900 011 122 233 344 455\n5\na\nb\nC\nC\no\no\nn\nn\nt\nt\nr\nr\ni\ni\nb\nb\nu\nu\nt\nt\ni\ni\no\no\nn\nn\ns\ns\na\nm\nll\na\no\nd\nc\ne\na t\nt\ne\no\nd\na\nt\nv\no\no\nw\nid\na r\nr\nd\ne s\nu\nt\nn\nri\np\nc\na\nti\ni\no\nd\nn\nm\ns\ni\na\nn\nd\nim\nju\nu\ns\nm\nte d\nre\nt\nq\no\nu\nv\nir\na\ne\nlu\nd\na\nc\nti\no\no\nn\nn\nt r\nd\nib\na\nu\nte\nti\n.\no\n.\nn\n..\ns\n.. .\nf\n.\nr\n.\no\n..\nm\n... .\np\n..\nr\n.\ni\n.\no\n..\nr\n. .\ny\n..\ne\n..\na\n.\nr\n..\ns\n.\n.\n. .\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n.\n1\n1\n1\n1\n.\n.\n.\n.\n2\n2\n2\n2\n.\n.\n.\n.\n.\n.\n3\n3\n3\n3\n.\n.\n.\n.\n.\n.\n4\n4\n4\n4\n.\n.\n.\n.\n5\n5\n5\n5\n.\n.\n.\n.\n.\n.\n6\n6\n6\n6\n.\n.\n.\n.\n.\n.\n7\n7\n7\n7 .\n..\n.\n8\n8\n8\n8\n.\n.\n.\n.\n.\n.\n9\n9\n9\n9\n.\n.\n0\n0\n0\n0\n1\n1\n9 1\n1\n1\n1 9\nb\na\n2\n2\n2\n2\n3\n3\n3\n3\n4\n4\n4\n45\n- 5\n-5\n-\n--\n-\n-\n-\n11\n1\n1\n1\n22\n2\n2\n2\n33\n3\n3\n3\n44\n4\n4\n4\n55\n5\n5\n5\n66\n6\n6\n6\n77\n7\n7\n7\n88\n8\n8\n8\n99\n9\n9\n9\n00\n0\n0\n0\n11\n1\n1\n1\n22\n2\n2\n2\n33\n3\n3\n3\n0\n0\n44\n4\n4\n4\n55\n5\n5\n5\n-\nc Contributions allocated toward minimum required contribution for current year adjusted to valuation date\n1\n1.\n2\n2...\n3\n3...\n4\n4..\n5\n5...\n6\n6...\n7\n7..\n8\n8...\n9\n9.\n0\n01\n1\n19c\n2\n2\n3\n3\n4\n45 5 -1234567890123045\n-\n20 Quarterly contributions and liquidity shortfalls: 12345678901234 - 5 5\na Did the plan have a \u201cfunding shortfall\u201d for the prior year? ............................................................... 1 1 .. 2 2 ... 3 3 ... 4 4 .. 5 5 ... 6 6 ... 7 7 .. 8 8 ... 9 9 ... 0 0 .. 1 1 ... 2 2 .. 3 3 ... 4 45 - 5 - ... ...................... XX Yes X No\nb If line 20a is \u201cYes,\u201d were required quarterly installments for the current year made in a timely man 1 ne 2 r 3 ?. 4 .. 5 ... 6 ... 7 .. 8 ... 9 ... 0 .. 1 ... 2 .. 3 ... 4 -\n5\n- 5... ...................... XX Yes X No\nc If line 20a is \u201cYes,\u201d see instructions and complete the following table as applicable: 1 1 2 2 3 3 4 4 5 5 6 6 7 7 8 8 9 9 0 0 1 1 2 2 3 3 4 4 - -\n5\nLiquidity shortfall as of end of quarter of this plan ye1\n1\nar2\n2\n3\n3\n4\n4\n5\n5\n6\n6\n7\n7\n8\n8\n9\n9\n0\n0\n1\n1\n2\n2\n3\n3\n4\n45\n-\n5\n(1) 1st (2) 2nd (3) 3r1d 2345678901234 5 - (4) 4th\n0 -1234567890012345 -1234567890012345 5 -1234567890012345\n12345678901234\n5\n-123456789012345\n\nSchedule SB (Form 5500) 2024 Page 3\nPart V Assumptions Used to Determine Funding Target and Target Normal Cost\n21 Discount rate:\na Segment rates: 1 1s 2 t 3 s . eg 1 m 2 e _ n % t: 1 2n 2 d 3 s . e 1 gm 2 e _ n % t: 1 3r 2 d 3 s . eg 1 m 2 e n % t: XX N/A, full yield curve used\nb Applicable month (enter code) ........................................................................................................................ 21b 1\n22 Weighted average retirement age ......................................................................................................................... 22 61 12\n23 Mortality table(s) (see instructions) _ Prescribed - combined _ X Prescribed - separate _ Substitute\nPart VI Miscellaneous Items\n24 Has a change been made in the non-prescribed actuarial assumptions for the current plan year? If \u201cYes,\u201d see instructions regarding required\nattachment. ................................................................................................................................................................................................... XX Yes X No\n25 Has a method change been made for the current plan year? If \u201cYes,\u201d see instructions regarding required attachment. ................................ X Yes XX No\n26 Demographic and benefit information\na Is the plan required to provide a Schedule of Active Participants? If \u201cYes,\u201d see instructions regarding required attachment. ............... XX Yes X No\nb Is the plan required to provide a projection of expected benefit payments? If \u201cYes,\u201d see instructions regarding required attachment ... XX Yes X No\n27 If the plan is subject to alternative funding rules, enter applicable code and see instructions regarding\n27\nattachment ..........................................................................................................................................................\nPart VII Reconciliation of Unpaid Minimum Required Contributions For Prior Years\n28 Unpaid minimum required contributions for all prior years ................................................................................... 28 -1234567890120345\n29 Discounted employer contributions allocated toward unpaid minimum required contributions from prior years\n29 -1234567890120345\n(line 19a) .............................................................................................................................................................\n30 Remaining amount of unpaid minimum required contributions (line 28 minus line 29) ........................................... 30 -1234567890120345\nPart VIII Minimum Required Contribution For Current Year\n31 Target normal cost and excess assets (see instructions):\na Target normal cost (line 6c) ............................................................................................................................. 31a -12345671879150010200345\nb Excess assets, if applicable, but not greater than line 31a ................................................................................ 31b 0\n32 Amortization installments: Outstanding Balance Installment\na Net shortfall amortization installment ............................................................................ -123456783936051021831455 -12345673849800715288345\nb Waiver amortization installment .................................................................................... -1234567890123405 -1234567890120345\n33 If a waiver has been approved for this plan year, enter the date of the ruling letter granting the approval\n33\n(Month _________ Day _________ Year _________ )_and the waived amount ............................................ -123456789012345\n34 Total funding requirement before reflecting carryover/prefunding balances (lines 31a - 31b + 32a + 32b - 33)..... 34 -12345675819950715288345\nCarryover balance Prefunding balance Total balance\n35 Balances elected for use to offset funding\n0 51957588 51957588\nrequirement .............................................................. -123456789012345 -123456789012345 -123456789012345\n36 Additional cash requirement (line 34 minus line 35) ............................................................................................ 36 -1234567890120345\n37 Contributions allocated toward minimum required contribution for current year adjusted to valuation date (line 37 -1234567890120345\n19c) ......................................................................................................................................................................\n38 Present value of excess contributions for current year (see instructions)\na Total (excess, if any, of line 37 over line 36) 38a\n-123456789012\n0\n345\nb Portion included in line 38a attributable to use of prefunding and funding standard carryover balances ............. 38b 0\n39 Unpaid minimum required contribution for current year (excess, if any, of line 36 over line 37) ........................... 39 -1234567890120345\n40 Unpaid minimum required contributions for all years ............................................................................................. 40 -1234567890120345\nPart IX Pension Funding Relief Under the American Rescue Plan Act of 2021 (See Instructions)\n41 If an election was made to use the extended amortization rule for a plan year beginning on or before December 31, 2021, check the box to indicate the first\nplan year for which the rule applies. X 2019 X 2020 XX 2021",
    "char_count": 17243
  },
  {
    "chunk_id": "PFIZER_135315170_001_2024_SCHEDULE_C",
    "schedule_type": "SCHEDULE_C",
    "page_range": "7-12",
    "page_count": 6,
    "raw_text": "SCHEDULE C Service Provider Information OMB No. 1210-0110\n(Form 5500)\n2024\nDepartment of the Treasury This schedule is required to be filed under section 104 of the Employee\nInternal Revenue Service Retirement Income Security Act of 1974 (ERISA).\nEmployee B D e e n p e a f r it t s m S en e t c u o r f it L y a A bo d r m inistration \uf034 File as an attachment to Form 5500. This Form is Open to Public\nInspection.\nPension Benefit Guaranty Corporation\nFor calendar plan year 2024 or fiscal plan year beginning 0 1 / 0 1 / 2 0 2 4 and ending 1 2 / 3 1 / 2 0 2 4\nA Name of plan B Three-digit\nA P B F C IZ D E E R F C G O H N I S O LIDATED PENSION PLAN plan number (PN) \uf034 000011\nC Plan sponsor\u2019s name as shown on line 2a of Form 5500 D Employer Identification Number (EIN)\nABCDEFGHI 012345678\nPFIZER INC 13-5315170\nPart I Service Provider Information (see instructions)\nYou must complete this Part, in accordance with the instructions, to report the information required for each person who received, directly or indirectly,\n$5,000 or more in total compensation (i.e., money or anything else of monetary value) in connection with services rendered to the plan or the person's\nposition with the plan during the plan year. If a person received only eligible indirect compensation for which the plan received the required disclosures,\nyou are required to answer line 1 but are not required to include that person when completing the remainder of this Part.\n1 Information on Persons Receiving Only Eligible Indirect Compensation\na Check \"Yes\" or \"No\" to indicate whether you are excluding a person from the remainder of this Part because they received only eligible\nindirect compensation for which the plan received the required disclosures (see instructions for definitions and conditions).. . . . . . . . . . . . . . . X Yes XX\nNo\nb If you answered line 1a \u201cYes,\u201d enter the name and EIN or address of each person providing the required disclosures for the service providers who\nreceived only eligible indirect compensation. Complete as many entries as needed (see instructions).\n(b) Enter name and EIN or address of person who provided you disclosures on eligible indirect compensation\n(b) Enter name and EIN or address of person who provided you disclosures on eligible indirect compensation\n(b) Enter name and EIN or address of person who provided you disclosures on eligible indirect compensation\n(b) Enter name and EIN or address of person who provided you disclosures on eligible indirect compensation\nFor Paperwork Reduction Act Notice, see the Instructions for Form 5500. Schedule C (Form 5500) 2024\nv. 240311\n\nSchedule C (Form 5500) 2024 Page 2- 1 1 x\n(b) Enter name and EIN or address of person who provided you disclosures on eligible indirect compensation\n(b) Enter name and EIN or address of person who provided you disclosures on eligible indirect compensation\n(b) Enter name and EIN or address of person who provided you disclosures on eligible indirect compensation\n(b) Enter name and EIN or address of person who provided you disclosures on eligible indirect compensation\n(b) Enter name and EIN or address of person who provided you disclosures on eligible indirect compensation\n(b) Enter name and EIN or address of person who provided you disclosures on eligible indirect compensation\n(b) Enter name and EIN or address of person who provided you disclosures on eligible indirect compensation\n(b) Enter name and EIN or address of person who provided you disclosures on eligible indirect compensation\n\nSchedule C (Form 5500) 2024 Page 3 - 1 1 x\n2. Information on Other Service Providers Receiving Direct or Indirect Compensation. Except for those persons for whom you\nanswered \u201cYes\u201d to line 1a above, complete as many entries as needed to list each person receiving, directly or indirectly, $5,000 or more in total compensation\n(i.e., money or anything else of value) in connection with services rendered to the plan or their position with the plan during the plan year. (See instructions).\n(a) Enter name and EIN or address (see instructions)\n(b) (c) (d) (e) (f) (g) (h)\nService Relationship to Enter direct Did service provider Did indirect compensation Enter total indirect Did the service\nCode(s) employer, employee compensation paid receive indirect include eligible indirect compensation received by provider give you a\norganization, or by the plan. If none, compensation? (sources compensation, for which the service provider excluding formula instead of\nperson known to be enter -0-. other than plan or plan plan received the required eligible indirect an amount or\na party-in-interest sponsor) disclosures? compensation for which you estimated amount?\nanswered \u201cYes\u201d to element\n(f). If none, enter -0-.\nABCDEFGHI 123456789012 123456789012345\nABCDEFGHI 345 Yes X No X Yes X No X Yes X No X\nABCD\n(a) Enter name and EIN or address (see instructions)\n(b) (c) (d) (e) (f) (g) (h)\nService Relationship to Enter direct Did service provider Did indirect compensation Enter total indirect Did the service\nCode(s) employer, employee compensation paid receive indirect include eligible indirect compensation received by provider give you a\norganization, or by the plan. If none, compensation? (sources compensation, for which the service provider excluding formula instead of\nperson known to be enter -0-. other than plan or plan plan received the required eligible indirect an amount or\na party-in-interest sponsor) disclosures? compensation for which you estimated amount?\nanswered \u201cYes\u201d to element\n(f). If none, enter -0-.\nABCDEFGHI 123456789012 123456789012345\nABCDEFGHI 345 Yes X No X Yes X No X Yes X No X\nABCD\n(a) Enter name and EIN or address (see instructions)\n(b) (c) (d) (e) (f) (g) (h)\nService Relationship to Enter direct Did service provider Did indirect compensation Enter total indirect Did the service\nCode(s) employer, employee compensation paid receive indirect include eligible indirect compensation received by provider give you a\norganization, or by the plan. If none, compensation? (sources compensation, for which the service provider excluding formula instead of\nperson known to be enter -0-. other than plan or plan plan received the required eligible indirect an amount or\na party-in-interest sponsor) disclosures? compensation for which you estimated amount?\nanswered \u201cYes\u201d to element\n(f). If none, enter -0-.\nABCDEFGHI 123456789012\nABCDEFGHI 345 Yes X No X Yes X No X Yes X No X\nABCD\n\nSchedule C (Form 5500) 2024 Page 4 - 1 1 x\nPart I Service Provider Information (continued)\n3. If you reported on line 2 receipt of indirect compensation, other than eligible indirect compensation, by a service provider, and the service provider is a fiduciary\nor provides contract administrator, consulting, custodial, investment advisory, investment management, broker, or recordkeeping services, answer the following\nquestions for (a) each source from whom the service provider received $1,000 or more in indirect compensation and (b) each source for whom the service\nprovider gave you a formula used to determine the indirect compensation instead of an amount or estimated amount of the indirect compensation. Complete as\nmany entries as needed to report the required information for each source.\n(a) Enter service provider name as it appears on line 2 (b) Service Codes (c) Enter amount of indirect\n(see instructions) compensation\n(d) Enter name and EIN (address) of source of indirect compensation (e) Describe the indirect compensation, including any\nformula used to determine the service provider\u2019s eligibility\nfor or the amount of the indirect compensation.\n(a) Enter service provider name as it appears on line 2 (b) Service Codes (c) Enter amount of indirect\n(see instructions) compensation\n(d) Enter name and EIN (address) of source of indirect compensation (e) Describe the indirect compensation, including any\nformula used to determine the service provider\u2019s eligibility\nfor or the amount of the indirect compensation.\n(a) Enter service provider name as it appears on line 2 (b) Service Codes (c) Enter amount of indirect\n(see instructions) compensation\n(d) Enter name and EIN (address) of source of indirect compensation (e) Describe the indirect compensation, including any\nformula used to determine the service provider\u2019s eligibility\nfor or the amount of the indirect compensation.\n\nSchedule C (Form 5500) 2024 Page 5 - 1 1 x\nPart II Service Providers Who Fail or Refuse to Provide Information\n4 Provide, to the extent possible, the following information for each service provider who failed or refused to provide the information necessary to complete\nthis Schedule.\n(a) Enter name and EIN or address of service provider (see (b) Nature of (c) Describe the information that the service provider failed or refused to\ninstructions) Service provide\nCode(s)\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD 10 11 ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDE\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD 12 13 ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDE\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDE\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDE\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDE\n1234567890 ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDE\n(a) Enter name and EIN or address of service provider (see (b) Nature of (c) Describe the information that the service provider failed or refused to\ninstructions) Service provide\nCode(s)\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD 10 11 ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDE\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD 12 13 ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDE\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDE\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDE\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDE\n1234567890 ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDE\n(a) Enter name and EIN or address of service provider (see (b) Nature of (c) Describe the information that the service provider failed or refused to\ninstructions) Service provide\nCode(s)\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD 10 11 12 ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDE\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD 13 ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDE\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDE\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDE\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDE\n1234567890 ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDE\n(a) Enter name and EIN or address of service provider (see (b) Nature of (c) Describe the information that the service provider failed or refused to\ninstructions) Service provide\nCode(s)\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD 10 11 12 ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDE\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD 13 ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDE\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDE\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDE\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDE\n1234567890 ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDE\n(a) Enter name and EIN or address of service provider (see (b) Nature of (c) Describe the information that the service provider failed or refused to\ninstructions) Service provide\nCode(s)\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD 10 11 12 ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDE\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD 13 ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDE\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDE\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDE\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDE\n1234567890 ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDE\n(a) Enter name and EIN or address of service provider (see (b) Nature of (c) Describe the information that the service provider failed or refused to\ninstructions) Service provide\nCode(s)\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDE\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDE\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDE\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDE\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDE\n1234567890 ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDE\n\nSchedule C (Form 5500) 2024 Page 6 - 1 1 x\nPart III Termination Information on Accountants and Enrolled Actuaries (see instructions)\n(complete as many entries as needed)\na Name: ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD b EIN: 123456789\nc Position: ABCDEFGHI ABCDEFGHI ABCD\nd Address: ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD e Telephone: 1234567890\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD\nExplanation:\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\nABCDEFGHI\na Name: ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD b EIN: 123456789\nc Position: ABCDEFGHI ABCDEFGHI ABCD\nd Address: ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD e Telephone: 1234567890\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD\nExplanation:\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\nABCDEFGHI\na Name: ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD b EIN: 123456789\nc Position: ABCDEFGHI ABCDEFGHI ABCD\nd Address: ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD e Telephone: 1234567890\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD\nExplanation:\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\nABCDEFGHI\na Name: ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD b EIN: 123456789\nc Position: ABCDEFGHI ABCDEFGHI ABCD\nd Address: ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD e Telephone: 1234567890\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD\nExplanation:\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\nABCDEFGHI\na Name: ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD b EIN: 123456789\nc Position: ABCDEFGHI ABCDEFGHI ABCD\nd Address: ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD e Telephone: 1234567890\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD\nExplanation:\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\nABCDEFGHI",
    "char_count": 15043
  },
  {
    "chunk_id": "PFIZER_135315170_001_2024_SCHEDULE_D",
    "schedule_type": "SCHEDULE_D",
    "page_range": "13-15",
    "page_count": 3,
    "raw_text": "SCHEDULE D DFE/Participating Plan Information\nOMB No. 1210-0110\n(Form 5500)\nThis schedule is required to be filed under section 104 of the Employee\nDepartment of the Treasury 2024\nInternal Revenue Service Retirement Income Security Act of 1974 (ERISA).\nDepartment of Labor \uf034 File as an attachment to Form 5500.\nEmployee Benefits Security Administration\nThis Form is Open to Public\nInspection.\nFor calendar plan year 2024 or fiscal plan year beginning 0 1 / 0 1 / 2 0 2 4 and ending 1 2 / 3 1 / 2 0 2 4\nA Name of plan B Three-digit\nAPBFCIZDEERF CGOHNIS OALBIDCADTEEFDG PHEIN SAIOBNC DPLEAFNGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI plan number (PN) \uf034 001 001\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\nABCDEFGHI ABCDEFGHI\nC Plan or DFE sponsor\u2019s name as shown on line 2a of Form 5500 D Employer Identification Number (EIN)\nAPBFCIZDEERF IGNHCI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI 01132-5334155167078\nABCDEFGHI\nPart I Information on interests in MTIAs, CCTs, PSAs, and 103-12 IEs (to be completed by plans and DFEs)\n(Complete as many entries as needed to report all interests in DFEs)\na Name of MTIA, CCT, PSA, or 103-12 IE: MASTERA BTCRDUESTF GBTHWI NA PBFCIZDEERF &G NHOIR TAHBECRDNEFGHI ABCD\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\nb Name of sponsor of entity listed in (a): PFIZER A I B NC CDEFGHI\nc EIN-PN 1123-3640654617128-900-1123 d E\nc\nn\no\nt\nd\nit\ne\ny 1M e D\n1\no\n0\nl\n3\nla\n-1\nr\n2\nv a\nIE\nlu e\na t\no\ne\nf\nn\nin\nd\nt e\no\nr\nf\ne\ny\ns\ne\nt\na\nin\nr (\nM\nse\nT\ne\nIA\ni\n,\nn s\nC\nt\nC\nru\nT\nc\n,\nt i\nP\non\nS\ns\nA\n)\n, or -1239743536377680950012345\na Name of MTIA, CCT, PSA, or 103-12 IE: EQUITYA IBNCDEDXE FAG FHUIN DABCDEFGHI ABCDEFGHI ABCD\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\nb Name of sponsor of entity listed in (a): BLACKR A O B C C K D E IN F S G T H IT I U TIONAL TRUST CO NA\nc EIN-PN 1924-3640552627858-900-1123 d E\nc\nn\no\nt\nd\nit\ne\ny 1C e D\n10\no\n3\nlla\n-1\nr\n2\nv a\nIE\nlu e\na t\no\ne\nf\nn\nin\nd\nt e\no\nr\nf\ne\ny\ns\ne\nt\na\nin\nr (\nM\nse\nT\ne\nIA\nin\n,\ns\nC\ntr\nC\nu\nT\nc\n,\nt io\nP\nn\nS\ns\nA\n)\n, or -12347556467184923012345\na Name of MTIA, CCT, PSA, or 103-12 IE: ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\nb Name of sponsor of entity listed in (a): ABCDEFGHI\nc EIN-PN 123456789-123 d E\nc\nn\no\nt\nd\nit\ne\ny 1 e D\n10\no\n3\nlla\n-1\nr\n2\nv a\nIE\nlu e\na t\no\ne\nf\nn\nin\nd\nt e\no\nr\nf\ne\ny\ns\ne\nt\na\nin\nr (\nM\nse\nT\ne\nIA\nin\n,\ns\nC\ntr\nC\nu\nT\nc\n,\nt io\nP\nn\nS\ns\nA\n)\n, or -123456789012345\na Name of MTIA, CCT, PSA, or 103-12 IE: ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\nb Name of sponsor of entity listed in (a): ABCDEFGHI\nc EIN-PN 123456789-123 d E\nc\nn\no\nt\nd\nit\ne\ny 1 e D\n10\no\n3\nlla\n-1\nr\n2\nv a\nIE\nlu e\na t\no\ne\nf\nn\nin\nd\nt e\no\nr\nf\ne\ny\ns\ne\nt\na\nin\nr (\nM\nse\nT\ne\nIA\nin\n,\ns\nC\ntr\nC\nu\nT\nc\n,\nt io\nP\nn\nS\ns\nA\n)\n, or -123456789012345\na Name of MTIA, CCT, PSA, or 103-12 IE: ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\nb Name of sponsor of entity listed in (a): ABCDEFGHI\nc EIN-PN 123456789-123 d E\nc\nn\no\nt\nd\nit\ne\ny 1 e D\n10\no\n3\nlla\n-1\nr\n2\nv a\nIE\nlu e\na t\no\ne\nf\nn\nin\nd\nt e\no\nr\nf\ne\ny\ns\ne\nt\na\nin\nr (\nM\nse\nT\ne\nIA\nin\n,\ns\nC\ntr\nC\nu\nT\nc\n,\nt io\nP\nn\nS\ns\nA\n)\n, or -123456789012345\na Name of MTIA, CCT, PSA, or 103-12 IE: ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\nb Name of sponsor of entity listed in (a): ABCDEFGHI\nc EIN-PN 123456789-123 d E\nc\nn\no\nt\nd\nit\ne\ny 1 e D\n10\no\n3\nlla\n-1\nr\n2\nv a\nIE\nlu e\na t\no\ne\nf\nn\nin\nd\nt e\no\nr\nf\ne\ny\ns\ne\nt\na\nin\nr (\nM\nse\nT\ne\nIA\nin\n,\ns\nC\ntr\nC\nu\nT\nc\n,\nt io\nP\nn\nS\ns\nA\n)\n, or -123456789012345\na Name of MTIA, CCT, PSA, or 103-12 IE: ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\nb Name of sponsor of entity listed in (a): ABCDEFGHI\nc EIN-PN 123456789-123 d E\nc\nn\no\nt\nd\nit\ne\ny 1 e D\n10\no\n3\nlla\n-1\nr\n2\nv a\nIE\nlu e\na t\no\ne\nf\nn\nin\nd\nt e\no\nr\nf\ne\ny\ns\ne\nt\na\nin\nr (\nM\nse\nT\ne\nIA\nin\n,\ns\nC\ntr\nC\nu\nT\nc\n,\nt io\nP\nn\nS\ns\nA\n)\n, or -123456789012345\nFor Paperwork Reduction Act Notice, see the Instructions for Form 5500. Schedule D (Form 5500) 2024\nv. 240311\n\nSchedule D (Form 5500) 2024 Page 2 - 11 x\na Name of MTIA, CCT, PSA, or 103-12 IE: ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\nb Name of sponsor of entity listed in (a): ABCDEFGHI\nc EIN-PN 123456789-123 d E\nc\nn\no\nt\nd\nit\ne\ny 1 e D\n10\no\n3\nlla\n-1\nr\n2\nv a\nIE\nlu e\na t\no\ne\nf\nn\nin\nd\nt e\no\nr\nf\ne\ny\ns\ne\nt\na\nin\nr (\nM\nse\nT\ne\nIA\nin\n,\ns\nC\ntr\nC\nu\nT\nc\n,\nt io\nP\nn\nS\ns\nA\n)\n, or -123456789012345\na Name of MTIA, CCT, PSA, or 103-12 IE: ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\nb Name of sponsor of entity listed in (a): ABCDEFGHI\nc EIN-PN 123456789-123 d E\nc\nn\no\nt\nd\nit\ne\ny 1 e D\n10\no\n3\nlla\n-1\nr\n2\nv a\nIE\nlu e\na t\no\ne\nf\nn\nin\nd\nt e\no\nr\nf\ne\ny\ns\ne\nt\na\nin\nr (\nM\nse\nT\ne\nIA\nin\n,\ns\nC\ntr\nC\nu\nT\nc\n,\nt io\nP\nn\nS\ns\nA\n)\n, or -123456789012345\na Name of MTIA, CCT, PSA, or 103-12 IE: ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\nb Name of sponsor of entity listed in (a): ABCDEFGHI\nc EIN-PN 123456789-123 d E\nc\nn\no\nt\nd\nit\ne\ny 1 e D\n10\no\n3\nlla\n-1\nr\n2\nv a\nIE\nlu e\na t\no\ne\nf\nn\nin\nd\nt e\no\nr\nf\ne\ny\ns\ne\nt\na\nin\nr (\nM\nse\nT\ne\nIA\nin\n,\ns\nC\ntr\nC\nu\nT\nc\n,\nt io\nP\nn\nS\ns\nA\n)\n, or -123456789012345\na Name of MTIA, CCT, PSA, or 103-12 IE: ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\nb Name of sponsor of entity listed in (a): ABCDEFGHI\nc EIN-PN 123456789-123 d E\nc\nn\no\nt\nd\nit\ne\ny 1 e D\n10\no\n3\nlla\n-1\nr\n2\nv a\nIE\nlu e\na t\no\ne\nf\nn\nin\nd\nt e\no\nr\nf\ne\ny\ns\ne\nt\na\nin\nr (\nM\nse\nT\ne\nIA\nin\n,\ns\nC\ntr\nC\nu\nT\nc\n,\nt io\nP\nn\nS\ns\nA\n)\n, or -123456789012345\na Name of MTIA, CCT, PSA, or 103-12 IE: ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\nb Name of sponsor of entity listed in (a): ABCDEFGHI\nc EIN-PN 123456789-123 d E\nc\nn\no\nt\nd\nit\ne\ny 1 e D\n10\no\n3\nlla\n-1\nr\n2\nv a\nIE\nlu e\na t\no\ne\nf\nn\nin\nd\nt e\no\nr\nf\ne\ny\ns\ne\nt\na\nin\nr (\nM\nse\nT\ne\nIA\nin\n,\ns\nC\ntr\nC\nu\nT\nc\n,\nt io\nP\nn\nS\ns\nA\n)\n, or -123456789012345\na Name of MTIA, CCT, PSA, or 103-12 IE: ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\nb Name of sponsor of entity listed in (a): ABCDEFGHI\nc EIN-PN 123456789-123 d E\nc\nn\no\nt\nd\nit\ne\ny 1 e D\n10\no\n3\nlla\n-1\nr\n2\nv a\nIE\nlu e\na t\no\ne\nf\nn\nin\nd\nt e\no\nr\nf\ne\ny\ns\ne\nt\na\nin\nr (\nM\nse\nT\ne\nIA\nin\n,\ns\nC\ntr\nC\nu\nT\nc\n,\nt io\nP\nn\nS\ns\nA\n)\n, or -123456789012345\na Name of MTIA, CCT, PSA, or 103-12 IE: ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\nb Name of sponsor of entity listed in (a): ABCDEFGHI\nc EIN-PN 123456789-123 d E\nc\nn\no\nt\nd\nit\ne\ny 1 e D\n10\no\n3\nlla\n-1\nr\n2\nv a\nIE\nlu e\na t\no\ne\nf\nn\nin\nd\nt e\no\nr\nf\ne\ny\ns\ne\nt\na\nin\nr (\nM\nse\nT\ne\nIA\nin\n,\ns\nC\ntr\nC\nu\nT\nc\n,\nt io\nP\nn\nS\ns\nA\n)\n, or -123456789012345\na Name of MTIA, CCT, PSA, or 103-12 IE: ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\nb Name of sponsor of entity listed in (a): ABCDEFGHI\nc EIN-PN 123456789-123 d E\nc\nn\no\nt\nd\nit\ne\ny 1 e D\n10\no\n3\nlla\n-1\nr\n2\nv a\nIE\nlu e\na t\no\ne\nf\nn\nin\nd\nt e\no\nr\nf\ne\ny\ns\ne\nt\na\nin\nr (\nM\nse\nT\ne\nIA\nin\n,\ns\nC\ntr\nC\nu\nT\nc\n,\nt io\nP\nn\nS\ns\nA\n)\n, or -123456789012345\na Name of MTIA, CCT, PSA, or 103-12 IE: ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\nb Name of sponsor of entity listed in (a): ABCDEFGHI\nc EIN-PN 123456789-123 d E\nc\nn\no\nt\nd\nit\ne\ny 1 e D\n10\no\n3\nlla\n-1\nr\n2\nv a\nIE\nlu e\na t\no\ne\nf\nn\nin\nd\nt e\no\nr\nf\ne\ny\ns\ne\nt\na\nin\nr (\nM\nse\nT\ne\nIA\nin\n,\ns\nC\ntr\nC\nu\nT\nc\n,\nt io\nP\nn\nS\ns\nA\n)\n, or -123456789012345\na Name of MTIA, CCT, PSA, or 103-12 IE: ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\nb Name of sponsor of entity listed in (a): ABCDEFGHI\nc EIN-PN 123456789-123 d E\nc\nn\no\nt\nd\nit\ne\ny 1 e D\n10\no\n3\nlla\n-1\nr\n2\nv a\nIE\nlu e\na t\no\ne\nf\nn\nin\nd\nt e\no\nr\nf\ne\ny\ns\ne\nt\na\nin\nr (\nM\nse\nT\ne\nIA\nin\n,\ns\nC\ntr\nC\nu\nT\nc\n,\nt io\nP\nn\nS\ns\nA\n)\n, or -123456789012345\n\nSchedule D (Form 5500) 2024 Page 3 - 11 x\n6\nPart II Information on Participating Plans (to be completed by DFEs, other than DCGs)\n(Complete as many entries as needed to report all participating plans. DCGs must report each participating plan using Schedule DCG.)\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\na Plan name ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\nb Name of ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI c EIN-PN\nplan sponsor ABCDEFGHI ABCDEFGHI 123456789-123\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\na Plan name ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\nb Name of ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI c EIN-PN\nplan sponsor ABCDEFGHI ABCDEFGHI 123456789-123\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\na Plan name ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\nb Name of ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI c EIN-PN\nplan sponsor ABCDEFGHI ABCDEFGHI 123456789-123\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\na Plan name ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\nb Name of ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI c EIN-PN\nplan sponsor ABCDEFGHI ABCDEFGHI 123456789-123\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\na Plan name ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\nb Name of ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI c EIN-PN\nplan sponsor ABCDEFGHI ABCDEFGHI 123456789-123\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\na Plan name ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\nb Name of ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI c EIN-PN\nplan sponsor ABCDEFGHI ABCDEFGHI 123456789-123\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\na Plan name ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\nb Name of ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI c EIN-PN\nplan sponsor ABCDEFGHI ABCDEFGHI 123456789-123\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\na Plan name ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\nb Name of ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI c EIN-PN\nplan sponsor ABCDEFGHI ABCDEFGHI 123456789-123\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\na Plan name ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\nb Name of ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI c EIN-PN\nplan sponsor ABCDEFGHI ABCDEFGHI 123456789-123\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\na Plan name ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\nb Name of ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI c EIN-PN\nplan sponsor ABCDEFGHI ABCDEFGHI 123456789-123\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\na Plan name ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\nb Name of ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI c EIN-PN\nplan sponsor ABCDEFGHI ABCDEFGHI 123456789-123\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\na Plan name ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\nb Name of ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI c EIN-PN\nplan sponsor ABCDEFGHI ABCDEFGHI 123456789-123",
    "char_count": 11487
  },
  {
    "chunk_id": "PFIZER_135315170_001_2024_SCHEDULE_G",
    "schedule_type": "SCHEDULE_G",
    "page_range": "16-19",
    "page_count": 4,
    "raw_text": "SCHEDULE G Financial Transaction Schedules OMB No. 1210-0110\n(Form 5500)\nThis schedule is required to be filed under section 104 of the Employee Retirement\n2024\nDepartment of Treasury\nInternal Revenue Service Income Security Act of 1974 (ERISA) and section 6058(a) of the Internal Revenue\nCode (the Code).\nEmployee B D e e n p e a f r i t t m s S en e t c o ur f it L y a A bo d r m inistration \uf034 File as an attachment to Form 5500. This Form is Open to Public\nInspection.\nFor calendar plan year 2024 or fiscal plan year beginning 0 1 / 0 1 / 2 0 2 4 and ending 1 2 / 3 1 / 2 0 2 4\nA Name of plan B Three-digit\nAPBFICZDEERF CGOHNIS OALBIDCADTEEDF GPHEIN SIAOBNC PDLEAFNGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\nplan number (PN)\n\uf034 001001\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\nABCDEFGHI ABCDEFGHI\nC Plan sponsor\u2019s name as shown on line 2a of Form 5500 D Employer Identification Number (EIN)\nA\nP\nB\nFI\nC\nZ\nD\nE\nE\nR\nF\nIN\nG\nC\nHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI 0113-25331455167078\nABCDEFGHI\nPart I Schedule of Loans or Fixed Income Obligations in Default or Classified as Uncollectible\nComplete as many entries as needed to report all loans or fixed income obligations in default or classified as uncollectible. Check box (a) if obligor\nis known to be a party in interest. Attach Overdue Loan Explanation for each loan listed. See Instructions.\n(c) Detailed description of loan including dates of making and maturity, interest rate, the\n(a) (b) Identity and address of obligor type and value of collateral, any renegotiation of the loan and the terms of the\nrenegotiation, and other material items\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\nX ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD ABCDE\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD\nAmount received during reporting year Amount overdue\n(d) Original amount of (g) Unpaid balance at end\n(e) Principal (f) Interest (h) Principal (i) Interest\nloan of year\n123456789012345 123456789012345 123456789012345 123456789012345 123456789012345 123456789012345\n(c) Detailed description of loan including dates of making and maturity, interest rate, the\n(a) (b) Identity and address of obligor type and value of collateral, any renegotiation of the loan and the terms of the\nrenegotiation, and other material items\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\nX ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD ABCDE\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD\nAmount received during reporting year Amount overdue\n(d) Original amount of (g) Unpaid balance at end\n(e) Principal (f) Interest (h) Principal (i) Interest\nloan of year\n123456789012345 123456789012345 123456789012345 123456789012345 123456789012345\n(c) Detailed description of loan including dates of making and maturity, interest rate, the\n(a) (b) Identity and address of obligor type and value of collateral, any renegotiation of the loan and the terms of the\nrenegotiation, and other material items\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\nX ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD ABCDE\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD\nAmount received during reporting year Amount overdue\n(d) Original amount of (g) Unpaid balance at end\n(e) Principal (f) Interest (h) Principal (i) Interest\nloan of year\n123456789012345 123456789012345 123456789012345 123456789012345 123456789012345 123456789012345\nFor Paperwork Reduction Act Notice, see the Instructions for Form 5500. Schedule G (Form 5500) 2024\nv. 240311\n\nSchedule G (Form 5500) 2024 Page 2 - 11 x\n(c) Detailed description of loan including dates of making and maturity, interest rate, the type\n(a) (b) Identity and address of obligor and value of collateral, any renegotiation of the loan and the terms of the renegotiation, and\nother material items\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\nX ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD ABCDE\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD\nAmount received during reporting year Amount overdue\n(d) Original amount of (g) Unpaid balance at end\n(e) Principal (f) Interest (h) Principal (i) Interest\nloan of year\n123456789012345 123456789012345 123456789012345 123456789012345 123456789012345 123456789012345\n(c) Detailed description of loan including dates of making and maturity, interest rate, the type\n(a) (b) Identity and address of obligor and value of collateral, any renegotiation of the loan and the terms of the renegotiation, and\nother material items\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\nX ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD ABCDE\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD\nAmount received during reporting year Amount overdue\n(d) Original amount of (g) Unpaid balance at end\n(e) Principal (f) Interest (h) Principal (i) Interest\nloan of year\n123456789012345 123456789012345 123456789012345 123456789012345 123456789012345 123456789012345\n(c) Detailed description of loan including dates of making and maturity, interest rate, the type\n(a) (b) Identity and address of obligor and value of collateral, any renegotiation of the loan and the terms of the renegotiation, and\nother material items\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\nX ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD ABCDE\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD\nAmount received during reporting year Amount overdue\n(d) Original amount of (g) Unpaid balance at end\n(e) Principal (f) Interest (h) Principal (i) Interest\nloan of year\n123456789012345 123456789012345 123456789012345 123456789012345 123456789012345 123456789012345\n(c) Detailed description of loan including dates of making and maturity, interest rate, the type\n(a) (b) Identity and address of obligor and value of collateral, any renegotiation of the loan and the terms of the renegotiation, and\nother material items\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\nX ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD ABCDE\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD\nAmount received during reporting year Amount overdue\n(d) Original amount of (g) Unpaid balance at end\n(e) Principal (f) Interest (h) Principal (i) Interest\nloan of year\n123456789012345 123456789012345 123456789012345 123456789012345 123456789012345 123456789012345\n(c) Detailed description of loan including dates of making and maturity, interest rate, the type\n(a) (b) Identity and address of obligor and value of collateral, any renegotiation of the loan and the terms of the renegotiation, and\nother material items\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\nX ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD ABCDE\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCD\nAmount received during reporting year Amount overdue\n(d) Original amount of (g) Unpaid balance at end\n(e) Principal (f) Interest (h) Principal (i) Interest\nloan of year\n123456789012345 123456789012345 123456789012345 123456789012345 123456789012345 123456789012345\n\nSchedule G (Form 5500) 2024 Page 3 - 11 x\nPart II Schedule of Leases in Default or Classified as Uncollectible\nComplete as many entries as needed to report all leases in default or classified as uncollectible. Check box (a) if lessor or lessee is known to be a\nparty in interest. Attach Overdue Lease Explanation for each lease listed. (See instructions)\n(c) Relationship to plan, employer, (d) Terms and description (type of property, location and date it was\n(a) (b) Identity of lessor/lessee employee organization, or other purchased, terms regarding rent, taxes, insurance, repairs,\nparty-in-interest expenses, renewal options, date property was leased)\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\nX ABCDEFGHI ABCD ABCDEFGHI ABCD ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\nABCDEFGHI ABCDEFGHI ABCD\n(f) Current value at time of (g) Gross rental receipts (h) Expenses paid during\n(e) Original cost\nlease during the plan year the plan year\n(i) Net receipts (j) Amount in arrears\n123456789012345 123456789012345 123456789012345 123456789012345 123456789012345 123456789012345\n(c) Relationship to plan, employer, (d) Terms and description (type of property, location and date it was\n(a) (b) Identity of lessor/lessee employee organization, or other purchased, terms regarding rent, taxes, insurance, repairs,\nparty-in-interest expenses, renewal options, date property was leased)\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\nX ABCDEFGHI ABCD ABCDEFGHI ABCD ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\nABCDEFGHI ABCDEFGHI ABCD\n(f) Current value at time of (g) Gross rental receipts (h) Expenses paid during\n(e) Original cost\nlease during the plan year the plan year\n(i) Net receipts (j) Amount in arrears\n123456789012345 123456789012345 123456789012345 123456789012345 123456789012345 123456789012345\n(c) Relationship to plan, employer, (d) Terms and description (type of property, location and date it was\n(a) (b) Identity of lessor/lessee employee organization, or other purchased, terms regarding rent, taxes, insurance, repairs,\nparty-in-interest expenses, renewal options, date property was leased)\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\nX ABCDEFGHI ABCD ABCDEFGHI ABCD ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\nABCDEFGHI ABCDEFGHI ABCD\n(f) Current value at time of (g) Gross rental receipts (h) Expenses paid during\n(e) Original cost\nlease during the plan year the plan year\n(i) Net receipts (j) Amount in arrears\n123456789012345 123456789012345 123456789012345 123456789012345 123456789012345 123456789012345\n(c) Relationship to plan, employer, (d) Terms and description (type of property, location and date it was\n(a) (b) Identity of lessor/lessee employee organization, or other purchased, terms regarding rent, taxes, insurance, repairs,\nparty-in-interest expenses, renewal options, date property was leased)\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\nX ABCDEFGHI ABCD ABCDEFGHI ABCD ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\nABCDEFGHI ABCDEFGHI ABCD\n(f) Current value at time of (g) Gross rental receipts (h) Expenses paid during\n(e) Original cost\nlease during the plan year the plan year\n(i) Net receipts (j) Amount in arrears\n123456789012345 123456789012345 123456789012345 123456789012345 123456789012345 123456789012345\n(c) Relationship to plan, employer, (d) Terms and description (type of property, location and date it was\n(a) (b) Identity of lessor/lessee employee organization, or other purchased, terms regarding rent, taxes, insurance, repairs,\nparty-in-interest expenses, renewal options, date property was leased)\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\nX ABCDEFGHI ABCD ABCDEFGHI ABCD ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\nABCDEFGHI ABCDEFGHI ABCD\n(f) Current value at time of (g) Gross rental receipts (h) Expenses paid during\n(e) Original cost\nlease during the plan year the plan year\n(i) Net receipts (j) Amount in arrears\n123456789012345 123456789012345 123456789012345 123456789012345 123456789012345 123456789012345\n(c) Relationship to plan, employer, (d) Terms and description (type of property, location and date it was\n(a) (b) Identity of lessor/lessee employee organization, or other purchased, terms regarding rent, taxes, insurance, repairs,\nparty-in-interest expenses, renewal options, date property was leased)\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\nX ABCDEFGHI ABCD ABCDEFGHI ABCD ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\nABCDEFGHI ABCDEFGHI ABCD\n(f) Current value at time of (g) Gross rental receipts (h) Expenses paid during\n(e) Original cost\nlease during the plan year the plan year\n(i) Net receipts (j) Amount in arrears\n123456789012345 123456789012345 123456789012345 123456789012345 123456789012345 123456789012345\n\nSchedule G (Form 5500) 2024 Page 4 - 11 x\nPart III Nonexempt Transactions\nComplete as many entries as needed to report all nonexempt transactions. Caution: If a nonexempt prohibited transaction occurred with respect\nto a disqualified person, file Form 5330 with the IRS to pay the excise tax on the transaction.\n(b) Relationship to plan, employer, (c) Description of transaction including maturity date,\n(a) Identity of party involved (d) Purchase price\nor other party-in-interest rate of interest, collateral, par or maturity value\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI 123456789012345\nMASTER TRUST BETWEEN PLAN TRUST/TRUSTEE PYMNT OF INELIGIBLE EXPENSES FROM PLAN 0\nPFIZERA ABNCDD NETFGHI ABCDEFGHI ABCD ASSAEBTCSD IEN F2G02H2I B YA TBHCED MEFT;G RHEIP AAIDB ICND 2E0F24G WHIIT H\nABCDEFGHI ABCD INTAEBRCESDTE OFGF H15I, 60A9B.CDEFGHI ABCDEFGHI\nABCDEFGHI ABCD\n(i) Current value of (j) Net gain (or loss) on\n(e) Selling price (f) Lease rental (g) Transaction expenses (h) Cost of asset\nasset each transaction\n12345678901293344500 1234567890123405 123456789012345 12345678901293344050 1234567890913243005 -1234567890123455\n(b) Relationship to plan, employer, (c) De scription of transaction including maturity date,\n(a) Identity of party involved (d) Purchase price\nor other party-in-interest rate of interest, collateral, par or maturity value\nMASTE\nA\nR\nB\nT\nC\nR\nD\nU\nE\nS\nF\nT\nG\nB\nH\nE\nI\nT WEEN P\nA\nL\nB\nA\nC\nN\nD\nT\nE\nR\nF\nU\nG\nS\nH\nT/\nI\nT R\nA\nU\nB\nST\nC\nE\nD\nE\nEFGHI\nPYM\nA\nN\nB\nT\nC D\nO\nE\nF\nF\nIN\nG\nE\nH\nL\nI\nIG I\nA\nBL\nB\nE\nC\nE\nD\nX\nE\nP\nF\nE\nG\nN\nH\nS\nI\nE S\nA\nF\nB\nR\nC\nO\nD\nM\nE\nP\nF\nL\nG\nA\nH\nN\nI 1234567890123450\nPFIZERA ABNCDD NETFGHI ABCDEFGHI ABCD ASSAEBTCSD IEN F2G02H3I B YA TBHCED MEFT;G RHEIP AAIDB ICND 2E0F24G WHIIT H\nABCDEFGHI ABCD INTAEBRCESDTE OFGF H52I, 29A4B.CDEFGHI ABCDEFGHI\nABCDEFGHI ABCD\n(i) Current value of (j) Net gain (or loss) on\n(e) Selling price (f) Lease rental (g) Transaction expenses (h) Cost of asset\nasset each transaction\n677135 0 677135 677135\n(b) Relationship to plan, employer, (c) Description of transaction including maturity date,\n(a) Identity of party involved (d) Purchase price\nor other party-in-interest rate of interest, collateral, par or maturity value\nMASTE\nA\nR\nB\nT\nC\nR\nD\nU\nE\nS\nF\nT\nG\nB\nH\nE\nI\nT WEEN P\nA\nL\nB\nA\nC\nN\nD\nT\nE\nR\nF\nU\nG\nS\nH\nT/\nI\nT R\nA\nU\nB\nST\nC\nE\nD\nE\nEFGHI\nPYM\nA\nN\nB\nT\nC D\nO\nE\nF\nF\nIN\nG\nE\nH\nL\nI\nIG I\nA\nBL\nB\nE\nC\nE\nD\nX\nE\nP\nF\nE\nG\nN\nH\nS\nI\nE S\nA\nF\nB\nR\nC\nO\nD\nM\nE\nP\nF\nL\nG\nA\nH\nN\nI 1234567890123450\nPFIZERA ABNCDD NETFGHI ABCDEFGHI ABCD ASSAEBTCSD IEN F2G02H4I B YA TBHCED MEFT;G RHEIP AAIDB ICND 2E0F24G WHIIT H\nABCDEFGHI ABCD INTAEBRCESDTE OFGF H43I, 13A5B.CDEFGHI ABCDEFGHI\nABCDEFGHI ABCD\n(i) Current value of (j) Net gain (or loss) on\n(e) Selling price (f) Lease rental (g) Transaction expenses (h) Cost of asset\nasset each transaction\n123456789012783249586 1234567890123450 123456789012345 123456789017282394856 12345678907182293865 -1234567890123455\n(b) Relationship to plan, employer, (c) Description of transaction including maturity date,\n(a) Identity of party involved (d) Purchase price\nor other party-in-interest rate of interest, collateral, par or maturity value\nMASTE\nA\nR\nB\nT\nC\nR\nD\nU\nE\nS\nF\nT\nG\nB\nH\nE\nI\nTW EEN P\nA\nL\nB\nA\nC\nN\nD\nT\nE\nR\nF\nU\nG\nS\nH\nT/\nI\nT R\nA\nUS\nB\nT\nC\nE\nD\nE\nEFGHI\nPYM\nA\nN\nB\nT\nC\nO\nD\nF\nE F\nIN\nG\nE\nH\nL\nI\nIG IB\nA\nL\nB\nE\nC\nE\nD\nX\nE\nP\nF\nE\nG\nN\nH\nS\nI\nE S\nA\nF\nB\nR\nC\nO\nD\nM\nE\nP\nF\nL\nG\nA\nH\nN\nI 1234567890123450\nPFIZERA ABNCDD NETFGHI ABCDEFGHI ABCD ASSAEBTCSD INE F2G02H4I B YA TBHCED METF;G WHIILL BAEB CRDEPEAFIGDH INI\nABCDEFGHI ABCD 202A5 BWCITDHE FINGTHEIR ESATB.CDEFGHI ABCDEFGHI\nABCDEFGHI ABCD\n(i) Current value of (j) Net gain (or loss) on\n(e) Selling price (f) Lease rental (g) Transaction expenses (h) Cost of asset\nasset each transaction\n1101160 0 1101160 1101160\n(b) Relationship to plan, employer, (c) Description of transaction including maturity date,\n(d) Purchase price\n(a) Identity of party involved or other party-in-interest rate of interest, collateral, par or maturity value\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI 123456789012345\nABCDEFGHI ABCDEFGHI ABCD ABCDEFGHI ABCDEFGHI ABCDEFGHI\nABCDEFGHI ABCD ABCDEFGHI ABCDEFGHI ABCDEFGHI\nABCDEFGHI ABCD\n(i) Current value of (j) Net gain (or loss) on\n(e) Selling price (f) Lease rental (g) Transaction expenses (h) Cost of asset\nasset each transaction\n123456789012345 123456789012345 123456789012345 123456789012345 12345678901235 -1234567890123455\n(b) Relationship to plan, employer, (c) Description of transaction including maturity date,\n(a) Identity of party involved (d) Purchase price\nor other party-in-interest rate of interest, collateral, par or maturity value\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI 123456789012345\nABCDEFGHI ABCDEFGHI ABCD ABCDEFGHI ABCDEFGHI ABCDEFGHI\nABCDEFGHI ABCD ABCDEFGHI ABCDEFGHI ABCDEFGHI\nABCDEFGHI ABCD\n(i) Current value of (j) Net gain (or loss) on\n(e) Selling price (f) Lease rental (g) Transaction expenses (h) Cost of asset\nasset each transaction\n123456789012345 123456789012345 123456789012345 123456789012345 12345678901235 -1234567890123455",
    "char_count": 17830
  },
  {
    "chunk_id": "PFIZER_135315170_001_2024_SCHEDULE_H",
    "schedule_type": "SCHEDULE_H",
    "page_range": "20-24",
    "page_count": 5,
    "raw_text": "SCHEDULE H Financial Information OMB No. 1210-0110\n(Form 5500)\nDepartment of the Treasury This schedule is required to be filed under section 104 of the Employee 2024\nDepartment of the Treasury\nInternal Revenue Service\nRetirement Income Security Act of 1974 (ERISA), and section 6058(a) of the\nInternal Revenue Code (the Code).\nDepartment of Labor\nEmployee Benefits Security Administration \uf034 File as an attachment to Form 5500. This Form is Open to Public\nPension Benefit Guaranty Corporation Inspection\nFor calendar plan year 2024 or fiscal plan year beginning 0 1 / 0 1 / 2 0 2 4 and ending 1 2 / 3 1 / 2 0 2 4\nA Name of plan B Three-digit\nABPCFIDZEEFRG CHOIN SAOBLCIDDAETFEDG HPIE NASIBOCND PELFAGNHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\nplan number (PN)\n\uf034 001001\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\nABCDEFGHI ABCDEFGHI\nC Plan sponsor\u2019s name as shown on line 2a of Form 5500 D Employer Identification Number (EIN)\nABPCFDIZEEFRG INHCI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI 0123143-556317581 70\nABCDEFGHI\nPart I Asset and Liability Statement\n1 Current value of plan assets and liabilities at the beginning and end of the plan year. Combine the value of plan assets held in more than one trust. Report\nthe value of the plan\u2019s interest in a commingled fund containing the assets of more than one plan on a line-by-line basis unless the value is reportable on\nlines 1c(9) through 1c(14). Do not enter the value of that portion of an insurance contract which guarantees, during this plan year, to pay a specific dollar\nbenefit at a future date. Round off amounts to the nearest dollar. MTIAs, CCTs, PSAs, and 103-12 IEs do not complete lines 1b(1), 1b(2), 1c(8), 1g, 1h,\nand 1i. CCTs, PSAs, and 103-12 IEs also do not complete lines 1d and 1e. See instructions.\nAssets (a) Beginning of Year (b) End of Year\na Total noninterest-bearing cash ....................................................................... 1a -12345678948071625933405 -12345678946001682534495\nb Receivables (less allowance for doubtful accounts):\n(1) Employer contributions ......................................................................... 1b(1) -123456789012345 -123456789012345\n(2) Participant contributions ........................................................................ 1b(2) -123456789012345 -123456789012345\n(3) Other .................................................................................................... 1b(3) -123456789012345 -123456789012345\nc General investments:\n(1) Interest-bearing cash (include money market accounts & certificates\n1c(1) -123456789012345 -123456789012345\nof deposit) ...........................................................................................\n(2) U.S. Government securities .................................................................. 1c(2) -123456789012345 -123456789012345\n(3) Corporate debt instruments (other than employer securities):\n(A) Preferred ........................................................................................ 1c(3)(A) -123456789012345 -123456789012345\n(B) All other .......................................................................................... 1c(3)(B) -123456789012345 -123456789012345\n(4) Corporate stocks (other than employer securities):\n(A) Preferred ........................................................................................ 1c(4)(A) -123456789012345 -123456789012345\n(B) Common ........................................................................................ 1c(4)(B) -123456789012345 -123456789012345\n(5) Partnership/joint venture interests ......................................................... 1c(5) -123456789012345 -123456789012345\n(6) Real estate (other than employer real property) .................................... 1c(6) -123456781930281629376465 -123456781915041320932445\n(7) Loans (other than to participants) .......................................................... 1c(7) -123456789012345 -123456789012345\n(8) Participant loans ................................................................................... 1c(8) -123456789012345 -123456789012345\n(9) Value of interest in common/collective trusts ......................................... 1c(9) -12345678960761321375415 -12345678975041621432435\n(10) Value of interest in pooled separate accounts ....................................... 1c(10) -123456789012345 -123456789012345\n(11) Value of interest in master trust investment accounts ............................ 1c(11) -12345671086910851520308495 -1234567987933031726035405\n(12) Value of interest in 103-12 investment entities ...................................... 1c(12) -123456789012345 -123456789012345\n(13) Value of interest in registered investment companies (e.g., mutual -123456789012345 -123456789012345\n1c(13)\nfunds) ...................................................................................\n(14) Value of funds held in insurance company general account (unallocated -123456789012345 -123456789012345\n1c(14)\ncontracts)..............................................................................................\n(15) Other ..................................................................................................... 1c(15) -12345678980741425308425 -123456789012137435\nFor Paperwork Reduction Act Notice, see the Instructions for Form 5500. Schedule H (Form 5500) 2024\nv. 240311\n\nSchedule H (Form 5500) 2024 Page 2\n1d Employer-related investments: (a) Beginning of Year (b) End of Year\n(1) Employer securities ............................................................................... 1d(1) -123456789012345 -123456789012345\n(2) Employer real property .......................................................................... 1d(2) -123456789012345 -123456789012345\n1e Buildings and other property used in plan operation .................................... 1e -123456789012345 -123456789012345\n1f Total assets (add all amounts in lines 1a through 1e) .................................. 1f -12345160795859206216213845 -1234569977809330711219345\nLiabilities\n1g Benefit claims payable ................................................................................ 1g -12345678869209618283745 -12345671819040919244345\n1h Operating payables ..................................................................................... 1h -123456789012345 -123456789012345\n1i Acquisition indebtedness ............................................................................. 1i -123456789012345 -123456789012345\n1j Other liabilities ............................................................................................. 1j -123456789012345 -123456789012345\n1k Total liabilities (add all amounts in lines 1g through1j) ................................. 1k -12345678869209618283745 -12345671819040919244345\nNet Assets\n1l Net assets (subtract line 1k from line 1f) ...................................................... 1l -12345160786889906517233145 -1234569975899280711275345\nPart II Income and Expense Statement\n2 Plan income, expenses, and changes in net assets for the year. Include all income and expenses of the plan, including any trust(s) or separately maintained\nfund(s) and any payments/receipts to/from insurance carriers. Round off amounts to the nearest dollar. MTIAs, CCTs, PSAs, and 103-12 IEs do not\ncomplete lines 2a, 2b(1)(E), 2e, 2f, and 2g.\nIncome (a) Amount (b) Total\na Contributions:\n(1) Received or receivable in cash from: (A) Employers ............................. 2a(1)(A) -123456789012345\n(B) Participants ................................................................................... 2a(1)(B) -123456789012345\n(C) Others (including rollovers) ............................................................ 2a(1)(C) -123456789012345\n(2) Noncash contributions ........................................................................... 2a(2) -123456789012345\n(3) Total contributions. Add lines 2a(1)(A), (B), (C), and line 2a(2) ............. 2a(3) -1234567890120345\nb Earnings on investments:\n(1) Interest:\n(A) Interest-bearing cash (including money market accounts and -123456789012345\n2b(1)(A)\ncertificates of deposit) ....................................................................\n(B) U.S. Government securities ........................................................... 2b(1)(B) -123456789012345\n(C) Corporate debt instruments ........................................................... 2b(1)(C) -123456789012345\n(D) Loans (other than to participants) .................................................. 2b(1)(D) -123456789012345\n(E) Participant loans ............................................................................ 2b(1)(E) -123456789012345\n(F) Other ............................................................................................. 2b(1)(F) -123456789012345\n(G) Total interest. Add lines 2b(1)(A) through (F) ................................. 2b(1)(G) -1234567890120345\n(2) Dividends: (A) Preferred stock ............................................................... 2b(2)(A) -123456789012345\n(B) Common stock .............................................................................. 2b(2)(B) -123456789012345\n(C) Registered investment company shares (e.g. mutual funds) .......... 2b(2)(C)\n(D) Total dividends. Add lines 2b(2)(A), (B), and (C) 2b(2)(D) -1234567890120345\n(3) Rents .................................................................................................... 2b(3) -123456789012345\n(4) Net gain (loss) on sale of assets: (A) Aggregate proceeds ................... 2b(4)(A) -123456789012345\n(B) Aggregate carrying amount (see instructions) ................................ 2b(4)(B) -123456789012345\n(C) Subtract line 2b(4)(B) from line 2b(4)(A) and enter result .............. 2b(4)(C) -1234567890120345\n(5) Unrealized appreciation (depreciation) of assets: (A) Real estate .................... 2b(5)(A) -2646016\n(B) Other ............................................................................................. 2b(5)(B) 1333360\n(C) Total unrealized appreciation of assets.\n2b(5)(C) -1312656\nAdd lines 2b(5)(A) and (B) .............................................................\n\nSchedule H (Form 5500) 2024 Page 3\n(a) Amount (b) Total\n(6) Net investment gain (loss) from common/collective trusts ...................... 2b(6) 12345671859610916211345\n(7) Net investment gain (loss) from pooled separate accounts .................... 2b(7)\n-123456789012345-\n(8) Net investment gain (loss) from master trust investment accounts ......... 2b(8)\n-1122334455667784 895 9046 012 125 2325 34455-\n(9) Net investment gain (loss) from 103-12 investment entities ................... 2b(9)\n-112233445566778899001122334455-\n-112233445566778899001122334455-\n(10) Net investment gain (loss) from registered investment 2b(10) 123456789012345\ncompanies (e.g., mutual funds) .............................................................\nc Other income .............................................................................................. 2c -123456789012345\nd Total income. Add all income amounts in column (b) and enter total .................. 2d 59769480\nExpenses\ne Benefit payment and payments to provide benefits:\n(1) Directly to participants or beneficiaries, including direct rollovers ........... 2e(1) -123456778449202105263145\n(2) To insurance carriers for the provision of benefits ................................. 2e(2) -123456789012345\n(3) Other ..................................................................................................... 2e(3) -123456789012345\n(4) Total benefit payments. Add lines 2e(1) through (3) .............................. 2e(4) 744220561\nf Corrective distributions (see instructions) .................................................... 2f\ng Certain deemed distributions of participant loans (see instructions) ............. 2g\nh Interest expense .......................................................................................... 2h\ni Administrative expenses:\n(1) Salaries and allowances ........................................................................ 2i(1)\n(2) Contract administrator fees ................................................................... 2i(2) -123456789012345\n(3) Recordkeeping fees .............................................................................. 2i(3)\n(4) IQPA audit fees ..................................................................................... 2i(4)\n(5) Investment advisory and investment management fees ........................ 2i(5)\n(6) Bank or trust company trustee/custodial fees ........................................ 2i(6)\n(7) Actuarial fees ........................................................................................ 2i(7)\n(8) Legal fees ............................................................................................. 2i(8)\n(9) Valuation/appraisal fees ........................................................................ 2i(9)\n(10) Other trustee fees and expenses ......................................................... 2i(10)\n(11) Other expenses.................................................................................... 2i(11)\n(12) Total administrative expenses. Add lines 2i(1) through (11) ................. 2i(12) 0\nj Total expenses. Add all expense amounts in column (b) and enter total ..... 2j -123456774849220015261345\nNet Income and Reconciliation\nk Net income (loss). Subtract line 2j from line 2d ........................................................ 2k -684451081\nl Transfers of assets:\n(1) To this plan............................................................................................ 2l(1) -12345675899770615250345\n(2) From this plan ....................................................................................... 2l(2) -123456278859000410225345\n\nSchedule H (Form 5500) 2024 Page 4\nPart III Accountant\u2019s Opinion\n3 Complete lines 3a through 3c if the opinion of an independent qualified public accountant is attached to this Form 5500. Complete line 3d if an opinion is not\nattached.\na The attached opinion of an independent qualified public accountant for this plan is (see instructions):\n(1) XX Unmodified (2) X Qualified (3) X Disclaimer (4) X Adverse\nb Check the appropriate box(es) to indicate whether the IQPA performed an ERISA section 103(a)(3)(C) audit. Check both boxes (1) and (2) if the audit was\nperformed pursuant to both 29 CFR 2520.103-8 and 29 CFR 2520.103-12(d). Check box (3) if pursuant to neither.\n(1) X DOL Regulation 2520.103-8 (2) X DOL Regulation 2520.103-12(d) (3) XX neither DOL Regulation 2520.103-8 nor DOL Regulation 2520.103-12(d).\nc Enter the name and EIN of the accountant (or accounting firm) below:\n(1) Name: AKPBMCGDE LFLPGHI ABCDEFGHI ABCDEFGHI ABCD (2) EIN: 11233-5455656270879\nd The opinion of an independent qualified public accountant is not attached as part of Schedule H because:\n(1) X This form is filed for a CCT, PSA, DCG or MTIA. (2) X It will be attached to the next Form 5500 pursuant to 29 CFR 2520.104-50.\nPart IV Compliance Questions\n4 CCTs and PSAs do not complete Part IV. MTIAs, 103-12 IEs, and GIAs do not complete lines 4a, 4e, 4f, 4g, 4h, 4k, 4m, 4n, or 5.\n103-12 IEs also do not complete lines 4j and 4l. MTIAs also do not complete line 4l. DCGs do not complete lines 4e, 4f, 4k, 4l, and 5, and DCGs generally\ncomplete the rest of Part IV collectively for all plans in the DCG, except as otherwise provided (see instructions).\nDuring the plan year: Yes No Amount\na Was there a failure to transmit to the plan any participant contributions within the time\nperiod described in 29 CFR 2510.3-102? Continue to answer \u201cYes\u201d for any prior year failures until\nfully corrected. (See instructions and DOL\u2019s Voluntary Fiduciary Correction Program.) .................. 4a\nX\nb Were any loans by the plan or fixed income obligations due the plan in default as of the\nclose of the plan year or classified during the year as uncollectible? Disregard participant loans\nsecured by participant\u2019s account balance. (Attach Schedule G (Form 5500) Part I if \u201cYes\u201d is\nX\nchecked.) ........................................................................................................................................ 4b\nc Were any leases to which the plan was a party in default or classified during the year as\nuncollectible? (Attach Schedule G (Form 5500) Part II if \u201cYes\u201d is checked.) ................................... 4c X -123456789012345\nd Were there any nonexempt transactions with any party-in-interest? (Do not include transactions\nreported on line 4a. Attach Schedule G (Form 5500) Part III if \u201cYes\u201d is\nchecked.) ........................................................................................................................................ 4d X -1234567268594068112345\ne Was this plan covered by a fidelity bond? ....................................................................................... 4e X -12345627508090000102345\nf Did the plan have a loss, whether or not reimbursed by the plan\u2019s fidelity bond, that was caused\nby fraud or dishonesty? ................................................................................................................. 4f X -123456789012345\ng Did the plan hold any assets whose current value was neither readily determinable on an\nestablished market nor set by an independent third party appraiser? .............................................. 4g X -123456789012345\nh Did the plan receive any noncash contributions whose value was neither readily\ndeterminable on an established market nor set by an independent third party appraiser? ............... 4h X -123456789012345\ni Did the plan have assets held for investment? (Attach schedule(s) of assets if \u201cYes\u201d is checked,\nand see instructions for format requirements.) ................................................................................ 4i X\nj Were any plan transactions or series of transactions in excess of 5% of the current\nvalue of plan assets? (Attach schedule of transactions if \u201cYes\u201d is checked and\nsee instructions for format requirements.) ....................................................................................... 4j X\nk Were all the plan assets either distributed to participants or beneficiaries, transferred to another\nplan, or brought under the control of the PBGC? ............................................................................ 4k X\nl Has the plan failed to provide any benefit when due under the plan? .............................................. 4l X -123456789012345\nm If this is an individual account plan, was there a blackout period? (See instructions and 29 CFR\n2520.101-3.) ................................................................................................................................... 4m X\nn If 4m was answered \u201cYes,\u201d check the \u201cYes\u201d box if you either provided the required notice or one\nof the exceptions to providing the notice applied under 29 CFR 2520.101-3. .................................. 4n\n5a Has a resolution to terminate the plan been adopted during the plan year or any prior plan year?........ X Yes XX No\nIf \u201cYes,\u201d enter the amount of any plan assets that reverted to the employer this year ____________________________________.\n\nSchedule H (Form 5500) 2024 Page 5- 1 1\n5b If, during this plan year, any assets or liabilities were transferred from this plan to another plan(s), identify the plan(s) to which assets or liabilities were\ntransferred. (See instructions.)\n5b(1) Name of plan(s) 5b(2) EIN(s) 5b(3) PN(s)\nMASTER TRUST BETWEEN PFIZER INC AND THE NORTHERN TRUST COMPANY 3162-33144650677589 001123\nWYETHA CBOCODREDFINGAHTIE DA BBACRDGEAFINGIHNIG RAEBTCIRDEEMFEGNHTI P LAANB-CUDSEFGHI ABCDEFGHI ABCDEFGHI 1132-53341551677089 011923\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI 123456789 123\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHII 123456789 123\nABCDEFHI\n5c Was the plan a defined benefit plan covered under the PBGC insurance program at any time during this plan year? (See ERISA section 4021 and\ninstructions.) \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026.. XX Yes X No X Not determined\nIf \u201cYes\u201d is checked, enter the My PAA confirmation number from the PBGC premium filing for this plan year _5_6_1_2_1_9______________.",
    "char_count": 20458
  },
  {
    "chunk_id": "PFIZER_135315170_001_2024_SCHEDULE_R",
    "schedule_type": "SCHEDULE_R",
    "page_range": "25-27",
    "page_count": 3,
    "raw_text": "SCHEDULE R Retirement Plan Information OMB No. 1210-0110\n(Form 5500)\n2024\nThis schedule is required to be filed under sections 104 and 4065 of the\nD\nI\ne\nn\np\nte\na\nr\nr\nn\ntm\nal\ne\nR\nn\ne\nt\nv\no\ne\nf\nn\nth\nu\ne\ne\nT\nS\nr\ne\ne\nr\na\nv\ns\nic\nu\ne\nr y\nEmployee Retirement Income Security Act of 1974 (ERISA) and section\n6058(a) of the Internal Revenue Code (the Code).\nDepartment of Labor This Form is Open to Public\nEmployee Benefits Security Administration \uf034 File as an attachment to Form 5500. Inspection.\nPension Benefit Guaranty Corporation\nFor calendar plan year 2024 or fiscal plan year beginning 0 1 / 0 1 / 2 0 2 4 and ending 1 2 / 3 1 / 2 0 2 4\nA Name of plan B Three-digit\nAPBFCIZDEERF CGOHNIS OALBIDCADTEEFDG PHEIN SAIOBNC DPELAFNGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI plan number\nABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI (PN) \uf034 001 001\nABCDEFGHI ABCDEFGHI\nC Plan sponsor\u2019s name as shown on line 2a of Form 5500 D Employer Identification Number (EIN)\nAPBFCIZDEERF IGNHCI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI ABCDEFGHI 0\n1\n1\n3-\n2\n5\n3\n31\n4\n5\n5\n17\n6\n0\n78\nABCDEFGHI\nPart I Distributions\nAll references to distributions relate only to payments of benefits during the plan year.\n1 Total value of distributions paid in property other than in cash or the forms of property specified in the 1 0\ninstructions\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026...... -123456789012345\n2 Enter the EIN(s) of payor(s) who paid benefits on behalf of the plan to participants or beneficiaries during the year (if more than two, enter EINs of the\ntwo payors who paid the greatest dollar amounts of benefits):\n13-6058950 36-3046063\nEIN(s): _______________________________ ________________________________\nProfit-sharing plans, ESOPs, and stock bonus plans, skip line 3.\n3 Number of participants (living or deceased) whose benefits were distributed in a single sum, during the plan 3 1853\nyear ..................................................................................................................................................................\n12345678\nPart II Funding Information (If the plan is not subject to the minimum funding requirements of section 412 of the Internal Revenue Code or\nERISA section 302, skip this Part.)\n4 Is the plan administrator making an election under Code section 412(d)(2) or ERISA section 302(d)(2)? ....................... X Yes X No XX N/A\nIf the plan is a defined benefit plan, go to line 8.\n5 If a waiver of the minimum funding standard for a prior year is being amortized in this\nplan year, see instructions and enter the date of the ruling letter granting the waiver. Date: Month _________ Day _________ Year _________\nIf you completed line 5, complete lines 3, 9, and 10 of Schedule MB and do not complete the remainder of this schedule.\n6 a Enter the minimum required contribution for this plan year (include any prior year accumulated funding\n6a -123456789012345\n)\ndeficiency not waived ................................................................................................................................\nb Enter the amount contributed by the employer to the plan for this plan year ................................................ 6b -123456789012345\nc Subtract the amount in line 6b from the amount in line 6a. Enter the result\n(enter a minus sign to the left of a negative amount) .................................................................................... 6c\n-123456789012345\nIf you completed line 6c, skip lines 8 and 9.\n7 Will the minimum funding amount reported on line 6c be met by the funding deadline? ........................................ X Yes X No X N/A\n8 If a change in actuarial cost method was made for this plan year pursuant to a revenue procedure or other\nauthority providing automatic approval for the change or a class ruling letter, does the plan sponsor or plan X Yes X No XX N/A\nadministrator agree with the change? .................................................................................................................\nPart III Amendments\n9 If this is a defined benefit pension plan, were any amendments adopted during this plan\nyear that increased or decreased the value of benefits? If yes, check the appropriate\nbox. If no, check the \u201cNo\u201d box. .........................................................................................\nX Increase X Decrease X Both XX No\nPart IV ESOPs (see instructions). If this is not a plan described under section 409(a) or 4975(e)(7) of the Internal Revenue Code, skip this Part.\n10 Were unallocated employer securities or proceeds from the sale of unallocated securities used to repay any exempt loan? ............. X Yes X No\n11 a Does the ESOP hold any preferred stock? ................................................................................................................................. X Yes X No\nb If the ESOP has an outstanding exempt loan with the employer as lender, is such loan part of a \u201cback-to-back\u201d loan? X Yes X No\n(See instructions for definition of \u201cback-to-back\u201d loan.) ...............................................................................................................\n12 Does the ESOP hold any stock that is not readily tradable on an established securities market? ....................................................... X Yes X No\nFor Paperwork Reduction Act Notice, see the Instructions for Form 5500. Schedule R (Form 5500) 2024\nv. 240311\n\nSchedule R (Form 5500) 2024 Page 2 - 1-1 x\nPart V Additional Information for Multiemployer Defined Benefit Pension Plans\n13 Enter the following information for each employer that (1) contributed more than 5% of total contributions to the plan during the plan year or (2) was one of\nthe top-ten highest contributors (measured in dollars). See instructions. Complete as many entries as needed to report all applicable employers.\na Name of contributing employer\nb EIN c Dollar amount contributed by employer\nd Date collective bargaining agreement expires (If employer contributes under more than one collective bargaining agreement, check box X\nand see instructions regarding required attachment. Otherwise, enter the applicable date.) Month _______ Day _______ Year _______\ne Contribution rate information (If more than one rate applies, check this box X and see instructions regarding required attachment. Otherwise,\ncomplete lines 13e(1) and 13e(2).)\n(1) Contribution rate (in dollars and cents) _____________\n(2) Base unit measure: X Hourly X Weekly X Unit of production X Other (specify):\na Name of contributing employer\nb EIN c Dollar amount contributed by employer\nd Date collective bargaining agreement expires (If employer contributes under more than one collective bargaining agreement, check box X\nand see instructions regarding required attachment. Otherwise, enter the applicable date.) Month _______ Day _______ Year _______\ne Contribution rate information (If more than one rate applies, check this box X and see instructions regarding required attachment. Otherwise,\ncomplete lines 13e(1) and 13e(2).)\n(1) Contribution rate (in dollars and cents) _____________\n(2) Base unit measure: X Hourly X Weekly X Unit of production X Other (specify): _______________________________\na Name of contributing employer\nb EIN c Dollar amount contributed by employer\nd Date collective bargaining agreement expires (If employer contributes under more than one collective bargaining agreement, check box X\nand see instructions regarding required attachment. Otherwise, enter the applicable date.) Month _______ Day _______ Year _______\ne Contribution rate information (If more than one rate applies, check this box X and see instructions regarding required attachment. Otherwise,\ncomplete lines 13e(1) and 13e(2).)\n(1) Contribution rate (in dollars and cents) _____________\n(2) Base unit measure: X Hourly X Weekly X Unit of production X Other (specify): _______________________________\na Name of contributing employer\nb EIN c Dollar amount contributed by employer\nd Date collective bargaining agreement expires (If employer contributes under more than one collective bargaining agreement, check box X\nand see instructions regarding required attachment. Otherwise, enter the applicable date.) Month _______ Day _______ Year _______\ne Contribution rate information (If more than one rate applies, check this box X and see instructions regarding required attachment. Otherwise,\ncomplete lines 13e(1) and 13e(2).)\n(1) Contribution rate (in dollars and cents) _____________\n(2) Base unit measure: X Hourly X Weekly X Unit of production X Other (specify): _______________________________\na Name of contributing employer\nb EIN c Dollar amount contributed by employer\nd Date collective bargaining agreement expires (If employer contributes under more than one collective bargaining agreement, check box X\nand see instructions regarding required attachment. Otherwise, enter the applicable date.) Month _______ Day _______ Year _______\ne Contribution rate information (If more than one rate applies, check this box X and see instructions regarding required attachment. Otherwise,\ncomplete lines 13e(1) and 13e(2).)\n(1) Contribution rate (in dollars and cents) _____________\n(2) Base unit measure: X Hourly X Weekly X Unit of production X Other (specify): _______________________________\na Name of contributing employer\nb EIN c Dollar amount contributed by employer\nd Date collective bargaining agreement expires (If employer contributes under more than one collective bargaining agreement, check box X\nand see instructions regarding required attachment. Otherwise, enter the applicable date.) Month _______ Day _______ Year _______\ne Contribution rate information (If more than one rate applies, check this box X and see instructions regarding required attachment. Otherwise,\ncomplete lines 13e(1) and 13e(2).)\n(1) Contribution rate (in dollars and cents) _____________\n(2) Base unit measure: X Hourly X Weekly X Unit of production X Other (specify): _______________________________\n\nSchedule R (Form 5500) 2024 Page 3\n14 Enter the number of deferred vested and retired participants (inactive participants), as of the beginning of the\n123456789012345\nplan year, whose contributing employer is no longer making contributions to the plan for:\na The current plan year. Check the box to indicate the counting method used to determine the number of\ninactive participants: X last contributing employer X alternative X reasonable approximation (see 14a\ninstructions for required attachment).....................................................................................................................\nb The plan year immediately preceding the current plan year. X Check the box if the number reported is a 14b\nchange from what was previously reported (see instructions for required attachment)..........................................\n123456789012345\nc The second preceding plan year. X Check the box if the number reported is a change from what was 14c\npreviously reported (see instructions for required attachment) ..............................................................................\n123456789012345\n15 Enter the ratio of the number of participants under the plan on whose behalf no employer had an obligation to make an\nemployer contribution during the current plan year to:\na The corresponding number for the plan year immediately preceding the current plan year ............................. 15a 123456789012345\nb The corresponding number for the second preceding plan year ..................................................................... 15b 123456789012345\n16 Information with respect to any employers who withdrew from the plan during the preceding plan year:\na Enter the number of employers who withdrew during the preceding plan year ............................................. 16a 123456789012345\nb If line 16a is greater than 0, enter the aggregate amount of withdrawal liability assessed or estimated to be 16b\nassessed against such withdrawn employers .................................................................................................\n123456789012345\n17 If assets and liabilities from another plan have been transferred to or merged with this plan during the plan year, check box and see instructions regarding\nsupplemental information to be included as an attachment ................................................................................................................................................ X\nPart VI Additional Information for Single-Employer and Multiemployer Defined Benefit Pension Plans\n18 If any liabilities to participants or their beneficiaries under the plan as of the end of the plan year consist (in whole or in part) of liabilities to such\nparticipants and beneficiaries under two or more pension plans as of immediately before such plan year, check box and see instructions regarding\nsupplemental information to be included as an attachment ................................................................................................................................................ XX\n19 If the total number of participants is 1,000 or more, complete lines (a) and (b):\na Enter the percentage of plan assets held as:\nPublic Equity: __14_.8__% Private Equity: __0_.0__% Investment-Grade Debt and Interest Rate Hedging Assets: __56_._8_%\nHigh-Yield Debt: __1_.7__% Real Assets: __2_.9__% Cash or Cash Equivalents: __0_.0__% Other: __23_._8_%\nb Provide the average duration of the Investment-Grade Debt and Interest Rate Hedging Assets:\nX 0-5 years X 5-10 years XX 10-15 years X 15 years or more\n20 PBGC missed contribution reporting requirements. If this is a multiemployer plan or a single-employer plan that is not covered by PBGC, skip line 20.\na Is the amount of unpaid minimum required contributions for all years from Schedule SB (Form 5500) line 40 greater than zero? Yes X No\nb If line 20a is \u201cYes,\u201d has PBGC been notified as required by ERISA sections 4043(c)(5) and/or 303(k)(4)? Check the applicable box:\nYes.\n_ No. Reporting was waived under 29 CFR 4043.25(c)(2) because contributions equal to or exceeding the unpaid minimum required contribution\nwere made by the 30th day after the due date.\n_ No. The 30-day period referenced in 29 CFR 4043.25(c)(2) has not yet ended, and the sponsor intends to make a contribution equal to or\nexceeding the unpaid minimum required contribution by the 30th day after the due date.\n_ No. Other. Provide explanation.__________________________________________________________________________________________\nPart VII IRS Compliance Questions\n21a Does the plan satisfy the coverage and nondiscrimination tests of Code sections 410(b) and 401(a)(4) by combining this plan with any other plans under\nthe permissive aggregation rules? Yes X No\n21b If this is a Code section 401(k) plan, check all boxes that apply to indicate how the plan is intended to satisfy the nondiscrimination requirements for\nemployee deferrals and employer matching contributions (as applicable) under Code sections 401(k)(3) and 401(m)(2).\n_ Design-based safe harbor method\n_ \u201cPrior year\u201d ADP test\n_ \u201cCurrent year\u201d ADP test\n_X N/A\n22 If the plan sponsor is an adopter of a pre-approved plan that received a favorable IRS Opinion Letter, enter the date of the Opinion Letter ___/___/_____\n(MM/DD/YYYY) and the Opinion Letter serial number__________.",
    "char_count": 15359
  },
  {
    "chunk_id": "PFIZER_135315170_001_2024_FINANCIAL_STATEMENTS",
    "schedule_type": "FINANCIAL_STATEMENTS",
    "page_range": "28, 33-47",
    "page_count": 16,
    "raw_text": "PFIZER CONSOLIDATED PENSION PLAN\nFinancial Statements and Supplemental Schedules\nDecember 31, 2024 and 2023\n(With Independent Auditors\u2019 Report Thereon)\n\nPFIZER CONSOLIDATED PENSION PLAN\nSTATEMENTS OF NET ASSETS AVAILABLE FOR PLAN BENEFITS\nAs of\nDecember 31,\n(DOLLARS IN THOUSANDS) 2024 2023\nAssets\nPlan\u2019s interest in the Pfizer Master Trust $ 9,733,376 $ 10,618,550\nInvestment in Separate Account 50 insurance contract \u2014 87,445\nInvestment in equity index fund 75,461 67,632\nInvestment in real estate funds 115,431 132,870\nCash on deposit 46,069 48,766\nTotal assets and net assets available for plan benefits $ 9,970,337 $ 10,955,263\nAmounts may not add due to rounding.\nSee accompanying Notes to Financial Statements.\n4\n\nPFIZER CONSOLIDATED PENSION PLAN\nSTATEMENTS OF CHANGES IN NET ASSETS AVAILABLE FOR PLAN BENEFITS\nYear Ended December 31,\n(DOLLARS IN THOUSANDS) 2024 2023\nPlan\u2019s interest in the net investment gain/(loss) of the Pfizer Master Trust $ 58,632 $ 1,155,188\nNet appreciation/(depreciation) in fair value of segregated investments 14,307 (1,791)\nBenefits paid (819,468) (984,365)\nPurchase of group annuity contract (277,464) \u2014\nTransfer into Plan 59,777 \u2014\nPlan to Plan transfer (7,540) \u2014\nAdministrative expenses (13,170) (18,068)\nNet increase/(decrease) (984,925) 150,963\nNet assets available for plan benefits:\nBeginning of year 10,955,263 10,804,299\nEnd of year $ 9,970,337 $ 10,955,263\nAmounts may not add due to rounding.\nSee accompanying Notes to Financial Statements.\n5\n\nPFIZER CONSOLIDATED PENSION PLAN\nSTATEMENT OF ACCUMULATED PLAN BENEFITS\n(DOLLARS IN THOUSANDS) As of December 31, 2023\nActuarial present value of accumulated plan benefits:\nVested benefits\nParticipants currently receiving payments $ 3,298,925\nOther participants 4,673,135\nNonvested benefits 178,529\nTotal actuarial present value of accumulated plan benefits $ 8,150,589\nAmounts may not add due to rounding.\nSee accompanying Notes to Financial Statements.\n6\n\nPFIZER CONSOLIDATED PENSION PLAN\nSTATEMENT OF CHANGES IN ACCUMULATED PLAN BENEFITS\n(DOLLARS IN THOUSANDS) Year Ended December 31, 2023\nActuarial present value of accumulated plan benefits at beginning of year $ 8,602,258\nIncrease/(decrease) during the year attributable to:\nBenefits accumulated and plan experience 85,653\nInterest 603,215\nBenefits paid (984,365)\nChange in actuarial assumptions (156,171)\nActuarial present value of accumulated plan benefits at end of year $ 8,150,589\nAmounts may not add due to rounding.\nSee accompanying Notes to Financial Statements.\n7\n\nPFIZER CONSOLIDATED PENSION PLAN\nNOTES TO FINANCIAL STATEMENTS\n1. Description of the Plan\nThe following description of the Pfizer Consolidated Pension Plan (the Plan) provides only general information. Participants\nshould refer to the Plan document for a more complete description of the Plan\u2019s provisions.\nGeneral\nThe Plan is a defined benefit pension plan funded entirely by contributions made by Pfizer Inc. and affiliated companies\n(Pfizer, the Company or Plan Sponsor), except for certain legacy Warner-Lambert participant contributions before 1977. In\n2010, the Plan was amended to close participation to employees hired after December 31, 2010. Any employee hired prior to\nJanuary 1, 2011 within a group or class designated by the Company is eligible to participate in the Plan as of the date of his or\nher employment. The Plan is a qualified plan under Section 401(a) of the Internal Revenue Code of 1986, as amended (IRC).\nThe Plan is subject to the provisions of the Employee Retirement Income Security Act of 1974, as amended (ERISA).\nThe Plan is an umbrella plan that is composed of the following sub-plans: Pfizer Sub-Plan, Warner-Lambert Sub-Plan,\nPharmacia Sub-Plan, Wyeth Retirement Plan \u2013 U.S. Sub-Plan, Pharmacia Cash Balance Sub-Plan, Alpharma Inc. Sub-Plan\nFaulding Inc. Sub-Plan and Wyeth Coordinated Bargaining Retirement Plan \u2013 U.S. (Wyeth) Sub-Plan.\nThe Plan\u2019s assets are held in, and until December 31, 2024, were held with the assets of one other U.S. pension plan (Wyeth)\nand, when funded, a 401(h) account of the Company to form the Master Trust Agreement between Pfizer Inc. and The\nNorthern Trust Company (Pfizer Master Trust) held by The Northern Trust Company (Trustee or Northern Trust). The Pfizer\nMaster Trust is intended to be a qualified trust exempt from taxation under Section 501(a) of the IRC. Plan Sponsor\ncontributions and benefit payments are identified with respect to each participating plan by the Trustee. See Note 6 for\nadditional information.\nAs of December 31, 2024, the Plan also held (i) a segregated investment in real estate portfolio funds managed by J.P.\nMorgan Investment Management Inc. (JP Morgan) and Morgan Stanley Real Estate Investor Services (Morgan Stanley) with\nNorthern Trust as trustee and (ii) a segregated investment in the BlackRock Institutional Trust Company, NA (BlackRock)\nEquity Index Fund with Northern Trust as trustee. As of December 31, 2023, the Plan also held a segregated investment in a\nseparate custodial account held by Metropolitan Life Insurance Company (MetLife) called Separate Account 50 with\nNorthern Trust as trustee. See Note 2.\nEffective December 20, 2021, the Plan was amended to allow usage of the medical benefit accounts in the Plan in accordance\nwith Section 401(h) of the IRC. See 401(h) Account section below in Note 1 for additional information.\nStarting in 2019, the Company began adding up to a total of five points to a participant\u2019s age and/or service under certain\nU.S. separation programs to help those participants age 50 and older as of their termination date reach retirement milestones\nunder certain benefits. Effective June 30, 2023, this \"five points\" provision expired.\nFrom June 23, 2023 to July 20, 2023, eligible active colleagues, who were at least age 59 \u00bd and eligible for a full unreduced\npension benefit, were provided the ability to commence their pension benefits as an annuity or a lump sum with lump sums\nbeing transferred to the Pfizer Savings Plan (PSP), a Pfizer defined contribution plan. The total amount transferred in the\nfourth quarter of 2023 was $63.7 million. These amounts are included in benefits paid in the Statements of Changes in Net\nAssets Available for Plan Benefits and the Statement of Changes in Accumulated Plan Benefits. There were no such transfers\nin 2024.\nOn December 1, 2024, Wyeth was frozen to all participation and further benefit accruals, though no eligible participants were\nactive in the Wyeth plan since June 1, 2021. Effective December 31, 2024, Wyeth was merged into the Plan, and all account\nbalances totaling $59.8 million in assets were transferred to the Plan.\nVesting\nPlan participants acquired a vested interest in their benefits under the Plan upon completion of three years of vesting service\nor attaining their normal retirement age of 65 per the Plan provisions. If a Plan participant did not complete at least\nthree years of vesting service or retire under the normal, early or late retirement provisions of the Plan, the participant was not\nentitled to any retirement benefits from the Plan.\n8\n\nPFIZER CONSOLIDATED PENSION PLAN\nNOTES TO FINANCIAL STATEMENTS\nFunding Policy\nPlan Sponsor contributions are actuarially determined based upon the unit credit cost method. The Plan Sponsor contributes\nat least such amounts that are determined to be necessary to satisfy the minimum funding requirements of ERISA on an\nactuarial basis and to provide the Plan with assets sufficient to meet the benefits to be paid to Plan participants or their\nbeneficiaries. During the years ended December 31, 2024 and 2023, the Plan Sponsor\u2019s contributions met the minimum\nfunding requirements of ERISA.\nBenefits\nAs noted above, the Plan is an umbrella plan consisting of several sub-plans. All eligible employees employed by the\nCompany on January 1, 2012 and earning benefits under one of the sub-plan formulas were transitioned to the Pfizer sub-plan\nformula, otherwise referred to as the Pfizer Retirement Annuity Plan (PRAP). The sub-plans retained their original benefit\nformulas for applicable credited service prior to transitioning to the PRAP formula on January 1, 2012. Salary recognized for\neligible earnings was frozen as of December 31, 2017 for all sub-plans that had not already been previously frozen, with the\nexception of certain bonuses paid during March 2018 that apply to the 2017 PRAP and Wyeth Retirement Plan \u2013 U.S. Sub-\nPlan pension accruals. The Plan continues to recognize service towards vesting and retirement milestones only. Specific\nbenefit information can be referenced in the Plan document.\nPlan Administration\nThe Retirement Committee of Pfizer Inc. is the Plan Administrator and the \u201cnamed fiduciary\u201d of the Plan. The Plan Assets\nCommittee of Pfizer Inc. is responsible for the oversight of the investments, the Trustee, the custodians and the investment\nmanagers of the Plan assets.\n401(h) Account\nIn June 2006, the Plan was amended to include a medical benefit component (401(h) account), in addition to the normal\nretirement benefits, to fund a portion of the post-retirement health benefit obligations for certain eligible retirees and their\nbeneficiaries in accordance with Section 401(h) of the IRC. A separate account in the Pfizer Master Trust was established and\nmaintained for the net assets related to the 401(h) account. Effective January 1, 2013 the 401(h) account could only be used\nto provide prescription drug benefits for certain eligible retirees and their beneficiaries. As of January 2016 the account was\ndepleted, but was again funded by the Company on December 21, 2021. Effective January 1, 2022, the limitation on the\n401(h) account's usage for prescription drugs was eliminated and the account can now be used for all medical expenses\nincurred by eligible retirees and their beneficiaries on or after this date. In 2023, the account was again depleted.\nIn accordance with IRC Section 401(h), the Plan's investments in the 401(h) account may not be used for, or diverted to, any\npurpose other than providing reimbursement for eligible medical claims for retirees and their beneficiaries. The related\nobligations for eligible medical claims are not included in this Plan's obligations for accumulated plan benefits (see Note 4),\nbut are reflected as obligations in the financial statements of the Pfizer Retiree Medical Plan (the PRMP), a welfare benefit\nplan of the Company. Plan participants do not contribute to the 401(h) account. Employer contributions or qualified transfers\nto the 401(h) account are determined annually and are at the discretion of the Plan Sponsor.\n2. Summary of Significant Accounting Policies\nBasis of Accounting\nThe financial statements of the Plan are prepared on the accrual basis of accounting.\nSome amounts in the financial statements, notes to financial statements and supplemental schedule of the Plan may not add\ndue to rounding.\nUse of Estimates\nThe preparation of financial statements in conformity with U.S. generally accepted accounting principles (U.S. GAAP)\nrequires Plan management to make estimates and assumptions that affect the reported amounts of assets, liabilities and\nchanges therein, disclosure of contingent assets and liabilities, and the actuarial present value of accumulated plan benefits at\nthe date of the financial statements and changes therein. Actual results could differ from those estimates.\n9\n\nPFIZER CONSOLIDATED PENSION PLAN\nNOTES TO FINANCIAL STATEMENTS\nInvestment Valuation and Income Recognition\nMaster Trust Accounting \u2013 The Plan\u2019s assets are held in the Pfizer Master Trust. The assets of the plans comprising the Pfizer\nMaster Trust have been commingled for investment and administrative purposes. Accordingly, the plans do not own specific\nassets in the Pfizer Master Trust, but rather maintain an undivided beneficial interest in such assets. The allocation of the\nassets and of the earnings/(losses) and expenses of the Pfizer Master Trust among the plans is determined by the Trustee in\naccordance with the Master Trust Agreement. The Trustee maintains separate accounts reflecting the equitable share in the\nPfizer Master Trust of each plan. Company contributions, benefit payments and other transactions relating to a specific plan\nare accounted for as transactions affecting that plan\u2019s separate account. Each plan\u2019s separate account is allocated its equitable\nshare of each item of collected or accrued investment income, gain or loss, general expenses and other transactions allocable\nfrom the Pfizer Master Trust as a whole based on the undivided beneficial interest of each plan in the Pfizer Master Trust.\nInvestments \u2013 Each plan\u2019s interest in the net assets of the Pfizer Master Trust is based on the beginning-of-the-year fair value\nof the plan\u2019s interest in the Pfizer Master Trust plus actual contributions and allocated investment income/(loss), less actual\ndistributions and allocated administrative expenses. The Pfizer Master Trust maintains investment records on an accrual\nbasis. Purchases and sales of securities are reflected on a trade-date basis.\nInvestment Valuation \u2013 Investments of the Pfizer Master Trust that are traded on a national securities exchange are valued\nmonthly based upon the last published quotations for the last business day of the month. Certain short-term investments held\nby the Pfizer Master Trust are valued at cost, which approximates fair value. Common/commingled funds are valued at net\nasset value (NAV) per unit as determined by the commingled trusts as of the valuation date, based on the fair values of the\nunderlying assets. Other investments of the Pfizer Master Trust are valued at fair value based on market prices, if available,\nor other appropriate values, including redemption values, underlying ownership interests and values determined by third-\nparty appraising services (see Note 6).\nThe Plan also invested in a separate account held by MetLife called Separate Account 50. Separate Account 50 represents an\ninsurance group annuity contract (GAC) between the Plan and MetLife to provide certain guaranteed annuity benefits to a\ndesignated group of participants for the life of the contract. The Separate Account 50 insurance contract invested in interest\nbearing cash, U.S. Government securities and corporate debt instruments. U.S. Government securities and corporate debt\ninstruments are valued at fair value on the basis of reputable pricing services that utilize pricing models which incorporate\ntrade, bid and other market information. This investment was disposed of during 2024.\nThe Plan holds a segregated investment in a commingled equity index fund, which is categorized as a Level 2 investment.\nNet appreciation/(depreciation) consists of realized and unrealized gains and losses (see Note 7).\nThe Plan holds a segregated investment in several commingled real estate portfolio funds, which are primarily valued at NAV\nand are broadly diversified by geographic region and property type (e.g., apartments and office buildings). The properties\nheld within the funds are independently appraised on a rotating basis throughout the year, where each property is appraised at\nleast once during the year.\nInvestment Income/(Loss) \u2013 Net appreciation/(depreciation) in fair value of investments consists of realized and unrealized\ngains and losses. Gains and losses on security transactions are computed on an average cost basis. Interest and other income\nare recorded as earned. Dividend income is recorded on the ex-dividend date.\nPayment of Benefits\nBenefit payments to participants are recorded upon distribution.\nAdministrative Expenses\nAll direct costs and expenses of administering the Plan are paid by the Plan or by the Company.\n3. Plan Termination\nThe Company expects to continue the Plan indefinitely, although it may discontinue it at any time by action of the\nCompany\u2019s Board of Directors, subject to provisions set forth in ERISA. In the event of termination, the Plan provides for the\nPlan\u2019s interest in the net assets of the Pfizer Master Trust and the segregated investment accounts to be allocated in\n10\n\nPFIZER CONSOLIDATED PENSION PLAN\nNOTES TO FINANCIAL STATEMENTS\naccordance with the provisions of ERISA and its related regulations. Generally, the Plan will provide the following benefits\nin the order indicated:\ni. Annuity benefits being paid to those former employees (or their beneficiaries) who have been retired with benefits under\nthe normal form of an annuity under the Plan for at least three years prior to the date of termination of the Plan.\nii. Annuity benefits available to those employees (or their beneficiaries) who have been eligible to retire with benefits under\nthe normal form of an annuity under the Plan for at least three years prior to the date of termination of the Plan.\niii. Other vested benefits insured by the Pension Benefit Guaranty Corporation (PBGC), a U.S. government agency, up to\napplicable limitations.\niv. All other vested benefits (i.e., vested benefits not insured by the PBGC).\nv. All non-vested benefits.\nCertain benefits under the Plan are insured by the PBGC if the Plan terminates. Generally, the PBGC guarantees most vested\nnormal age retirement benefits, early retirement benefits and certain disability and survivor\u2019s pensions. However, the PBGC\ndoes not guarantee all types of benefits under the Plan, and the amount of benefit protection is subject to certain limitations.\nVested benefits under the Plan are guaranteed at the level in effect on the date of the Plan\u2019s termination.\nWhether all participants receive their benefits should the Plan terminate at some future time will depend on the sufficiency, at\nthat time, of the Plan\u2019s net assets to provide for accumulated benefit obligations and may also depend on the financial\ncondition of the Plan Sponsor and the level of benefits guaranteed by the PBGC.\n4. Actuarial Present Value of Accumulated Plan Benefits\nAccumulated plan benefits are those future periodic payments, including lump sum distributions, that are attributable under\nthe Plan\u2019s provisions to the service rendered by the employees. Accumulated plan benefits include benefits expected to be\npaid to (a) retired or terminated employees or their beneficiaries, (b) beneficiaries of employees who have died and (c)\npresent employees or their beneficiaries.\nThe actuarial present value of accumulated plan benefits is determined by an independent actuary as of the beginning of the\nPlan year and is that amount that results from applying actuarial assumptions to adjust the accumulated plan benefits to\nreflect the time value of money (through discounts for interest) and the probability of payment (by means of decrements, such\nas for death, disability, withdrawals or retirement) between the valuation date and the expected date of payment. The\nsignificant actuarial assumptions used in the valuation as of January 1, 2024 were (a) life expectancy of participants (the sex-\ndistinct Pri-2012 mortality tables, without collar adjustment, with generational projection scale MMP-2021), (b) retirement\nage assumptions (the assumed average retirement age was 61 in 2024 and 2023) and (c) expected investment return utilized\nas the interest rate used to discount the obligation (long-term rate of return on assets was 8.00% as of December 31, 2023 and\n7.50% as of December 31, 2022).\nThe foregoing actuarial assumptions are based on the presumption that the Plan will continue. If the Plan were to terminate,\ndifferent actuarial assumptions and other factors might be applicable in determining the actuarial present value of\naccumulated plan benefits.\nIn October 2024, the Plan purchased a new GAC from a third-party insurance company, which replaced an existing\nparticipating agreement with the same insurer. This GAC transferred direct payment obligations from the Plan to the third-\nparty insurance company, updated benefit provisions reflected in the existing GAC, and added coverage for residual benefits\nfor certain retirees and deferred participants whose benefit were partially covered under the existing GAC. The third-party\ninsurance company assumed future benefit obligations of $221.3 million as of the transaction date. The benefit obligations\nassociated with this contract as of January 1, 2024 were $223.6 million. The Plan expects to finalize the remaining regulatory\napprovals for this transaction with the New York State Department of Financial Services in due course.\n5. Tax Status of the Plan\nThe Internal Revenue Service (IRS) has determined and informed the Plan Sponsor by letter dated November 7, 2017 that the\nPlan and related trust are designed in accordance with the applicable sections of the IRC. The Plan has been amended since\nreceiving the determination letter; however, the Plan Administrator believes the Plan is currently designed and being operated\nin compliance with the applicable requirements of the IRC. Accordingly, no provision has been made for U.S. federal income\ntaxes in the accompanying financial statements.\n11\n\nPFIZER CONSOLIDATED PENSION PLAN\nNOTES TO FINANCIAL STATEMENTS\nU.S. GAAP requires Plan management to evaluate tax positions taken by the Plan and recognize a tax liability (or asset) if the\nPlan has taken an uncertain position that more likely than not would not be sustained upon examination by the IRS. The Plan\nAdministrator has confirmed that there are no uncertain tax positions taken that would require recognition of a liability (or\nasset) or disclosure in the financial statements. The Plan is subject to routine audits by taxing jurisdictions; however, there are\ncurrently no audits for any tax periods in progress. The Plan Administrator believes that the Plan is generally no longer\nsubject to income tax examinations for years prior to 2021.\n6. Pfizer Master Trust Financial Information\nThe Plan\u2019s assets are held in the Pfizer Master Trust, and until December 31, 2024, the Plan's assets were held along with the\nassets of one other U.S. pension plan. Previously, the Pfizer Master Trust also held a 401(h) account of the Company. Each\nparticipating plan had an undivided beneficial interest in the net assets of the Pfizer Master Trust. The net assets of the Pfizer\nMaster Trust are held by the Trustee.\nAt December 31, 2024 and 2023, the Plan\u2019s interest in the net assets of the Pfizer Master Trust was 100.0% and 99.4%,\nrespectively.\nThe net assets of the Pfizer Master Trust were as follows:\nAs of December 31,\n(DOLLARS IN THOUSANDS) 2024 2023\nPlan's Plan's\nInterest in Interest in\nMaster Master Master Master\nTrust Trust Trust Trust\nBalance Balances Balance Balances\nAssets\nInvestments at fair value:\nCash and cash equivalents $ 533,737 $ 533,737 $ 636,190 $ 632,451\nEquity securities:\nGlobal equity securities 1,340,096 1,340,096 1,535,896 1,526,869\nEquity commingled funds 20,925 20,925 32,918 32,725\nFixed income securities:\nCorporate debt securities 2,560,388 2,560,388 3,348,701 3,329,019\nGovernment and government agency obligations 2,321,723 2,321,723 2,239,937 2,226,772\nFixed income commingled funds 42,541 42,541 25,145 24,997\nOther investments:\nPartnership investments(a) 2,690,592 2,690,592 2,553,997 2,538,986\nOther commingled funds(b) 222,521 222,521 343,936 341,915\nTotal investments 9,732,521 9,732,521 10,716,719 10,653,731\nReceivables\nSecurities sold 9,745 9,745 41,423 41,180\nAccrued interest and dividends 67,024 67,024 65,635 65,249\nTotal receivables 76,769 76,769 107,057 106,428\nTotal assets 9,809,290 9,809,290 10,823,776 10,760,159\nLiabilities\nSecurities purchased 70,052 70,052 135,083 134,289\nAccounts payable and accrued liabilities 5,862 5,862 7,363 7,320\nTotal liabilities 75,914 75,914 142,446 141,609\nNet assets $ 9,733,376 $ 9,733,376 $ 10,681,330 $ 10,618,550\n(a) Primarily includes investments in private equity, private debt, real estate and venture capital as of December 31, 2024 and 2023.\n(b)Primarily includes investments in hedge funds and real estate funds as of December 31, 2024 and 2023.\n12\n\nPFIZER CONSOLIDATED PENSION PLAN\nNOTES TO FINANCIAL STATEMENTS\nThe changes in net assets of the Pfizer Master Trust were as follows:\nYear Ended December 31,\n(DOLLARS IN THOUSANDS) 2024 2023\nDividends $ 26,087 $ 34,386\nInterest 223,700 257,907\nNet appreciation/(depreciation) in fair value of investments (222,100) 790,001\nOther income 112,892 75,640\nInvestment expenses (78,967) (59,628)\nPurchase of group annuity contract(a) (209,330) \u2014\nDistributions to participants and their beneficiaries (824,014) (1,003,784)\nTransfer from/(to) segregated investment accounts 37,053 (111,022)\nAdministrative expenses (13,275) (18,123)\nNet increase/(decrease) (947,954) (34,623)\nNet assets:\nBeginning of year 10,681,330 10,715,953\nEnd of year $ 9,733,376 $ 10,681,330\nPlan\u2019s interest in the net investment gain/(loss) of the Pfizer Master Trust $ 58,632 $ 1,155,188\n(a) In October 2024, the Plan purchased a GAC from a third party insurance company for $277.5 million. Wyeth also purchased a GAC from a third party\ninsurance company for $20.7 million. The purchases were completed through the conversion of $88.8 million of pre-existing GACs to non participating\ncontracts, coupled with a cash payout from the PMT for $209.3 million. See Note 4 for further information.\nAs of December 31, 2024, the Pfizer Master Trust did not hold an investment in Pfizer Inc. common stock. As of December\n31, 2023, the Pfizer Master Trust's investment in Pfizer Inc. common stock totaled approximately $196,800. The Pfizer\nMaster Trust did not receive dividends in 2024 from its previously held investment in Pfizer Inc. common stock. The Pfizer\nMaster Trust received dividends in 2023 from its then current and previously held investment in Pfizer Inc. common stock of\napproximately $21,700.\n7. Fair Value Measurements\nThe framework for measuring fair value provides a fair value hierarchy that prioritizes the inputs to valuation techniques used\nto measure fair value. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in\nan orderly transaction between market participants at the measurement date. There are three levels of inputs to fair value\nmeasurements \u2013 Level 1 meaning the use of quoted prices for identical assets or liabilities in active markets; Level 2 meaning\nquoted prices for similar assets or liabilities in active markets or quoted prices for identical or similar assets or liabilities in\nmarkets that are not active, or inputs other than quoted prices that are directly or indirectly observable, or inputs that are\nderived principally from, or corroborated by, observable market data by correlation or other means; and Level 3 meaning the\nuse of unobservable inputs that reflect estimates and assumptions.\nSee Note 2 for information regarding the methods used to determine the fair value of the investments in the Pfizer Master\nTrust. These methods may produce a fair value calculation that may not be indicative of net realizable value or reflective of\nfuture fair values. Furthermore, while the Plan believes its valuation methods are appropriate and consistent with other\nmarket participants, the use of different methodologies or assumptions to determine the fair value of certain financial\ninstruments could result in a different fair value measurement at the reporting date.\nThe valuation of Level 3 investments requires significant judgment due to the absence of quoted market prices, the inherent\nlack of liquidity, and the long-term nature of such assets. Certain Level 3 investments are valued based upon\nrecommendations of the Company\u2019s investment managers incorporating factors such as contributions and distributions,\nmarket transactions, market comparables and performance multiples.\n13\n\nPFIZER CONSOLIDATED PENSION PLAN\nNOTES TO FINANCIAL STATEMENTS\nFair Value Measurements \u2013 Pfizer Master Trust\nThe following tables set forth by level, within the fair value hierarchy, the Pfizer Master Trust's investments at fair value:\nInvestments at Fair Value as of December 31, 2024\n(DOLLARS IN THOUSANDS) Level 1 Level 2 Level 3 Total\nCash and cash equivalents $ 10,074 $ 523,662 $ \u2014 $ 533,737\nEquity securities:\nGlobal equity securities 1,339,934 \u2014 162 1,340,096\nEquity commingled funds \u2014 20,925 \u2014 20,925\nFixed income securities:\nCorporate debt securities 4,281 2,556,107 \u2014 2,560,388\nGovernment and government agency obligations(a) \u2014 2,321,723 \u2014 2,321,723\nFixed income commingled funds \u2014 11,799 \u2014 11,799\nTotal investments in fair value hierarchy $ 1,354,289 $ 5,434,216 $ 162 6,788,666\nAssets measured at net asset value(b) 2,943,855\nTotal investments at fair value $ 9,732,521\nInvestments at Fair Value as of December 31, 2023\n(DOLLARS IN THOUSANDS) Level 1 Level 2 Level 3 Total\nCash and cash equivalents $ 5,456 $ 630,733 $ \u2014 $ 636,190\nEquity securities:\nGlobal equity securities 1,535,364 \u2014 532 1,535,896\nEquity commingled funds \u2014 32,918 \u2014 32,918\nFixed income securities:\nCorporate debt securities 1,493 3,347,209 \u2014 3,348,701\nGovernment and government agency obligations(a) \u2014 2,239,937 \u2014 2,239,937\nFixed income commingled funds \u2014 13,731 \u2014 13,731\nPartnership investments 2 \u2014 \u2014 2\nTotal investments in fair value hierarchy $ 1,542,315 $ 6,264,527 $ 532 7,807,374\nAssets measured at net asset value(b) 2,909,344\nTotal investments at fair value $ 10,716,719\n(a) Government and agency obligations are inclusive of repurchase agreements which are in turn used to increase the Plan's allocation to government and\nagency obligations.\n(b)Certain investments that are measured at NAV per share (or its equivalent) have not been classified in the fair value hierarchy. The NAV amounts\npresented in these tables are intended to permit reconciliation of the fair value hierarchy to the amounts presented in the statements of net assets\navailable for plan benefits.\nDuring the years ended December 31, 2024 and 2023, the Pfizer Master Trust held Level 3 investments in global equity\nsecurities. There were $30,000 and $124,000 purchases of Level 3 investments in global equity securities in 2024 and 2023,\nrespectively. There were $48,000 and $53,000 sales of Level 3 investments in global equity securities in 2024 and 2023,\nrespectively. There were no issues of Level 3 global equity securities in 2024 or 2023. There were no transfers into and no\ntransfers out of Level 3 global equity securities in 2024. There were $11,000 transfers into and $42,000 transfers out of Level\n3 global equity securities in 2023.\nFair Value Measurements \u2013 Segregated Investment Accounts\nThe following tables set forth by level, within the fair value hierarchy, the Plan\u2019s investments in segregated investment\naccounts at fair value:\nInvestments at Fair Value as of December 31, 2024\n(DOLLARS IN THOUSANDS) Level 1 Level 2 Level 3 Total\nInvestment in equity index fund $ \u2014 $ 75,461 $ \u2014 $ 75,461\nCash and cash equivalents held in real estate funds \u2014 2,309 \u2014 2,309\nTotal investments in fair value hierarchy $ \u2014 $ 77,771 $ \u2014 77,771\nInvestment in real estate funds measured at net asset value(a) 113,122\nTotal segregated investment accounts at fair value $ 190,892\n14\n\nPFIZER CONSOLIDATED PENSION PLAN\nNOTES TO FINANCIAL STATEMENTS\nInvestments at Fair Value as of December 31, 2023\n(DOLLARS IN THOUSANDS) Level 1 Level 2 Level 3 Total\nInvestment in Separate Account 50 insurance contract $ \u2014 $ 87,445 $ \u2014 $ 87,445\nInvestment in equity index fund \u2014 67,632 \u2014 67,632\nCash and cash equivalents held in real estate funds \u2014 750 \u2014 750\nTotal investments in fair value hierarchy $ \u2014 $ 155,827 $ \u2014 155,827\nInvestment in real estate funds measured at net asset value(a) 132,120\nTotal segregated investment accounts at fair value $ 287,947\n(a) Certain investments that are measured at NAV per share (or its equivalent) have not been classified in the fair value hierarchy. The NAV amounts\npresented in these tables are intended to permit reconciliation of the fair value hierarchy to the amounts presented in the statements of net assets\navailable for plan benefits.\n8. Net Asset Value (NAV) Per Share\nThe Pfizer Master Trust owns units in commingled funds and limited partnership funds that invest in various types of assets.\nCommingled funds give investors the right, subject to predetermined redemption procedures, to redeem their investment at\nNAV. Most limited partnerships do not have redemption features. Most investments in limited partnerships represent long\nterm commitments, draw capital for investment in the first several years, and make distributions to investors in the last\nseveral years of the life of the partnership (as investments are liquidated). The distributions from the limited partnership\nportfolios are dependent on market conditions and unpredictable by nature, but some level of distributions can be expected\neach year. Plan management estimates that the majority of the currently outstanding fair value of the limited partnerships\nwould be distributed over a period of seven to twelve years.\nCommingled Funds\nThe following table summarizes the commingled funds investments as of December 31, 2024, for which NAV per share as a\npractical expedient is used to measure fair value:\n(DOLLARS IN THOUSANDS)\nRedemption Redemption Restrictions as of\nInvestments Fair Value Redemption Frequency Notice Period December 31, 2024\nHedge fund of funds $ 219,191 Quarterly 30 days Subject to varying gates\nReal estate 3,330 None None Closed ended commingled funds\nClosed ended commingled funds\nNone or 10 or 10% gate at the master fund\nFixed income 30,742 None or Monthly days level\nTotal commingled funds $ 253,263\nPartnership Investments\nThe following table summarizes the partnership investments as of December 31, 2024, for which NAV per share as a\npractical expedient is used to measure fair value:\n(DOLLARS IN THOUSANDS)\nRedemption Unfunded\nInvestments Fair Value Frequency Commitments Average Life of Distribution\nPrivate debt $ 460,142 No redemption feature $ 159,000 Approximately 7 to 9 years\nPrivate equity 1,889,992 No redemption feature 533,000 Approximately 9 to 12 years\nReal estate 312,974 No redemption feature 140,000 Approximately 9 to 12 years\nVenture capital 27,483 No redemption feature 15,500 Approximately 9 to 12 years\nTotal partnership investments $ 2,690,592\n15\n\nPFIZER CONSOLIDATED PENSION PLAN\nNOTES TO FINANCIAL STATEMENTS\nCommingled Funds\nThe following table summarizes the commingled funds investments as of December 31, 2023, for which NAV per share as a\npractical expedient is used to measure fair value:\n(DOLLARS IN THOUSANDS)\nRedemption Redemption Redemption Restrictions as of\nInvestments Fair Value Frequency Notice Period December 31, 2023\nHedge fund of funds $ 340,579 Quarterly 30 days Subject to varying gates\nReal estate 3,357 None None Closed ended commingled funds\nFixed income 11,414 None None Closed ended commingled funds\nTotal commingled funds $ 355,350\nPartnership Investments\nThe following table summarizes the partnership investments as of December 31, 2023, for which NAV per share as a\npractical expedient is used to measure fair value:\n(DOLLARS IN THOUSANDS)\nRedemption Unfunded\nInvestments Fair Value Frequency Commitments Average Life of Distribution\nPrivate debt $ 450,728 No redemption feature $ 153,000 Approximately 7 to 9 years\nPrivate equity 1,780,637 No redemption feature 576,000 Approximately 9 to 12 years\nReal estate 305,054 No redemption feature 178,000 Approximately 9 to 12 years\nVenture capital 17,575 No redemption feature 20,000 Approximately 9 to 12 years\nTotal partnership investments $ 2,553,994\nSegregated Investment Accounts\nIn the statements of net assets available for benefits, approximately $113.1 million and $132.1 million of investments in real\nestate funds as of December 31, 2024 and 2023, respectively, are in collective trust funds with the objective of investing in\nvalue-added real estate opportunities primarily in the office, industrial, residential and retail sectors and are valued at the\nNAV per share. The funds seek to provide a moderate level of current income and high residual property appreciation. The\nfunds do not attempt to benchmark geographic or property type diversification and have investments spanning the major U.S.\nmarkets and property types, including a balanced mix of stabilized properties and value-added properties with appreciation\npotential. Prior to February 2023, the segregated real estate investment held only one collective trust fund. In February 2023,\ntwo additional collective trust funds that were previously classified as non-segregated were recategorized into the segregated\nreal estate investment. The Company has no unfunded commitment relating to these investments as of December 31, 2024\nand 2023.\n9. Risks and Uncertainties\nThe Pfizer Master Trust invests in various investment securities, which may include Pfizer Inc. common stock. These\ninvestment securities are exposed to various risks such as interest rate, market and credit risks. Due to the level of risk\nassociated with certain investment securities, it is at least reasonably possible that changes in the fair value of investment\nsecurities will occur in the near term and that such changes could materially affect the amounts reported in the statements of\nnet assets available for plan benefits.\nPlan Sponsor contributions to be made and the actuarial present value of accumulated plan benefits are reported based on\ncertain assumptions pertaining to interest rates, inflation rates and employee demographics, all of which are subject to\nchange. Due to uncertainties inherent in the estimations and assumptions process, it is at least reasonably possible that\nchanges in these estimates and assumptions in the near term could materially affect the amounts reported in the financial\nstatements of the Plan.\n10. Related Party and Party-In-Interest Transactions\nHistorically, certain Plan investments in the Pfizer Master Trust have included common shares of Pfizer Inc., and therefore,\nthese transactions qualify as party-in-interest transactions. In 2024, the Pfizer Master Trust did not hold investments in\ncommon shares of Pfizer Inc.\n16\n\nPFIZER CONSOLIDATED PENSION PLAN\nNOTES TO FINANCIAL STATEMENTS\nCertain Plan investments are managed by Northern Trust and MetLife. Northern Trust is the trustee and custodian, as well as\nthe asset manager for certain investments, of the Pfizer Master Trust, as defined by the Plan. MetLife is the custodian of the\ninvestment in the Separate Account 50 insurance contract. Both Northern Trust and MetLife transactions qualify as party-in-\ninterest transactions.\n11. Subsequent Events\nThe Plan Sponsor has evaluated subsequent events from the statement of net assets available for plan benefits date through\nAugust 19, 2025, the date at which the financial statements were available to be issued, and no events were noted which\nwarrant adjustments to, or disclosure in, the financial statements.\n12. Reconciliation of Financial Statements to Form 5500\nThe following is a reconciliation of net assets available for plan benefits per the financial statements to the Form 5500:\nAs of December 31,\n(DOLLARS IN THOUSANDS) 2024 2023\nNet assets available for plan benefits per the financial statements $ 9,970,337 $ 10,955,263\nLess amounts allocated to withdrawing participants (11,050) (86,297)\nNet assets available for plan benefits per Form 5500 $ 9,959,287 $ 10,868,966\nThe net assets of the 401(h) account included in the Form 5500 are not available to pay pension benefits, but can be used only\nto pay retiree health benefits.\nFor financial statement purposes, participant withdrawals and distributions are recorded when paid rather than when\nprocessed and approved for payment. Amounts allocated to withdrawing participants are recorded on Form 5500 for benefit\nclaims that have been processed and approved for payment prior to December 31, 2024 and 2023, but not yet paid as of that\ndate.\nThe following is a reconciliation of benefits paid per the financial statements to the Form 5500:\nYear Ended December 31,\n(DOLLARS IN THOUSANDS) 2024 2023\nBenefits paid per the financial statements $ 819,468 $ 984,365\nAdd amounts allocated to withdrawing participants for the current year 11,050 86,297\nLess amounts allocated to withdrawing participants for the prior year (86,297) (17,471)\nBenefits paid per Form 5500 $ 744,221 $ 1,053,191\n17\n\nPFIZER CONSOLIDATED PENSION PLAN\nSCHEDULE G, PART III - SCHEDULE OF NONEXEMPT TRANSACTIONS\nFor the Year Ended December 31, 2024\n(a) (b) (c) (d) (e) (f) (g) (h) (i) (j)\nDescription of\nRelationship to transaction (including Expense Net\nplan, employer, or interest rate, maturity, incurred Current gain\nother party-in- collateral, par or Purchase Selling Lease with Cost of value of or\nIdentity of party involved interest maturity value) price price Rental transaction asset asset (loss)\nPart III\nMaster Trust Between Pfizer\nInc. and the Northern Trust Plan trust/\nCompany trustee See * below $ \u2014 $ 93,400 $ \u2014 $ \u2014 $ 93,400 $ 93,400 $ \u2014\nMaster Trust Between Pfizer\nInc. and the Northern Trust Plan trust/\nCompany trustee See ** below $ \u2014 $ 677,135 $ \u2014 $ \u2014 $ 677,135 $ 677,135 $ \u2014\nMaster Trust Between Pfizer\nInc. and the Northern Trust Plan trust/\nCompany trustee See *** below $ \u2014 $ 782,986 $ \u2014 $ \u2014 $ 782,986 $ 782,986 $ \u2014\nMaster Trust Between Pfizer\nInc. and the Northern Trust Plan trust/\nCompany trustee See **** below $ \u2014 $ 1,101,160 $ \u2014 $ \u2014 $ 1,101,160 $ 1,101,160 $ \u2014\n* This amount represents a payment of ineligible expenses from plan assets paid in 2022 by the Master Trust. This payment and interest of $15,609\nwere repaid in 2024.\n** This amount represents payments of ineligible expenses from plan assets paid in 2023 by the Master Trust. These payments and interest of $52,294\nwere repaid in 2024.\n*** This amount represents payments of ineligible expenses from plan assets paid in 2024 by the Master Trust. These payments and interest of $43,135\nwere repaid in 2024.\n**** This amount represents payments of ineligible expenses from plan assets paid in 2024 by the Master Trust. These payments and interest of $39,160\nwill be repaid in 2025.\nSee accompanying Independent Auditors\u2019 Report.\n18",
    "char_count": 42079
  },
  {
    "chunk_id": "PFIZER_135315170_001_2024_SCHEDULE_OF_ASSETS",
    "schedule_type": "SCHEDULE_OF_ASSETS",
    "page_range": "29-32, 48-107",
    "page_count": 64,
    "raw_text": "PFIZER CONSOLIDATED PENSION PLAN\nTable of Contents\nPage\nIndependent Auditors\u2019 Report Beginning on page 1\nFinancial Statements\nStatements of Net Assets Available for Plan Benefits as of December 31, 2024 and 2023 4\nStatements of Changes in Net Assets Available for Plan Benefits for the years ended\nDecember 31, 2024 and 2023 5\nStatement of Accumulated Plan Benefits as of December 31, 2023 6\nStatement of Changes in Accumulated Plan Benefits for the year ended December 31, 2023 7\nNotes to Financial Statements Beginning on page 8\nSupplemental Schedules*\nSchedule G, Part III \u2013 Schedule of Nonexempt Transactions 18\nSchedule H, Line 4i \u2013 Schedule of Assets (Held at End of Year) 19\n* Note: Other schedules required by 29 CFR 2520.103-10 of the Department of Labor\u2019s Rules and Regulations for Reporting and Disclosure under the\nEmployee Retirement Income Security Act of 1974, as amended, have been omitted because they are not applicable.\n\nKPMG LLP\nTriad Centre III\nSuite 450\n6070 Poplar Avenue\nMemphis, TN 38119-3901\nIndependent Auditors\u2019 Report\nTo the Plan Participants and Retirement Committee\nPfizer Consolidated Pension Plan:\nOpinion\nWe have audited the financial statements of Pfizer Consolidated Pension Plan (the Plan), an employee benefit\nplan subject to the Employee Retirement Income Security Act of 1974 (ERISA), which comprise the statements\nof net assets available for plan benefits as of December 31, 2024 and 2023, the related statements of changes\nin net assets available for plan benefits for the years then ended, the statement of accumulated plan benefits as\nof December 31, 2023, and the related statement of changes in accumulated plan benefits for the year then\nended, and the related notes to the financial statements.\nIn our opinion, the accompanying financial statements present fairly, in all material respects, the net assets\navailable for plan benefits of the Plan as of December 31, 2024 and 2023, the changes in its net assets\navailable for plan benefits for the years then ended, the accumulated plan benefits of the Plan as of December\n31, 2023, and the changes in its accumulated plan benefits for the year then ended, in accordance with U.S.\ngenerally accepted accounting principles.\nBasis for Opinion\nWe conducted our audits in accordance with auditing standards generally accepted in the United States of\nAmerica (GAAS). Our responsibilities under those standards are further described in the Auditors\u2019\nResponsibilities for the Audit of the Financial Statements section of our report. We are required to be\nindependent of the Plan and to meet our other ethical responsibilities, in accordance with the relevant ethical\nrequirements relating to our audits. We believe that the audit evidence we have obtained is sufficient and\nappropriate to provide a basis for our audit opinion.\nResponsibilities of Management for the Financial Statements\nManagement is responsible for the preparation and fair presentation of the financial statements in accordance\nwith U.S. generally accepted accounting principles, and for the design, implementation, and maintenance of\ninternal control relevant to the preparation and fair presentation of financial statements that are free from\nmaterial misstatement, whether due to fraud or error.\nIn preparing the financial statements, management is required to evaluate whether there are conditions or\nevents, considered in the aggregate, that raise substantial doubt about the Plan\u2019s ability to continue as a going\nconcern for one year after the date that the financial statements are available to be issued.\nManagement is also responsible for maintaining a current plan instrument, including all plan amendments,\nadministering the Plan, and determining that the Plan's transactions that are presented and disclosed in the\nfinancial statements are in conformity with the Plan's provisions, including maintaining sufficient records with\nrespect to each of the participants, to determine the benefits due or which may become due to such\nparticipants.\nKPMG LLP, a Delaware limited liability partnership and a member firm of\nthe KPMG global organization of independent member firms affiliated with\nK PMG International Limited, a private English company limited by guarantee.\n\nAuditors\u2019 Responsibilities for the Audit of the Financial Statements\nOur objectives are to obtain reasonable assurance about whether the financial statements as a whole are free\nfrom material misstatement, whether due to fraud or error, and to issue an auditors\u2019 report that includes our\nopinion. Reasonable assurance is a high level of assurance but is not absolute assurance and therefore is not\na guarantee that an audit conducted in accordance with GAAS will always detect a material misstatement when\nit exists. The risk of not detecting a material misstatement resulting from fraud is higher than for one resulting\nfrom error, as fraud may involve collusion, forgery, intentional omissions, misrepresentations, or the override of\ninternal control. Misstatements are considered material if there is a substantial likelihood that, individually or in\nthe aggregate, they would influence the judgment made by a reasonable user based on the financial\nstatements.\nIn performing an audit in accordance with GAAS, we:\n\u25cf Exercise professional judgment and maintain professional skepticism throughout the audit.\n\u25cf Identify and assess the risks of material misstatement of the financial statements, whether due to fraud\nor error, and design and perform audit procedures responsive to those risks. Such procedures include\nexamining, on a test basis, evidence regarding the amounts and disclosures in the financial\nstatements.\n\u25cf Obtain an understanding of internal control relevant to the audit in order to design audit procedures that\nare appropriate in the circumstances, but not for the purpose of expressing an opinion on the\neffectiveness of the Plan\u2019s internal control. Accordingly, no such opinion is expressed.\n\u25cf Evaluate the appropriateness of accounting policies used and the reasonableness of significant\naccounting estimates made by management, as well as evaluate the overall presentation of the\nfinancial statements.\n\u25cf Conclude whether, in our judgment, there are conditions or events, considered in the aggregate, that\nraise substantial doubt about the Plan\u2019s ability to continue as a going concern for a reasonable period\nof time.\nWe are required to communicate with those charged with governance regarding, among other matters, the\nplanned scope and timing of the audit, significant audit findings, and certain internal control related matters that\nwe identified during the audit.\nSupplemental Schedules Required by ERISA\nOur audits were conducted for the purpose of forming an opinion on the financial statements as a whole. The\nsupplemental schedules of Schedule G, Part III - Schedule of Nonexempt Transactions for the year ended\nDecember 31, 2024, and Schedule H, line 4i - Schedule of Assets (Held at End of Year) as of December 31,\n2024 are presented for purposes of additional analysis and are not a required part of the financial statements\nbut are supplementary information required by the Department of Labor's Rules and Regulations for Reporting\nand Disclosure under ERISA. Such information is the responsibility of management and was derived from and\nrelates directly to the underlying accounting and other records used to prepare the financial statements. The\ninformation has been subjected to the auditing procedures applied in the audits of the financial statements and\ncertain additional procedures, including comparing and reconciling such information directly to the underlying\naccounting and other records used to prepare the financial statements or to the financial statements\nthemselves, and other additional procedures in accordance with GAAS.\n2\n\nIn forming our opinion on the supplemental schedules, we evaluated whether the supplemental schedules,\nincluding their form and content, are presented in conformity with the Department of Labor's Rules and\nRegulations for Reporting and Disclosure under ERISA.\nIn our opinion, the information in the accompanying schedules is fairly stated, in all material respects, in relation\nto the financial statements as a whole, and the form and content are presented in conformity with the\nDepartment of Labor's Rules and Regulations for Reporting and Disclosure under ERISA.\nMemphis, Tennessee\nAugust 19, 2025\n3\n\nPFIZER CONSOLIDATED PENSION PLAN\nSCHEDULE H, LINE 4i - SCHEDULE OF ASSETS (HELD AT END OF YEAR)\nAs of December 31, 2024\n(DOLLARS IN THOUSANDS)\n(a) (b) (c) (d) (e)\nIdentity of issue, borrower, lessor, Description of investment, including maturity\nCost Current Value\nor similar party date, rate of interest, collateral, par, or maturity\nPercentage of Pfizer Master Trust \u2013 Cash, Debt\nSecurities, Corporate Equities and Other\n* Northern Trust Investments $ 9,860,749 $ 9,733,376\nBlackRock Equity Index A Fund Equity Commingled Fund 11,440 75,461\nJP Morgan Real Estate Funds 49,903 68,738\nMorgan Stanley Real Estate Fund 39,693 46,693\nTotal investment assets $ 9,961,785 $ 9,924,269\n* Represents a party-in-interest as defined by ERISA.\nAmounts may not add due to rounding.\nSee accompanying Independent Auditors\u2019 Report.\n19\n\n2024 Form 5500 \u2013 Schedule SB Plan: Pfizer Consolidated Pension Plan\nEIN/PN: 13-5315170/001\nSchedule SB, Line 26a \u2014 Schedule of Active Participant Data\nDistribution of active participants as of January 1, 2024\nYears of credited service\nAttained\nage Under 40 &\n1 1\u20134 5\u20139 10\u201314 15\u201319 20\u201324 25\u201329 30\u201334 35\u201339 up\nUnder 25\n25\u201329\n1\n30\u201334\n3 8 67 50\n35\u201339\n877 1,318\n6 33 215 477 116 2\n40\u201344\n343 1,243 1,809 2,057\n6 53 293 697 744 87 1\n45\u201349\n416 1,397 2,084 2,616 3,358\n4 63 267 656 909 389 89 5\n50\u201354\n456 1,489 2,450 3,156 4,056 3,981\n6 44 187 467 827 394 323 79 2\n55\u201359\n560 1,407 2,408 3,296 4,445 5,380 4,429\n24 113 255 417 174 128 71 24 1\n60\u201364\n760 1,362 2,274 3,029 4,123 4,074 4,067 3,635\n1 9 29 50 13 13 16 5 1\n65\u201369\n1,863 2,594\n3 4 2 3 3 1\n70 & up\nIn each cell, the top number is the count of active participants for each age/service combination and the\nbottom number is the average monthly frozen accrued benefit. Average accrued benefit is not shown\nfor cells with fewer than 20 participants.\n\n2024 Form 5500 \u2013 Schedule SB Plan: Pfizer Consolidated Pension Plan\nEIN/PN: 13-5315170/001\nSchedule SB, Line 26a \u2014 Schedule of Active Participant Data\nDistribution of active participants with a cash balance account as\nof January 1, 20244\nYears of credited service\nAttained\nage Under 40 &\n1 1\u20134 5\u20139 10\u201314 15\u201319 20\u201324 25\u201329 30\u201334 35\u201339 up\nUnder 25\n25\u201329\n30\u201334\n35\u201339\n40\u201344\n26 2\n45\u201349\n9,759\n1 1 39 24 2\n50\u201354\n20,645 42,745\n1 2 1 29 16 14 1\n55\u201359\n21,308\n3 17 13 13 8 2\n60\u201364\n3 3 1 1 3\n65\u201369\n1\n70 & up\nIn each cell, the top number is the count of active participants for each age/service combination and the\nbottom number is the average cash balance account as of January 1, 2024. Average cash balance\naccount is not shown for cells with fewer than 20 participants.\n4 Only includes former Pharmacia Cash Balance Pension Plan members with an account balance as of January 1, 2024.\n\n2024 Form 5500 \u2013 Schedule SB Plan: Pfizer Consolidated Pension Plan\nEIN/PN: 13-5315170/001\nSchedule SB, Part V \u2013 Statement of Actuarial Assumptions/Methods\nActuarial assumptions for January 1, 2024 funding valuation (all\nbenefit formulas)\nDiscount rate sponsor elections\n(cid:127) Segment rates or full yield curve Full yield curve\n(cid:127) PBGC method Alternative, first elected for 2020 premium payment year\nMortality sponsor elections\n(cid:127) Healthy participants Section 430(h)(3) prescribed separate static annuitant and\nnonannuitant mortality tables. These tables are based on the RP-2014\nmortality tables backed off to 2006 and then projected with mortality\nimprovement using scale MP-2021 in accordance with the IRS\nregulation 1.430(h)(3)-1.\n(cid:127) Disabled participants Revenue Ruling 96-7 table\n417(e) lump sums Liabilities are determined based on the underlying annuity used by the\nPlan to determine the lump sum amount, rather than valuing the lump\nsum payment. This annuity is valued based on funding interest rates\nrather than 417(e) rates and current year 417(e) unisex mortality.\nOther economic assumptions\n(cid:127) Expected investment return 7.05% per year for 2023 and 5.55% per year for 2022\n(cid:127) Administrative expenses Equal to the actual expenses for the prior year, adjusted for the\nexpected change in PBGC premiums, rounded to the nearest\n$50,000. The amount is $17,150,000 for 2024.\nDemographic assumptions\n(cid:127) Withdrawal See table of sample rates\n(cid:127) Retirement See table of sample rates\n(cid:127) Disability incidence Included in withdrawal and retirement decrements\n(cid:127) Withdrawal and retirement for Participants affected by the spinoff are valued as vested deferred\nparticipants affected by the Zoetis participants reflecting eligibility for early retirement subsidies attained\nspinoff through the earlier of termination of employment and the eligibility\nfreeze date of December 31, 2017.\n(cid:127) Participants Currently on Long- Participants under the PRAP, PPP, WLRP, and PCBPP formulas on\nTerm Disability (LTD) LTD as of the valuation date are assumed to retire at age 65, with no\nwithdrawal or retirement decrements prior to age 65. Participants\nunder the Wyeth formula on LTD as of the valuation date are valued\nwith the inactives and are assumed to retire under the inactive\nassumptions for Wyeth.\n(cid:127) Spouse assumptions Male participants Female participants\n\u2013 Percentage married 85.00% 60.00%\n\u2013 Spouse age difference 3 years younger 3 years older\n\n2024 Form 5500 \u2013 Schedule SB Plan: Pfizer Consolidated Pension Plan\nEIN/PN: 13-5315170/001\nSchedule SB, Part V \u2013 Statement of Actuarial Assumptions/Methods\nActuarial assumptions (specific to benefits determined under\nPRAP formula)1\nDemographic assumptions\nBenefit commencement age for\n(cid:127) Future vested deferred \u2013 40% of otherwise lump-sum-ineligible participants with no\ngrandfathered nonqualified benefit are assumed to elect an\nimmediate lump sum under the 6-month window;\n\u2013 Otherwise, commencement is assumed at age 60, or immediately\nif over age 60 on the valuation date\n(cid:127) Current vested deferred \u2013 If eligible for an enhancement payable from PCPP under the\nVoluntary Early Retirement Program (\u201cVERP\u201d) or Special\nSeparation Program (\u201cSSP\u201d)2, a colleague must wait to commence\ntheir benefit until the first of the month coincident with or next\nfollowing the date the colleague would have attained the milestone\nif they had continued working;\n\u2013 40% of participants within a 6-month lump sum window as of the\nvaluation date assumed to elect an immediate lump sum under the\n6-month window;\n\u2013 Otherwise, commencement is assumed at age 60, or immediately\nif over age 60 on the valuation date\nForm of payment Lump sum Single life 80% J&S\n(cid:127) Participants assumed to commence 100% 0% 0%\nunder the 6-month lump sum window\n(cid:127) All others:\n\u2013 Lump-sum-eligible participants 75% 10% 15%\n\u2013 Lump-sum-ineligible participants 0% 50% 50%\n(cid:127) Future deaths The spouses of married participants who die before reaching early\nretirement eligibility are expected to receive the survivor portion of the\n50% J&S benefit\nUnpredictable contingent event Not applicable\nassumptions\n1 Applies to all benefits accrued under the PRAP formula, including those accrued as a result of the harmonization of benefits effective\nJanuary 1, 2012.\n2 Enhancements under the SSP are not reflected for funding purposes unless the participant terminated employment prior to the valuation\ndate.\n\n2024 Form 5500 \u2013 Schedule SB Plan: Pfizer Consolidated Pension Plan\nEIN/PN: 13-5315170/001\nSchedule SB, Part V \u2013 Statement of Actuarial Assumptions/Methods\nActuarial assumptions (specific to benefits determined under PPP\nformula)\nDemographic assumptions\nBenefit commencement age for\n(cid:127) Future vested deferred \u2013 40% of otherwise retirement-ineligible participants with no\ngrandfathered nonqualified benefit are assumed to elect an\nimmediate lump sum under the 6-month window;\n\u2013 Otherwise, commencement is assumed at age 60. or immediately if\nover age 60 on the valuation date\n(cid:127) Current vested deferred \u2013 40% of participants within a 6-month lump sum window as of the\nvaluation date are assumed to elect an immediate lump sum under\nthe 6-month window;\n\u2013 Otherwise, age commencement is assumed at age 60, or\nimmediately if over age 60 on the valuation date\nForm of payment Lump sum Single life 80% J&S 50% J&S\n(cid:127) Participants assumed to\ncommence under the 6-month 100% 0% 0% 0%\nlump sum window\n(cid:127) All others:\n\u2500 Active retirements 60% 25% 15% 0%\n\u2500 Future vested deferred 60% 25% 15% 0%\n\u2500 Future deaths 0% 0% 0% 100%\n\u2500 Current vested deferred 60% 25% 15% 0%\nUnpredictable contingent event Not applicable\nassumptions\nActuarial assumptions (specific to benefits determined under\nPCBPP formula)\nCash balance plans\n(cid:127) Interest accumulation rate 5.00% through 2024 and 5.35%, thereafter\n(cid:127) Whipsaw calculations Yes\nDemographic assumptions\nBenefit commencement age for\n(cid:127) Future vested deferred Immediately upon termination for lump sum payments and age 60 for\nannuity commencements\n(cid:127) Current vested deferred Age 60, or immediately if over age 60 on the valuation date\nForm of payment Lump sum Single life 80% J&S 50% J&S\n(cid:127) Active retirements 65% 10% 25% 0%\n(cid:127) Future vested deferred 65% 10% 25% 0%\n(cid:127) Future deaths 85% 0% 0% 15%\n(cid:127) Current vested deferred 65% 10% 25% 0%\nUnpredictable contingent event assumptions Not applicable\n\n2024 Form 5500 \u2013 Schedule SB Plan: Pfizer Consolidated Pension Plan\nEIN/PN: 13-5315170/001\nSchedule SB, Part V \u2013 Statement of Actuarial Assumptions/Methods\nActuarial assumptions (specific to benefits determined under\nWLRP formula)\nDemographic assumptions\n(cid:127) Mortality for Equity Fund 1951 Group Annuity Tables for males, set back five years for females,\nas required by the plan document\n(cid:127) Retirement age for the Equity 60% of all employees are expected to retire at age 62 with the\nAnnuity Portion of Fund remaining 40% at age 65\nBenefit commencement age for\n(cid:127) Future vested deferred \u2013 40% of participants with no grandfathered nonqualified benefit are\nassumed to elect an immediate lump sum under the 6-month\nwindow;\n\u2013 Otherwise, commencement is assumed at age 60, or immediately if\nover age 60 on the valuation date\n(cid:127) Current vested deferred \u2013 40% of participants within a 6-month lump sum window as of the\nvaluation date are assumed to elect an immediate lump sum under\nthe 6-month window;\n\u2013 Otherwise, commencement is assumed at age 60, or immediately if\nover age 60 on the valuation date\nForm of payment\n(cid:127) Active retirements \u2013 For married participants, 20% of participants with no grandfathered\nnonqualified benefit are assumed to elect a lump sum; otherwise a\n50% Joint and Survivor annuity is assumed;\n\u2013 For unmarried participants, 50% of participants with no\ngrandfathered nonqualified benefit are assumed to elect a lump\nsum; otherwise a Single Life annuity is assumed\n(cid:127) Future vested deferred \u2013 100% lump sum if assumed to commence under the 6-month\nwindow;\n\u2013 Otherwise, 50% Joint and Survivor annuity for married participants\nand a Single Life annuity for unmarried participants is assumed\n(cid:127) Current vested deferred \u2013 100% lump sum if assumed to commence under the 6-month\nwindow;\n\u2013 Otherwise, 50% Joint and Survivor annuity for married participants\nand a Single Life annuity for unmarried participants is assumed\nUnpredictable contingent event Not applicable\nassumptions\n\n2024 Form 5500 \u2013 Schedule SB Plan: Pfizer Consolidated Pension Plan\nEIN/PN: 13-5315170/001\nSchedule SB, Part V \u2013 Statement of Actuarial Assumptions/Methods\nActuarial assumptions (specific to benefits determined under\nWyeth non-bargaining formula)\nNon-417(e) lump sums (for benefits accrued prior to January 1, 2012)\nMortality table 1994 Uninsured Pensioner Mortality Table projected to 2002 (blended\n50% male/50% female)\nInterest rate The PBGC lump sum interest rate in each future year is projected using\nthe formula described in PBGC guidance issued September 9, 2020.\nWe project future IRS full yield curves using implied forward rates\ndeveloped from the November 2023 full yield curve published by the\nIRS in December 2023 for PPA funding calculation purposes, and\nadjust to reflect changes in the spot rates of the Mercer Yield Curve\nfrom the November 30, 2023, to December 31, 2023, curves. We then\nproject future immediate lump sum rates using the spot rate\ncorresponding to year 12, in accordance with the PBGC guidance.\nDemographic assumptions\nBenefit commencement age for\n(cid:127) Future vested deferred \u2013 No participants are assumed to elect their Wyeth benefit during the\n6-month window;\n\u2013 Age 60 or immediately if over age 60 on the valuation date\n(cid:127) Current vested deferred \u2013 No participants are assumed to elect their Wyeth benefit during the\n6-month window;\n\u2013 Age 60 or immediately if over age 60 on the valuation date\nForm of payment Lump sum Single life 90% J&S 75% J&S\n(cid:127) Active retirements 85% 10% 5% 0%\n(cid:127) Future vested deferred 70% 15% 0% 15%\n(cid:127) Current vested deferred 70% 15% 0% 15%\n(cid:127) Future deaths The spouses of married participants who die before reaching early\nretirement eligibility are expected to receive the survivor portion of the\n50% J&S benefit\nUnpredictable contingent event Based on the latest information provided by Pfizer, there are no further\nassumptions planned terminations due to plant closures. Therefore, no additional\nparticipants are assumed to meet the eligibility requirements for an\nenhanced benefit under Pfizer\u2019s Plant Network Strategy program.\n\n2024 Form 5500 \u2013 Schedule SB Plan: Pfizer Consolidated Pension Plan\nEIN/PN: 13-5315170/001\nSchedule SB, Part V \u2013 Statement of Actuarial Assumptions/Methods\nActuarial assumptions (specific to benefits determined under\nAlpharma formula)\nDemographic assumptions\nBenefit commencement age for\n(cid:127) Future vested deferred Age 60 or immediately if over age 60 on the valuation date\n(cid:127) Current vested deferred Age 60 or immediately if over age 60 on the valuation date\nForm of payment Single life 75% J&S\n(cid:127) Active retirements 50% 50%\n(cid:127) Vested deferred retirement 50% 50%\nUnpredictable contingent event Not applicable\nassumptions\nActuarial assumptions (specific to benefits determined under\nFaulding formula)\nDemographic assumptions\nBenefit commencement age for\n(cid:127) Future vested deferred Age 60 or immediately if over age 60 on the valuation date\n(cid:127) Current vested deferred Age 60 or immediately if over age 60 on the valuation date\nForm of payment Single life 75% J&S Lump Sum\n(cid:127) Single participants 50% 20% 30%\n(cid:127) Married participants 50% 20% 30%\nUnpredictable contingent event Not applicable\nassumptions\nTable of sample rates\nWithdrawal assumption\nWithdrawal\nAttained age percentage\n<=30 12.50%\n31-33 9.70\n34-36 8.10\n37-39 7.30\n40-42 5.50\n43-45 5.10\n46-48 5.00\n49-51 4.40\n52-54 4.20\n55-60 10.00\n61-63 15.00\n64+ 20.00\n\n2024 Form 5500 \u2013 Schedule SB Plan: Pfizer Consolidated Pension Plan\nEIN/PN: 13-5315170/001\nSchedule SB, Part V \u2013 Statement of Actuarial Assumptions/Methods\nRetirement assumption\nRates\nAttained age <90 points >=90 points\n<=55 6% 12%\n56 7 12\n57 7 15\n58 8 16\n59 9 19\n60 12 19\n61 14 19\n62 15 19\n63 16 19\n64 30 50\n65 30 30\n66-68 25 25\n69 35 35\n70+ 100 100\nRationale for economic assumptions\n(cid:127) Expected investment return \u2013 This assumption is based on the median simulated investment return\nusing capital market assumptions published in Mercer Investment Consulting\u2019s January 2024\nCapital Markets Outlook for the Plan\u2019s target asset mix, adjusted by the expected alpha net of\ninvestment expenses.\n(cid:127) Administrative expenses \u2013 This assumption is equal to the actual administrative expenses for the\nprior year, adjusted for the expected change in PBGC premiums, rounded to the nearest $50,000.\n(cid:127) Cash balance interest crediting rate \u2013 The rate was determined as the mean expected rate over a\n10-year projection period based on Mercer\u2019s most recently published Capital Market Outlook as of\nthe measurement date and reflecting the Plan\u2019s floor and maximum crediting rates, while taking into\naccount the fact that 30-year Treasury yields are currently below the 5.00% floor.\nRationale for demographic assumptions\n(cid:127) Termination and retirement assumptions \u2013 The termination and retirement rates are based on an\nexperience study undertaken in 2020 using data from 2014 through 2018 and the expectation that\nthe future termination and retirement patterns and circumstances of the employer will not differ\nsignificantly from the period studied. Note the assumptions incorporate new disabilities; thus, no\nseparate disability decrements are used.\n(cid:127) Form of payment elections \u2013 The assumptions with respect to payment form elections are based on\nan analysis conducted in 2020 of experience from 2014 through 2018.\n\n2024 Form 5500 \u2013 Schedule SB Plan: Pfizer Consolidated Pension Plan\nEIN/PN: 13-5315170/001\nSchedule SB, Part V \u2013 Statement of Actuarial Assumptions/Methods\n(cid:127) Lump sum elections for expanded lump sum option \u2013 The lump sum election percentages are\nbased on Mercer\u2019s experience with deferred vested cashout offers as well as the specific provisions\nof each legacy formula that might influence a colleague\u2019s behavior.\n(cid:127) Deferred vested commencement age \u2013 The assumed commencement ages for current and future\ndeferred vested participants are based on an analysis of commencements during the 2014 through\n2018 plan years.\nActuarial methods for funding\nAsset methods\nThe asset valuation method is an average of the adjusted market value for each year during the last 2\nyears preceding the valuation date. The adjusted market value is the market value at each\ndetermination date adjusted to the valuation date based on actual cash flows and expected interest at\nthe lesser of the expected rate of return and the third segment rate. This amount is adjusted to be no\ngreater than 110% and no less than 90% of the fair market value, as defined in IRC Section 430.\nA characteristic of this asset method is that, over time, it is slightly more likely to produce an actuarial\nvalue of assets that is less than the market value of assets than an actuarial value that is greater than\nthe market value.\nParticipant methods\nParticipants or former participants are included or excluded from the valuation as described below:\n(cid:127) Participants included: Fidelity provides us with data on all employees as of the valuation date, but\nonly those employees who have completed the plan\u2019s eligibility requirements are included in the\nvaluation of liabilities.\n(cid:127) Participants excluded: No actuarial liability is included for nonvested participants who terminated\nprior to the valuation date. For this purpose, participants with a break-in-service on the valuation\ndate are treated as terminated participants.\n(cid:127) Insurance contracts: The Plan has insurance contracts, which have been included in Plan\nliabilities and assets.\n(cid:127) Transferred participants: The liabilities for employees who have transferred into another plan of\nthe plan sponsor have been included with the liabilities for active participants.\nMinimum funding methods\nThe funding target for minimum funding calculations is computed using the traditional unit credit method\nof funding. The objective under this method is to fund each participant\u2019s benefits under the plan as they\naccrue. Thus, the total pension to which each participant is expected to become entitled at retirement is\nbroken down into units, each associated with a year of past or future credited service.\nA detailed description of the calculation follows:\n(cid:127) The plan\u2019s valuation date is the beginning of the plan year.\n\n2024 Form 5500 \u2013 Schedule SB Plan: Pfizer Consolidated Pension Plan\nEIN/PN: 13-5315170/001\nSchedule SB, Part V \u2013 Statement of Actuarial Assumptions/Methods\n(cid:127) An individual\u2019s funding target is the present value of future benefits based on credited service and\naverage pay as of the beginning of the plan year, and an individual\u2019s target normal cost is the\npresent value of the benefit expected to accrue in the plan year. If multiple decrements are used,\nthe funding target and the target normal cost for an individual are the sum of the component funding\ntargets and target normal costs associated with the various anticipated separation dates.\n(cid:127) This plan values the cost of unpredictable contingent event benefits, if applicable, as described in\nthe Actuarial Assumptions section.\n(cid:127) The plan\u2019s target normal cost is the sum of the individual targets for all participants under the plan.\n\n\n\n\n\n\n\n2024 Form 5500 \u2013 Schedule SB Plan: Pfizer Consolidated Pension Plan\nEIN/PN: 13-5315170/001\nSchedule SB, Line 22 \u2013 Description of Weighted Average Retirement Age\nEach employee is assumed to retire in accordance with the table of retirement rates. The proportion of\nemployees expected to retire at each potential retirement age is shown below. It should be noted that\nwhile only integral (truncated) values are shown in the table, the full content of each cell including\ndecimal portions is used in the calculations.\nThe rates of retirement used are those that would apply to a representative participant with the average\nentry age of the group. The average retirement age is 61.\n(A) (B) (C) (D) (E)\nNumber of employees\nRetirement Retirement\nLx expected to retire\nage Percent\n(B) x (C) (A) x (D)\n55 6% 10,000 600 33,000\n56 7% 9,400 658 36,848\n57 7% 8,742 612 34,884\n58 8% 8,130 650 37,700\n59 9% 7,480 673 39,707\n60 12% 6,807 817 49,020\n61 19% 5,990 1,138 69,418\n62 19% 4,852 922 57,164\n63 19% 3,930 747 47,061\n64 50% 3,183 1,592 101,888\n65 30% 1,591 477 31,005\n66 25% 1,114 279 18,414\n67 25% 835 209 14,003\n68 25% 626 157 10,676\n69 35% 469 164 11,316\n70 100% 305 305 21,350\nTotal 10,000 613,454\nAverage 61.35\n\n2024 Form 5500 \u2013 Schedule SB Plan: Pfizer Consolidated Pension Plan\nEIN/PN: 13-5315170/001\nSchedule SB, line 26b \u2014 Schedule of Projection of Expected Benefit Payments\nSchedule SB, line 26b Schedule of Projection of Expected Benefit Payments\nRetired\nTerminated Participants and\nPlan Active\nVested Beneficiaries Total\nYear Participants\nParticipants Receiving\nPayments\n2024 71,932,772 582,974,689 387,738,932 1,042,646,393\n2025 81,046,834 163,180,643 375,799,584 620,027,061\n2026 93,319,945 177,408,115 363,709,242 634,437,301\n2027 103,637,013 185,345,683 351,541,972 640,524,669\n2028 117,270,573 190,862,264 339,378,647 647,511,484\n2029 128,187,815 196,768,342 327,432,138 652,388,295\n2030 138,651,475 203,238,287 315,411,502 657,301,264\n2031 150,595,310 204,951,565 303,393,808 658,940,682\n2032 159,754,337 204,081,571 291,267,339 655,103,246\n2033 168,047,908 208,581,056 279,066,908 655,695,871\n2034 175,282,351 208,565,484 266,789,570 650,637,406\n2035 181,704,549 210,831,559 254,368,806 646,904,915\n2036 185,565,950 210,508,973 241,883,484 637,958,407\n2037 189,596,621 208,952,989 229,271,384 627,820,994\n2038 191,796,169 207,268,474 216,556,327 615,620,970\n2039 193,250,166 202,455,905 203,746,751 599,452,822\n2040 193,843,002 200,267,140 190,876,373 584,986,514\n2041 193,199,867 196,235,055 177,989,640 567,424,561\n2042 192,126,316 192,736,761 165,123,691 549,986,768\n2043 190,324,181 187,529,360 152,316,046 530,169,587\n2044 187,595,170 182,858,553 139,654,940 510,108,663\n2045 184,736,196 177,953,682 127,206,201 489,896,079\n2046 181,035,178 172,325,964 115,041,733 468,402,875\n2047 176,721,557 166,311,812 103,244,898 446,278,266\n2048 171,918,586 160,052,451 91,902,608 423,873,645\n2049 166,627,832 153,453,868 81,102,617 401,184,316\n2050 160,910,873 146,506,738 70,928,317 378,345,928\n2051 154,753,455 139,247,670 61,453,026 355,454,151\n2052 148,231,948 131,716,135 52,735,777 332,683,860\n2053 141,381,696 123,965,889 44,817,679 310,165,264\n2054 134,195,756 116,043,075 37,719,559 287,958,389\n2055 126,747,020 108,020,814 31,441,816 266,209,650\n2056 119,071,639 99,972,182 25,964,789 245,008,611\n2057 111,233,332 91,973,091 21,251,396 224,457,820\n2058 103,290,836 84,098,387 17,250,554 204,639,777\n\n2024 Form 5500 \u2013 Schedule SB Plan: Pfizer Consolidated Pension Plan\nEIN/PN: 13-5315170/001\nSchedule SB, line 26b \u2014 Schedule of Projection of Expected Benefit Payments\nSchedule SB, line 26b Schedule of Projection of Expected Benefit Payments\nRetired\nTerminated Participants and\nPlan Active\nVested Beneficiaries Total\nYear Participants\nParticipants Receiving\nPayments\n2059 95,313,688 76,419,400 13,900,382 185,633,470\n2060 87,376,085 69,001,577 11,132,188 167,509,850\n2061 79,553,426 61,902,243 8,874,160 150,329,829\n2062 71,919,219 55,169,198 7,054,568 134,142,986\n2063 64,542,185 48,840,072 5,604,864 118,987,120\n2064 57,483,946 42,942,267 4,461,637 104,887,850\n2065 50,797,635 37,493,298 3,568,069 91,859,002\n2066 44,526,712 32,501,511 2,874,655 79,902,877\n2067 38,704,037 27,966,853 2,339,351 69,010,240\n2068 33,351,934 23,881,926 1,927,218 59,161,078\n2069 28,482,078 20,233,221 1,609,847 50,325,146\n2070 24,096,374 17,002,120 1,364,519 42,463,013\n2071 20,188,217 14,165,920 1,173,378 35,527,515\n2072 16,743,303 11,698,880 1,022,686 29,464,869\n2073 13,740,403 9,572,923 901,979 24,215,304\n\nPFIZER CONSOLIDATED PENSION PLAN\nSCHEDULE G, PART III - SCHEDULE OF NONEXEMPT TRANSACTIONS\nFor the Year Ended December 31, 2024\n(a) (b) (c) (d) (e) (f) (g) (h) (i) (j)\nRelationship to Description of Expense Net\nplan, employer, transaction (including incurred Current gain\nor other party-in- interest rate, maturity, Purchas Selling Lease with Cost of value of or\nIdentity of party involved interest collateral, par or e price price Rental transaction asset asset (loss)\ni l )\nPart III\nMaster Trust Between\nPlan\nPfizer Inc. and the Northern\ntrust/trustee See * below $ \u2014 $ 93,400 $ \u2014 $ \u2014 $ 93,400 $ 93,400 $ \u2014\nTrust Company\nMaster Trust Between\nPlan\nPfizer Inc. and the Northern\ntrust/trustee See ** below $ \u2014 $ 677,135 $ \u2014 $ \u2014 $ 677,135 $ 677,135 $ \u2014\nTrust Company\nMaster Trust Between\nPlan\nP\nT\nf\nr\ni\nu\nz\ns\ne\nt\nr\nC\nIn\no\nc\nm\n.\np\na\na\nn\nn\nd\ny\nt he Northern\ntrust/trustee See *** below $ \u2014 $ 782,986 $ \u2014 $ \u2014 $ 782,986 $ 782,986 $ \u2014\nMaster Trust Between $ 1,101,160 $ 1,101,160 $ 1,101,160\nPlan\nPfizer Inc. and the Northern\ntrust/trustee See **** below $ \u2014 $ \u2014 $ \u2014 $ \u2014\nTrust Company\n* This amount represents a payment of ineligible expenses from plan assets paid in 2022 by the Master Trust. This payment and interest of $15,609\nwere repaid in 2024.\n** This amount represents payments of ineligible expenses from plan assets paid in 2023 by the Master Trust. These payments and interest of $52,294\nwere repaid in 2024.\n*** This amount represents payments of ineligible expenses from plan assets paid in 2024 by the Master Trust. These payments and interest of $43,135\nwere repaid in 2024.\n**** This amount represents payments of ineligible expenses from plan assets paid in 2024 by the Master Trust. These payments and interest of $39,160\nwill be repaid in 2025.\nSee accompanying Independent Auditors\u2019 Report.\n19\n\n2024 Form 5500 \u2013 Schedule SB Plan: Pfizer Consolidated Pension Plan\nEIN/PN: 13-5315170/001\nSchedule SB, Part V \u2013 Summary of Plan Provisions\nSummary of major plan provisions\nEffective date and plan year Original plan: January 1, 1943\nRestated plan: January 1, 2016\nPlan year: January 1 to December 31\nStatus of the plan The Plan was frozen effective December 31, 2017. As of January 1, 2011,\nno newly hired, rehired, or transferred employees are eligible to participate\nin the plan. In addition, benefit accruals were frozen as of December 31,\n2015, for colleagues who elected to participate in the one-time non-\ngrandfathered benefit notional transfer opportunity in the Pfizer Inc.\nNonfunded Supplemental Retirement Plan (now the Pfizer Consolidated\nSupplemental Pension Plan for United States and Puerto Rico Employees).\nSignificant events that occurred The following events occurred during 2023:\nduring the year - Effective August 1, 2023, the Plan provided a one-time opportunity\nfor active participants who had attained an unreduced benefit\nmilestone with respect to their PRAP, Warner-Lambert and/or\nWyeth benefits to voluntarily elect to commence that(those) legacy\nbenefit(s) through an in-service distribution window.\n- The Plan provided a terminated vested lump sum window with a\nbenefit commencement date of November 1, 2023.\nZoetis grow-in Accrued benefits for active participants affected by the spinoff of Zoetis\nwere frozen effective December 31, 2012. However, affected participants\nwere deemed fully vested and eligible to receive up to five years of post-\nspinoff service with Zoetis from January 1, 2013 (even if Pfizer ownership\ndropped below 80%) toward vesting and retirement eligibility in their Pfizer\npension benefit. This service was credited while the affected participant\nwas still employed with Zoetis during the five-year period following the spin-\noff, ending on January 1, 2018.\nExpanded lump sum option Effective January 1, 2019, the Plan provides an opportunity for plan\nparticipants who are not otherwise immediately eligible to receive their\nbenefit as a lump sum, to receive an immediate lump sum or annuity within\na 6-month window following termination of employment. Colleagues who\nhave a grandfathered nonqualified benefit under any legacy benefit formula\nare not eligible for this option. Effective for terminations on or after January\n1, 2021, the Plan was amended to eliminate the requirement that a\ncolleague receive his or her entire plan benefit at the same time and in the\nsame form during the special window.\nMiscellaneous\n(cid:127) Maximum compensation Compensation for any 12-month period used to determine accrued benefits\nmay not exceed the limits in IRC Section 401(a)(17) for the calendar year in\nwhich the 12-month period begins. This limit is indexed annually. For 2017\n(the year of the plan freeze), the limit was $270,000.\n(cid:127) Maximum benefits Annual benefits may not exceed the limits in IRC Section 415. This limit is\nindexed annually. For 2024, the limit is $275,000.\nThe major plan provisions specific to each legacy formula are outlined below, subject to the\namendment to freeze the Plan effective December 31, 2017.\n\n2024 Form 5500 \u2013 Schedule SB Plan: Pfizer Consolidated Pension Plan\nEIN/PN: 13-5315170/001\nSchedule SB, Part V \u2013 Summary of Plan Provisions\nPfizer Retirement Annuity Plan (PRAP) benefit formula\nFollowing is a summary of the major plan provisions for participants who accrued benefits under the\nLegacy Pfizer Retirement Annuity Plan prior to January 1, 2012, and all active, eligible participants on\nor after January 1, 2012.\nDefinitions\n(cid:127) Covered employees All employees who meet one of the following criteria:\n\uf0a7 US citizens or resident aliens working in the US and who are on the\nPfizer US payroll\n\uf0a7 US citizens or resident aliens working for Pfizer outside the US who\nhave been designated as eligible to participate\n\uf0a7 Employees included in a group or class designated as eligible for\nmembership\n\uf0a7 Extended temporary employees\n(cid:127) Participation An employee joins the plan on his date of hire or the first day the employee\ntransfers to an eligible category of employment.\nEffective January 1, 2011, no newly hired, rehired or transferred employees\nare eligible to participate in the plan.\n(cid:127) Employee contributions The company bears the full cost of benefits under the plan.\n(cid:127) Vesting service A month of service is granted for each month in which a participant works\nat least one day.\nLeased employees and temporary employees will receive vesting service\nfrom their hire date upon transfer to an eligible class of employees.\n(cid:127) Credited service Credited service is used to determine the amount of the accrued benefit\nbased on the Plan\u2019s formula. It is calculated on an elapsed-time basis while\na participant. It is calculated in years and months, and if there are 15 or\nmore days remaining, service is rounded to the next whole month.\nOtherwise, service is rounded down to the last completed month. For\nservice earned on or after January 1, 2008, service is calculated in years\nand completed months by rounding the begin date to the first of the month\ncoincident or next following the actual begin date and rounding the end\ndate to the first of the month following the actual end date.\nCredited service is granted for the period of employment as a temporary\nemployee upon transfer to an eligible class of employees.\nFormer Synbiotics Corporation employees receive credited service from\ntheir December 30, 2010, acquisition date.\nFor active employees from a non-PRAP legacy group, credited service\nunder the PRAP formula begins on January 1, 2012.\n(cid:127) Pensionable earnings Employees\u2019 actual salary, wages, bonuses or other remuneration. Certain\nbonuses paid in the first quarter of a year are included as pensionable\ncompensation in the year in which the bonuses were earned as opposed to\npaid. Any compensation (including bonuses) that is deferred is excluded\nfrom pensionable compensation.\nFor active employees from a non-PRAP legacy group, pensionable\nearnings prior to January 1, 2012, are defined under the legacy formula\u2019s\ndefinition of pensionable earnings.\n\n2024 Form 5500 \u2013 Schedule SB Plan: Pfizer Consolidated Pension Plan\nEIN/PN: 13-5315170/001\nSchedule SB, Part V \u2013 Summary of Plan Provisions\n(cid:127) Final average earnings Average of the highest 5 calendar years of Compensation during a\nparticipant\u2019s career with Pfizer.\nIf a participant has less than 5 full calendar years of Compensation, Final\nAverage Earnings is the greater of the following:\n\uf0a7 Average of all full calendar years of Compensation\n\uf0a7 Average of all Compensation a participant received during his career\nwith Pfizer (total Compensation is averaged over the Participant\u2019s years\nof Credited Service).\n(cid:127) Primary Social Security The annual amount available to the participant at age 65 under the Old Age\nInsurance provisions of Title II of the Social Security Act in effect at the time\nbenefit\nof termination of employment.\nIf the participant is eligible for retirement under the Rule of 90, the Primary\nSocial Security Benefit is calculated assuming $0 projected future pay from\nthe year of termination to age 65.\nIf the participant is not eligible for retirement under the Rule of 90, the\nPrimary Social Security Benefit is calculated based on level projected\nfuture pay from the year of termination to age 65.\nNormal retirement\n(cid:127) Eligibility Age 65\n(cid:127) Benefit A monthly amount commencing at normal retirement date equal to the\ngreater of a), b) and c) below:\na) 1.40% of Final Average Earnings multiplied by Credited Service, not in\nexcess of 35 years:\nb) The difference between 1) and 2) below:\n1) 1.75% of the Final Average Earnings multiplied by Credited\nService, not in excess of 35 years\n2) 1.50% of the participant\u2019s Primary Social Security Benefit multiplied\nby Credited Service not in excess of 35 years; or\nc) The accrued benefit as of September 30, 1997, payable to the\nmember under the provisions of the Plan as of that date.\nEarly retirement\n(cid:127) Eligibility A participant may retire at his request on the first day of any month\nsubsequent to his:\na) 55th birthday and completion of 10 years of Retirement Eligibility\nService, or\nb) When his age plus Retirement Eligibility Service equals or exceeds 90\n(Rule of 90).\nA participant may retire, with respect to benefits accrued through\nDecember 31, 1993, at his request on the first day of any month\nsubsequent to his:\na) 50th birthday, completion of 10 years of Retirement Eligibility Service,\nand age plus Retirement Eligibility Service equals or exceeds 65; or\nb) When his age plus Retirement Eligibility Service equals or exceeds 90\n(Rule of 90).\n(cid:127) Benefit Benefits are determined in the same manner as normal retirement benefits,\nbut are reduced by 4% per year for each year benefits commence prior to\nage 65. However, if a participant satisfies the Rule of 90, there is no\nreduction to the benefit.\nLate retirement\n\n2024 Form 5500 \u2013 Schedule SB Plan: Pfizer Consolidated Pension Plan\nEIN/PN: 13-5315170/001\nSchedule SB, Part V \u2013 Summary of Plan Provisions\n(cid:127) Eligibility Any time after age 65\n(cid:127) Benefit The monthly benefit is computed as for normal retirement, recognizing\nCompensation and Credited Service after Normal Retirement Age.\nDeferred vested\n(cid:127) Eligibility Three years of vesting service\nPost-12/31/1993 accrued benefits:\nA vested participant may elect to commence benefits as early as the first of\nthe month following his 55th birthday.\nPre-1994 accrued benefits:\nA vested participant may elect to commence benefits accrued through\nDecember 31, 1993, as early as the first of the month following his 50th\nbirthday.\nThe pre-1994 accrued benefit and the post-12/31/1993 accrued benefit\nmust commence at the same time unless the participant elects to\ncommence the 12/31/1993 benefit prior to age 55.\n(cid:127) Benefit Post-12/31/1993 accrued benefits:\nThe benefit payable is equal to the vested accrued benefit otherwise\npayable at age 65, reduced by 6% per year for each year the benefit\ncommences prior to age 65.\nPre-1994 accrued benefits:\nThe benefit payable is equal to the vested accrued benefit otherwise\npayable at age 65, reduced by 4% per year for each year the benefit\ncommences prior to age 65.\nDisability\n(cid:127) Eligibility Three years of Vesting Service, and disability occurs before January 1,\n2012\n(cid:127) Benefit A monthly benefit computed based on Credited Service through the earlier\nof Normal Retirement Age or the age at which the participant elects to\ncommence benefits, and continued Compensation equal to the greater of\nCompensation in the last full calendar year of Compensation prior to the\ndisability or the Compensation received in the last 12 months of\nemployment prior to the disability.\nShould the participant elect to commence the Disability Benefit prior to his\nNormal Retirement Age, the Disability Benefit will be reduced according to\neither the Early Retirement or Deferred Vested provisions (whichever is\napplicable).\nParticipants who become disabled on or after January 1, 2012, do not\naccrue benefits while on disability.\nPre-retirement death - QJSA\n(cid:127) Eligibility Vested and legally married on the date of death.\n(cid:127) Benefit prior to early A monthly amount payable to the surviving spouse equal to the\nparticipant\u2019s accrued benefit as of the date of death, actuarially reduced for\nretirement\nthe 50% joint and survivor option. The benefit is further reduced for\ncommencement prior to the deceased participant\u2019s Normal Retirement Age\naccording to the Deferred Vested provisions. This benefit is payable as of\nthe participant\u2019s earliest commencement date (but no later than the\nparticipant\u2019s Normal Retirement Age) and is payable for the life of the\nsurviving spouse.\n\n2024 Form 5500 \u2013 Schedule SB Plan: Pfizer Consolidated Pension Plan\nEIN/PN: 13-5315170/001\nSchedule SB, Part V \u2013 Summary of Plan Provisions\n(cid:127) Benefit after early but before A monthly amount payable to the surviving spouse equal to the\nparticipant\u2019s accrued benefit as of the date of death, actuarially reduced for\nnormal retirement\nthe 50% joint and survivor option. The benefit is further reduced for\ncommencement prior to the deceased participant\u2019s Early Retirement Age\naccording to the Early Retirement provisions. This benefit is payable as of\nthe participant\u2019s earliest commencement date (but no later than the\nparticipant\u2019s Normal Retirement Age) and is payable for the life of the\nsurviving spouse.\n(cid:127) Benefit after normal A monthly amount payable to the surviving spouse equal to the\nparticipant\u2019s accrued benefit as of the date of death, actuarially reduced for\nretirement\nthe 50% joint and survivor option. This benefit is payable for the life of the\nsurviving spouse.\nPre-retirement death \u2013 enhanced active death benefit (effective June 1, 2015)\n(cid:127) Eligibility Actively employed and eligible for early retirement on the date of death.\n(cid:127) Benefit An amount payable to the beneficiary equal to the lump sum that would\nhave been payable to the participant if the participant had retired on his\ndate of death with a benefit commencement date on the first day of the\nmonth following date of death and survived to that date.\nIf the participant is married on the date of death, the surviving spouse must\nwaive his/her rights to the QJSA described above to receive this benefit.\nForm of benefits\n(cid:127) Automatic form for unmarried Single life annuity\nparticipants\n(cid:127) Automatic form for married 50% joint & survivor annuity (actuarially reduced)\nparticipants\n(cid:127) Optional forms The following optional forms of payment are available instead of the Normal\nForm of Payment for all participants:\n\uf0a7 Single life annuity\n\uf0a7 50% joint & survivor annuity\n\uf0a7 75% joint & survivor annuity\n\uf0a7 100% joint & survivor annuity\nIn addition to the optional forms listed above, a participant who terminates\nafter attaining early retirement eligibility may elect one of the following\noptional forms of payment:\n\uf0a7 Lump Sum\n\uf0a7 Social Security Level Income option to age 65\n\uf0a7 Social Security Level Income option to age 65 with a 50%\njoint & survivor option (only available through 12/31/2025)\n\uf0a7 Social Security Level Income option to age 65 with a 100% joint &\nsurvivor option (only available through 12/31/2025)\n(cid:127) Actuarial Basis for Lump Sum and Social Security Level Income options are converted using\nConversion to Optional the applicable interest rate and applicable mortality table as defined in IRC\nSection 417(e)(3). All other forms of payment are converted using the\nForms\nGATT2003 mortality table and 8.00% interest.\nProvisions for former Smithkline Beecham employees acquired on January 20, 1995\n\n2024 Form 5500 \u2013 Schedule SB Plan: Pfizer Consolidated Pension Plan\nEIN/PN: 13-5315170/001\nSchedule SB, Part V \u2013 Summary of Plan Provisions\n(cid:127) Eligibility A participant may commence the SKB minimum benefit upon attainment of\nthe following:\n\uf0a7 Three years of Vesting Service, and\n\uf0a7 Age plus Credited Service equal at least 55\n(cid:127) Benefit Benefits accrued under this Plan can never be less than the benefits\naccrued under the SmithKline Beecham (\u201cSKB\u201d) plan through January 20,\n1995.\nThe SKB benefit is unreduced for early commencement if any of the\nfollowing criteria are met:\n\uf0a7 Age 62 with 5 years of Vesting Service\n\uf0a7 Age 61 with at least 21 years of Retirement Eligibility Service\n\uf0a7 Age 60 with at least 27 years of Retirement Eligibility Service\nThe SKB benefit accrued through 12/31/1989 is reduced by 6% per year\nfrom age 65 through age 53, then 2% per year through age 44 and then 1%\nper year thereafter. The amount of the Early Retirement Benefit is\nincreased by 1% per year (up to a maximum of 10%) for each year\nCredited Service exceeds 20 years.\nThe SKB benefit accrued from 1/1/1990 through 1/20/1995 is reduced by\n6% per year from age 62 through age 51, 3% per year through age 46 and\nthen 1% per year thereafter. The amount of the Early Retirement Benefit is\nincreased by 1% per year (up to a maximum of 12%) for each year\nCredited Service exceeds 15 years.\nThe SKB Early Retirement Benefit is the greater of a) and b) below:\na) The sum of 1) and 2) below:\n1) The 12/31/1989 accrued benefit multiplied by the applicable early\nretirement factors described above\n2) The benefit accrued between 1/1/1990 and 1/20/1995 multiplied by\nthe applicable early retirement factors described above\nb) The benefit accrued through 1/20/1995 multiplied by the early\nretirement factors described above for the post-12/31/1989 accruals\n(cid:127) Form of benefits In addition to the Optional Forms of Payment described above, former SKB\nemployees are also eligible to receive a 5, 10, 15 or 20-year certain &\ncontinuous annuity.\nThe 15-year certain & continuous annuity was eliminated effective 1/1/2022\nand the 20-year certain & continuous annuity is only available through\n12/31/2025.\n\n2024 Form 5500 \u2013 Schedule SB Plan: Pfizer Consolidated Pension Plan\nEIN/PN: 13-5315170/001\nSchedule SB, Part V \u2013 Summary of Plan Provisions\nRestructuring A corporate restructuring plan was implemented by Pfizer in 2005. Under\nthis program, individuals whose jobs are eliminated due to the restructuring\nmay be entitled to enhanced benefits from the Plan.\nDepending upon the participant\u2019s age and service at layoff, these\nenhancements may provide more favorable early retirement reduction\nfactors, unreduced benefits, and/or eligibility for alternative forms of\npayment.\nIn general, participants are entitled to unreduced pension benefits through\nthis program if they satisfy either of the following conditions at termination:\n\uf0a7 Age 60 (but less than 65) or\n\uf0a7 Age plus service greater than or equal to 85 (but less than 90).\nMoreover, participants are generally considered retirement eligible at\ntermination under this program if they would attain age 55 with 10 years of\nRetirement Eligibility Service if a total of 5 years were added to their age\nand/or Retirement Eligibility Service. The enhanced benefits for highly\ncompensated employees are paid directly from corporate assets as\nopposed to this Plan.\nThe benefit enhancements provided under the corporate restructuring\nprogram were discontinued during 2012 for benefits accrued under the\nPRAP formula.\nEffective July 1, 2023, colleagues who terminate under the restructuring\nprogram are no longer eligible for enhanced benefits from the Plan.\nVoluntary Early Retirement Under these programs, enhancements of up to five additional points toward\nProgram (\u201cVERP\u201d) and Special retirement eligibility are provided to colleagues who are within five points of\nSeparation Program (\u201cSSP\u201d) a retirement milestone (age 55 & 10 years of service or \u2018Rule of 90\u2019) under\nunder the Organizing for the legacy Pfizer formula as of December 31, 2018 (for the VERP) and\nGrowth (\u201cOFG\u201d) initiative their termination date (for the SSP). Further details of the programs are\noutlined below:\n\uf0a7 The pension enhancement is paid from the Consolidated SERP if the\ncolleague has a nonqualified PRAP benefit, for 2022 terminations if the\ncolleague\u2019s 2020 pensionable earnings were at least $235,000, or for\n2023 terminations if the colleague\u2019s 2021 pensionable earnings were at\nleast $253,000.\n\uf0a7 A colleague whose enhancement is payable from PCPP must wait to\ncommence his/her benefit until the first of the month coincident with or\nnext following the date he would have attained the milestone if he had\ncontinued working.\n\uf0a7 An enhancement-eligible colleague who dies prior to his milestone date\nwill be treated as if he lived to the milestone date, and the enhanced\nbenefit will be payable as a lump sum in accordance with the Enhanced\nActive Death Benefit rules.\nEffective July 1, 2023, colleagues who terminate under the\nrestructuring program are no longer eligible for enhanced benefits from\nthe Plan.\n\n2024 Form 5500 \u2013 Schedule SB Plan: Pfizer Consolidated Pension Plan\nEIN/PN: 13-5315170/001\nSchedule SB, Part V \u2013 Summary of Plan Provisions\nPharmacia Pension Plan (PPP) benefit formula \u2013 pre-July 1, 2002\nFollowing is a summary of the major plan provisions for participants who accrued benefits under the\nLegacy Pharmacia Pension Plan prior to July 1, 2002.\nParticipating employees All regular full-time or regular part-time employees, who are currently\nemployed by Pfizer and were previously employed by Pharmacia or those\nsubsidiaries which have adopted the plan\nEligibility Immediate\nDefinitions\n(cid:127) Participant contributions None\n(cid:127) Employment Service For periods of employment prior to January 1, 1976:\nService equal to the period of employment with the Pharmacia & Upjohn\ncompanies, but excluding employment (subject to provisions in the plan\ndocument) with a subsidiary prior to its becoming a Pharmacia & Upjohn\nCompany.\nFor periods of employment after December 31, 1975:\nService equal to that portion of the period of employment with Pharmacia.\n(cid:127) Benefit Service For periods of employment prior to January 1, 1976:\nService credited as defined by \"Credited Service,\" which is service based\non a regular, temporary, full or part-time basis while employed by\nPharmacia & Upjohn.\nFor periods of employment after December 31, 1975:\nOne year credit for:\n(a) Each year of employment service if on a regular full-time basis; or\n(b) At least 2,035 or 2,088 hours worked if employed on a 39 or 40 hour\nstandard workweek, respectively. Fractional year credit given if less\nthan 2,035 or 2,088, respectively.\nBenefit Service for purposes of the pre-July 1, 2002, formula was frozen as\nof June 30, 2002.\nBenefit Service for all purposes is frozen as of December 31, 2011.\n(cid:127) Point Service For periods of employment prior to January 1, 1976:\nService credited as previously defined as \"Credited Service,\" plus service\nwhile covered by any other pension plan maintained by a Pharmacia &\nUpjohn Company or by a predecessor to a Pharmacia & Upjohn Company.\nFor periods of employment after December 31, 1975:\nService equal to that period of employment with Pharmacia while a covered\nemployee.\n(cid:127) Compensation considered Base wages or salary, amounts contributed on employee's behalf under the\nPharmacia & Upjohn Employee Savings Plan, overtime, premiums,\nincentive awards that are not deferred, and bonuses (including Christmas\nbonus)\n(cid:127) Final Average Salary Highest average monthly compensation during 36 consecutive calendar\nmonths within the last 120 months prior to the date of eligibility for benefits\n(cid:127) Adjusted Final Average The minimum of Final Average Salary and the Social Security taxable wage\nSalary base\n\n2024 Form 5500 \u2013 Schedule SB Plan: Pfizer Consolidated Pension Plan\nEIN/PN: 13-5315170/001\nSchedule SB, Part V \u2013 Summary of Plan Provisions\n(cid:127) Covered Compensation The monthly average (without indexing) of the Social Security taxable wage\nbases in effect for each of the 35 calendar years ending with the calendar\nyear in which the participant would attain Social Security Normal\nRetirement Age, under the assumption that the Social Security taxable\nwage base for future years within the 35-year period is the same as the\nSocial Security taxable wage base in effect at the beginning of the calendar\nyear for which the determination of the participant's covered compensation\nis being made\nNormal retirement\n(cid:127) Eligibility Age 65 with three years of vesting service\n(cid:127) Benefit A monthly benefit equal to the larger of (a), (b), or (c) below:\n(a) The sum of (i) and (ii), less (iii)\n(i) 2.0% of Final Average Salary multiplied by Benefit Service\n(maximum 30 years), reduced by the Required Reductions for\nIntegration,\n(ii) 0.5% of Final Average Salary multiplied by years of Benefit\nService in excess of 30 years (maximum 10 years),\n(iii) 0.6% of the minimum of 150% of Covered Compensation and\nAdjusted Final Average Salary, multiplied by Benefit Service\n(maximum 30 years), reduced by the Required Reductions for\nIntegration, or\n(b) $10 per month for each year of Benefit Service, or\n(c) The prior plan frozen monthly accrued benefit\nLate retirement benefit\n(cid:127) Eligibility Any time after age 65\n(cid:127) Benefit The monthly benefit is computed as for normal retirement, recognizing pay\nand service after normal retirement age.\nEarly retirement\n(cid:127) Eligibility Age 50 (no service requirement other than vesting)\n(cid:127) Benefit A monthly benefit equal to the larger of (a), (b), or (c) below:\n(a) The sum of (i) and (ii), less (iii)\n(i) 2.0% of Final Average Salary multiplied by Benefit Service\n(maximum 30 years), reduced by the Required Reductions for\nIntegration or the Old Formula Reductions, whichever causes a\ngreater reduction,\n(ii) 0.5% of Final Average Salary multiplied by years of Benefit\nService in excess of 30 years (maximum 10 years),\n(iii) 0.6% of the minimum of 150% of Covered Compensation and\nAdjusted Final Average Salary, multiplied by Benefit Service\n(maximum 30 years), reduced by the Required Reductions for\nIntegration, or\n(b) $10 per month for each year of Benefit Service, reduced by the Old\nFormula Reductions, or\n(c) The prior plan frozen monthly accrued benefit, reduced by the Old\nFormula Reductions\nReceipt of benefit may be deferred, whereupon reductions are based on\nage when payment begins.\n\n2024 Form 5500 \u2013 Schedule SB Plan: Pfizer Consolidated Pension Plan\nEIN/PN: 13-5315170/001\nSchedule SB, Part V \u2013 Summary of Plan Provisions\n(cid:127) Required Reductions for For part (i) of the formula, a reduction of 1/600th for each of the first 60\nIntegration months, 1/1,200th for each of the next 60 months, 31/30,000th for each of\nthe next 12 months (the 11th year), and 28/30,000th for each of the next 12\nmonths (the 12th year), by which retirement precedes Social Security\nNormal Retirement Age.\nFor part (iii) of the formula, a reduction of 1/180th for each of the first 60\nmonths, 1/360th for each of the next 60 months, 31/9,000th for each of the\nnext 12 months (the 11th year), and 28/9,000th for each of the next 12\nmonths (the 12th year), by which retirement precedes Social Security\nNormal Retirement Age.\nActuarially equivalent reductions from age 55 to age 50 are used. Actuarial\nequivalence is based on 7.50% and 83 GATT mortality.\n(cid:127) Social Security Normal Age 65 for participants with birth dates in 1937 or earlier years.\nRetirement Age\nAge 66 for participants with birth dates in the years 1938-1954 inclusive.\nAge 67 for participants born in 1955 or later years.\n(cid:127) Old Formula Reductions (a) or (b) whichever causes a smaller reduction:\n(a) \u00bd% for the first 120 months that the employee is under age 65 at\nretirement, and \u00bc% for each month that the employee is under age 55,\n(b) \u00bc% for each month that the total of age and service at early retirement\nis less than 92 years.\nDeferred vested\n(cid:127) Eligibility Three years of employment service.\nEmployees who terminated other than for cause within two years of the\nPharmacia & Upjohn merger are also vested.\n(cid:127) Benefit A monthly benefit equal to the normal retirement benefit earned to the date\nof termination and commencing at age 65. A reduced benefit (reduced by\nthe early retirement reduction factors) may commence any time subsequent\nto the attainment of age 50.\nDisability\n(cid:127) Eligibility Eligible for long-term disability (LTD) benefits under Pharmacia\u2019s LTD plan\nand the disability occurs before January 1, 2012.\n(cid:127) Benefit The plan provides continued accruals for disabled participants. Accruals\ncease if benefits are commenced. Pay is frozen as of the date of disability.\nDeath\n(cid:127) Eligibility Three years of employment service\n(cid:127) Benefit A monthly benefit in the form of a single life annuity of an amount equal to\nthe amount such spouse would have received had the participant\nterminated his employment the day before his death and elected to receive\na benefit in the form of an annuity with survivor protection. This benefit is\nelective and is paid by the employee through a reduction in the retirement\nbenefit otherwise calculated.\n(cid:127) Disability leave of absence Participants on disability leave of absence, who are not yet eligible for\ndisability retirement, continue to accrue benefit and point service while\ndisabled, but pay is frozen at the level on the date of disability.\n\n2024 Form 5500 \u2013 Schedule SB Plan: Pfizer Consolidated Pension Plan\nEIN/PN: 13-5315170/001\nSchedule SB, Part V \u2013 Summary of Plan Provisions\n(cid:127) Preretirement Terminal Participant in Employee Transition Assistance (ETA) program between\nLeave of Absence (PRTLOA) July 1, 1993, and December 31, 1994, and at least age 50 with 65 points\neligibility by the end of ETA status (three months), or\nParticipant in Merger Employee Transition Assistance (META) program\nbetween December 1, 1995, and December 31, 1997, and at least age 50\nwith 65 points by the end of META status (60 days).\n(cid:127) Preretirement Terminal PRTLOA participants continue to accrue benefit and point service while on\nLeave of Absence (PRTLOA) PRTLOA, but pay is frozen at the level prior to termination. Participants\nbenefit may remain on PRTLOA for up to five years.\n(cid:127) Special Separation Program Participant who terminates employment due to job elimination, job\n(SSP) eligibility restructuring, or decline to relocate on or after January 1, 2000 but before\nJanuary 1, 2002, after attaining age 50 with 10 years of service.\n(cid:127) Special Separation Program SSP participants receive the same benefits as PRTLOA participants.\n(SSP) benefit\n(cid:127) Normal form of retirement For a participant who is not married as of his annuity commencement date,\nbenefits a life annuity is the normal form. If a participant has an eligible spouse as of\nhis annuity commencement date, his monthly retirement income shall\nautomatically be paid in the form of a Qualified Joint and Survivor Annuity\nunless he elects in writing to have it paid in the form of a life annuity or\nother optional form and his spouse consents.\nThe amount of benefit otherwise payable under the Qualified Joint and\nSurvivor Annuity or other optional form shall be reduced by any applicable\ncharge for preretirement coverage.\n(cid:127) Optional forms of retirement Joint and Survivor Annuity with 50%, 75%, or 100% continued; Ten-Year\nbenefits Certain and Life; Annuity with Cash Death Benefit; Temporary Annuity.\nParticipants can also elect the lump sum equivalent of the normal form of\npayment. Grandfathered lump sums based on subsidized Early Retirement\nBenefits are payable based on the frozen accrued benefit as of June 30,\n2000.\nLump Sums are converted using the applicable interest rate and applicable\nmortality table as defined in IRC Section 417(e)(3). All other forms of\npayment are converted using the GATT2003 mortality table and 7.50%\ninterest.\n(cid:127) Optional pre-retirement Annual charge for active participants\ndeath benefit coverage\nFor ages 50% J&S 100% J&S Lump sum\nUnder 50 0.01% 0.03% 0.04%\n50-59 0.08% 0.16% 0.20%\n60 and Older 0.40% 0.80% 1.00%\nAnnual charge for terminated vested participants\nFor ages 50% J&S 100% J&S Lump sum\nUnder 50 0.05% 0.10% 0.20%\n50-59 0.25% 0.40% 0.60%\n60 and Older 0.50% 1.00% 1.15%\n\n2024 Form 5500 \u2013 Schedule SB Plan: Pfizer Consolidated Pension Plan\nEIN/PN: 13-5315170/001\nSchedule SB, Part V \u2013 Summary of Plan Provisions\nPPP benefit formula \u2013 post-June 30, 2002\nFollowing is a summary of the major plan provisions for participants who accrued benefits under the\nLegacy Pharmacia Pension Plan on or after July 1, 2002.\nDefinitions\n(cid:127) Compensation considered Compensation will be the sum of base annual pay or regular salary,\novertime, shift premiums, commissions, regular or recurring bonuses\n(including Christmas bonuses that are not deferred), cash sales incentives,\nvacation pay, pre-tax deferrals and other pre-tax benefits deducted from\npay, such as 401(k) deferrals, medical contributions (Section 125), and\ntransportation fringe benefits (Section 132(f)).\n(cid:127) Final Average Salary Highest compensation received in the 36 complete, consecutive months\nwithin the last 120 complete, consecutive months before termination.\nNormal Retirement\n(cid:127) Eligibility Age 65 with three years of vesting service\n(cid:127) Benefit Employees have an annual choice between two sets of benefit formulas.\nNote that this choice is available to all employees each year (employees\nwill be able to change their benefit choice from year to year) and has two\ncomponents - a pension plan benefit (outlined below) and a Pfizer Savings\nPlan (401(k)) benefit. Option 1 provides a greater pension plan accrual,\nwhereas Option 2 provides a greater company match in the Pfizer Savings\nPlan.\nFor both options listed below, benefit accrual service was frozen as\nDecember 31, 2011.\nOption 1\nDefined Benefit Plan Formula: 2% of Final Average Salary, less 0.5% of\nthe lesser of Final Average Salary and the Social Security Taxable Wage\nBase, multiplied by benefit accrual service after June 30, 2002.\nOption 2\nDefined Benefit Plan Formula: 1% of Final Average Salary, multiplied by\nbenefit accrual service after June 30, 2002 (unintegrated with the Social\nSecurity Taxable Wage Base).\nLate retirement\n(cid:127) Eligibility Any time after age 65\n(cid:127) Benefit The greater of (a) and (b) below:\n(a) The monthly benefit computed as for normal retirement, recognizing\npay and service after normal retirement age.\n(b) Actuarial increase of normal retirement benefit to date of late\nretirement.\n\n2024 Form 5500 \u2013 Schedule SB Plan: Pfizer Consolidated Pension Plan\nEIN/PN: 13-5315170/001\nSchedule SB, Part V \u2013 Summary of Plan Provisions\nEarly retirement\n(cid:127) Eligibility Age 50 (no service requirement other than vesting)\n(cid:127) Benefit Benefit as for normal retirement, reduced as follows according to the\npayment form elected:\nLife Annuity\nA portion reduced in accordance with provisions of the pre July 1, 2002\nplan. B portion reduced 6% per year from age 65 to age 55 and 3% per\nyear from age 55 through age 50.\nLump Sum\nA portion is valued as the greater of (a) or (b):\n(a) Frozen accrued benefit at June 30, 2000, including the early retirement\nsubsidy from the pre July 1, 2002 plan provisions, valued with an\nimmediate annuity factor.\n(b) Total accrued benefit (including all service through June 30, 2002)\nvalued with a deferred to age 65 annuity factor.\nB portion of benefit payable in lump sum form at age 50 or greater valued\nwith a deferred to age 65 annuity factor.\nNote that employees previously covered by the Pharmacia Pension Plan\nwho, at any time, select Option 1 and who, as of June 30, 2002, have at\nleast 50 points (age and service) and 10 years of service, are eligible for\ntransition early retirement factors with respect to their Option 1 pension\nbenefit. All other participants are ineligible for these transition early\nretirement factors. The transition early retirement reductions are the lesser\nof: 6% per year from age 65 to age 55 plus 3% per year from age 55 to age\n50 or 3% for each point under 92 points.\nDeferred vested\n(cid:127) Eligibility Three-year cliff for B portion of benefit\n(cid:127) Benefit A benefit: A monthly benefit equal to the normal retirement benefit earned\nto the date of termination and commencing at age 65. A reduced benefit\n(reduced by the early retirement reduction factors) may commence any\ntime subsequent to early retirement eligibility date.\nB benefit: Payable as an annuity or in lump sum form at age 50 or greater\nvalued with a deferred to age 65 annuity factor\nDisability\n(cid:127) Eligibility Eligible for long-term disability (LTD) benefits under Pharmacia's LTD plan\n(cid:127) Benefit The plan provides continued accruals for disabled participants. Accruals\ncease if benefits are commenced. Pay is frozen as of the date of disability.\nParticipants who become disabled on or after January 1, 2012 do not\naccrue benefits while on disability.\n\n2024 Form 5500 \u2013 Schedule SB Plan: Pfizer Consolidated Pension Plan\nEIN/PN: 13-5315170/001\nSchedule SB, Part V \u2013 Summary of Plan Provisions\nDeath\n(cid:127) Eligibility Three years of employment service\n(cid:127) Benefit Either a 50% J&S annuity, 100% J&S annuity or a lump sum determined as\nif the participant had terminated employment the day before his death and\nelected to receive a benefit in one of the aforementioned forms. This\nbenefit is elective and is paid by the employee through a reduction in the\nretirement benefit otherwise calculated. The B piece and/or A piece is\npayable to the designated beneficiary as early as the later of age 50 or the\ndate the employee is first vested. The combined benefit must commence at\nthe same time and no later than the date the employee would have attained\nage 65 had he/she survived to such age.\n(cid:127) Leave of absence Any authorized leave of absence (regardless of whether paid or unpaid and\nregardless of duration) will be treated as continued employment for vesting\nand benefit accrual purposes. An authorized leave of absence as approved\nby Pfizer does not incur a break in service.\n(cid:127) Preretirement Terminal Same as under the pre July 1, 2002 plan. PRTLOA participants are not\nLeave of Absence (PRTLOA) eligible for the B benefit.\neligibility\n(cid:127) Preretirement Terminal PRTLOA participants who entered the PRTLOA plan prior to July 1, 2002\nLeave of Absence (PRTLOA) retain pre July 1, 2002 plan formula through period of PRTLOA and are not\nbenefit eligible for the B benefit of the post July 1, 2002 plan formula. They\ncontinue to accrue benefit and point service but pay is frozen at the level\nprior to termination. Participants may remain on PRTLOA for up to five\nyears.\nParticipants who enter the PRTLOA program after July 1, 2002 maintain\nthe retirement choice program election in effect at the time of PRTLOA.\nThey continue to accrue benefit and point service while on PRTLOA but\npay is frozen at the level prior to termination. Participants may remain on\nPRTLOA for up to five years.\n(cid:127) Special Separation Program Same as under the pre July 1, 2002 plan provisions. SSP participants are\n(SSP) eligibility not eligible for the B benefit.\n(cid:127) Special Separation Program SSP participants receive the same benefits as PRTLOA participants.\n(SSP) benefit\n(cid:127) Normal form of retirement For a participant who is not married as of his annuity commencement date,\nbenefits a life annuity is the normal form. If a participant has an eligible spouse as of\nhis annuity commencement date, his monthly retirement income shall\nautomatically be paid in the form of a Qualified Joint and Survivor Annuity\nunless he elects in writing to have it paid in the form of a life annuity or\nother optional form and his spouse consents.\nThe amount of benefit otherwise payable under the Qualified Joint and\nSurvivor Annuity or other optional form shall be reduced by any applicable\ncharge for preretirement coverage.\n\n2024 Form 5500 \u2013 Schedule SB Plan: Pfizer Consolidated Pension Plan\nEIN/PN: 13-5315170/001\nSchedule SB, Part V \u2013 Summary of Plan Provisions\n(cid:127) Optional forms of retirement The plan offers the following five optional forms of payment:\nbenefits\n1. Lump sum (payable at age 50 or greater after vesting)\n2. 50% joint and survivor annuity\n3. 100% joint and survivor annuity\n4. 10 year certain and continuous annuity\n5. Single life annuity\nFor employees who were participants in the Pharmacia Pension Plan prior\nto July 1, 2002, in addition to the five options described above, the\ndistribution options under the pre July 1, 2002 plan will continue to be\navailable for both the pre- and post-July 1, 2002 benefits. Note that the total\ncombined benefit (A + B) must be taken at the same time and in the same\nform of payment.\nLump Sums are converted using the applicable interest rate and applicable\nmortality table as defined in IRC Section 417(e)(3). All other forms of\npayment are converted using the GATT2003 mortality table and 7.50%\ninterest.\n(cid:127) Optional pre-retirement Annual Charge for Active Participants\ndeath benefit coverage\nFor Ages 50% J&S 100% J&S Lump Sum\nUnder 50 0.01% 0.03% 0.04%\n50-59 0.08% 0.16% 0.20%\n60 and Older 0.40% 0.80% 1.00%\nAnnual Charge for Terminated Vested Participants\nFor Ages 50% J&S 100% J&S Lump Sum\nUnder 50 0.05% 0.10% 0.20%\n50-59 0.25% 0.40% 0.60%\n60 and Older 0.50% 1.00% 1.15%\n(cid:127) Restructuring Eligibility enhancement can add up to five years to age solely for the\npurposes of eligibility for unreduced benefits. In general, participants are\nentitled to these enhancements if they satisfy either of the following\nconditions at termination: (i) Age 60 (but less than 65), or (ii) Age plus\nservice greater than or equal to 87 (but less than 92) and age is less than\n60. Eligibility for this scenario applies to the P&U formula benefit, as well as\nthe Retirement Choice Option 1 benefit for US participants who (a) retire\nearly, (b) participated in the P&U Plan as of 6/30/2002, (c) had at least 50\npoints as of 6/30/2002, and (d) had at least 10 years of vesting service as\nof 6/30/2002.\nThe benefit enhancements provided under the corporate restructuring\nprogram were discontinued during 2012 for benefits accrued under the\nPPP formula.\n\n2024 Form 5500 \u2013 Schedule SB Plan: Pfizer Consolidated Pension Plan\nEIN/PN: 13-5315170/001\nSchedule SB, Part V \u2013 Summary of Plan Provisions\nPharmacia Cash Balance Pension Plan benefit formula\nFollowing is a summary of the major plan provisions for participants who accrued benefits under the\nLegacy Pharmacia Cash Balance Pension Plan, which was spun off from Monsanto Company Salaried\nEmployees' Pension Plan effective January 1, 2002.\nDefinitions\n(cid:127) Participating employees All employees who are employed on or after January 1, 1997, became\nparticipants immediately. Effective July 1, 2002, no new participants will\nearn benefits under this formula.\n(cid:127) Type of benefit formula Cash Balance\n(cid:127) Eligibility Immediate, not before age 18\n(cid:127) Participant contributions None\n(cid:127) Eligible Pay Base compensation (before any reductions for pre-tax contributions)\nincluding overtime, sick-leave pay, annual incentive awards, and gain\nsharing, but excluding Flex Credits, awards under long-term incentive plans\nand other special awards, pay in lieu of vacation or deferred compensation.\n(cid:127) Hour of service Each hour for which you are paid for work and each hour for which you are\nentitled to payment for time not actually worked. Hours of service are also\ngranted in special circumstances involving disability time and other leaves\nof absences.\n(cid:127) Vesting service Vesting Service is credited for each month during which the participant has\none hour of service. One year of Vesting Service is credited for each 12\nmonths of Vesting Service earned.\n(cid:127) Social Security wage base The amount of earnings subject to the pension (OASDI) portion of the FICA\ntax each year\n(cid:127) Prior Plan Account The lump sum value of a participant\u2019s benefit under the Pension Plan as of\nDecember 31, 1996 for employees earning benefits under final pay\nformulas at that time\n(cid:127) Cash Balance Account The account containing a participant\u2019s benefit under the Pension Plan\nbeginning January 1, 1997. It includes the accumulated balance as of\nDecember 31, 1996 for employees earning benefits under a cash balance\narrangement at that time. It includes the lump sum value of the Kelco Union\nparticipants\u2019 benefits under the Kelco Union Pension Plan as of\nDecember 31, 1998.\n(cid:127) Retirement Account An account for a participant consisting of the participant\u2019s Prior Plan\nAccount and Cash Balance Account, plus Annual Credits earned for both\naccounts during each plan year.\n(cid:127) Annual credits to the Prior (i) Pay Credits: Pay credits are credited to the Retirement Account at an\nPlan Account annual rate of 4% of a participant\u2019s Prior Plan Account until the earlier\nof termination or December 31, 2017.\n(ii) Restoration Credits: Interest Credits are credited to the Retirement\nAccount at an annual rate of 8.5% of a participant\u2019s Prior Plan Account\nuntil the earlier of reaching age 55 or the onset of benefit payments.\n\n2024 Form 5500 \u2013 Schedule SB Plan: Pfizer Consolidated Pension Plan\nEIN/PN: 13-5315170/001\nSchedule SB, Part V \u2013 Summary of Plan Provisions\n(cid:127) Annual credits to the Cash (i) Contribution credits: Contribution credits are added to the Cash\nBalance Account Balance Account at the end of each year of employment with the\ncompany. Credits are determined by multiplying Eligible Pay by a\npercentage based on the participant\u2019s age (see following chart).\nEligible pay in excess of the Social Security Wage Base is also\ncredited at a rate of 3%. Effective July 1, 2002, no future contribution\ncredits will be made, except for participants on LTD as of June 30,\n2002. Effective December 31, 2017, no future contribution credits will\nbe made to LTD participants.\n(ii) Transition credits: Transition Credits for certain groups are added to\nthe Cash Balance Account at the end of each year of employment for\nup to 10 years (based on Benefit Service on December 31, 1996) from\n1997 to 2006. Credits are determined by multiplying Eligible Pay by a\npercentage based on the participant\u2019s age (see chart below). Effective\nJuly 1, 2002, no future transition credits will be made, except for\nparticipants on LTD as of June 30, 2002. Effective December 31,\n2017, no future contribution credits will be made to LTD participants.\nContribution\ncredits Transition credits\npercentage of percentage of\nAge at year end eligible pay eligible pay\nBefore 30 3% 2%\n30-39 4% 3%\n40-44 5% 4%\n45-49 6% 5%\n50 & over 7% 6%\n(iii) Interest Credits: Interest Credits are added to the Cash Balance\nAccount monthly based on the balance in the account prior to the\naddition of contribution and transition credits for that year. The rate of\ninterest will be the average interest rate on 30-year Treasury Bonds for\nOctober of prior calendar year with minimum and maximum rates of\n5% and 10%, respectively.\nNormal retirement\n(cid:127) Eligibility Age 65\n(cid:127) Benefit Retirement Account as of the Retirement Date\nLate retirement\n(cid:127) Eligibility Any time after age 65\n(cid:127) Benefit (cid:127) Between Normal Retirement Date and April 1 of the calendar year\nfollowing the calendar year in which age 70 \u00bd is attained - account\nbalances are increased with Interest Credits\n(cid:127) From April 1 of the calendar year following the calendar year in which\nage 70 \u00bd is attained - account balances are actuarially increased using\nthe Plan\u2019s definition of actuarial equivalence\nEarly retirement\n(cid:127) Eligibility Vesting Age\n(cid:127) Benefit Retirement Account as of the Retirement Date. If form of payment is a life\nannuity, the benefit shall be the Retirement Account divided by 125 with the\n125 increased by 1/10 for each month under age 55.\n\n2024 Form 5500 \u2013 Schedule SB Plan: Pfizer Consolidated Pension Plan\nEIN/PN: 13-5315170/001\nSchedule SB, Part V \u2013 Summary of Plan Provisions\nDeferred vested\n(cid:127) Eligibility Earlier of three years of Vesting Service, attainment of age 65 while\nactively employed, permanent disability (LTD), or death while employed.\n(cid:127) Benefit Retirement Account upon termination\nDisability\n(cid:127) Eligibility While actively employed by the company, either becoming Totally and\nPermanently Disabled or having a company defined Long Term Disability\nbenefit.\n(cid:127) Benefit Either Retirement Account at time of disability or deferred until date the\nparticipant retires or is no longer considered disabled. Prior to\nDecember 31, 2011, the Retirement Account continued to receive all\ncredits based on Eligible Pay at the time of disability. On or after January 1,\n2012, all future accruals will be defined by the PRAP formula.\nFor participants who become disabled on or after January 1, 2012, there\nwill be no pension accruals.\nPre-retirement death\n(cid:127) Eligibility Death while actively employed by the company\n(cid:127) Benefit Retirement Account at time of death\nForm of benefits\n(cid:127) Optional forms of retirement In lieu of receiving a lump sum, a participant may elect to receive a pension\nbenefits in the form of a monthly benefit. The Retirement Account is converted to a\nSingle Life Annuity form of payment commencing on or after age 55 by\ndividing the account by 125. Reductions will apply for any other form of\npayment and for commencement of monthly benefits before age 55.\nThe following optional forms of payment are available instead of the Normal\nForm of Payment:\n(cid:127) Single life annuity\n(cid:127) 10-Year certain and life annuity\n(cid:127) 20-Year certain and life annuity\n(cid:127) 25% joint & survivor annuity\n(cid:127) 50% joint & survivor annuity\n(cid:127) 75% joint & survivor annuity\n(cid:127) 100% joint & survivor annuity\n(cid:127) Social Security Level Income option to age 65\n(cid:127) Social Security Level Income option with 100% joint & survivor\n(cid:127) Social Security Level Income option with 10-year certain\n(cid:127) Optional forms conversion Reductions for payments in forms other than a life annuity are based on the\nfactors plan-defined actuarial equivalence, which is based on GAR 1994 unisex\nmortality and an interest rate of 7.5%.\n(cid:127) Special minimum lump sum For certain eligible groups, if a participant was at least age 50 on\nbenefit December 31, 1996, leaves the company after age 55, and elects the\noptional Lump Sum form of payment, a Special Minimum Lump Sum\nBenefit will be payable if it exceeds the Prior Plan Account value.\n\n2024 Form 5500 \u2013 Schedule SB Plan: Pfizer Consolidated Pension Plan\nEIN/PN: 13-5315170/001\nSchedule SB, Part V \u2013 Summary of Plan Provisions\nMiscellaneous\n(cid:127) Kelco Union Merck Kelco Union participants retiring after age 55 are entitled to a temporary\nSupplement monthly supplement payable until age 65 equal to their Merck accrued\nbenefit.\n(cid:127) Kelco Union Grandfather Kelco Union participants retiring after age 55 and prior to 2003 receive the\ngreater of the value of the accrued benefit under the prior Kelco Union plan\nand the sum of the Cash Balance Account and Merck Supplement.\n(cid:127) Restructuring Enhancements may provide for immediate vesting for affected participants\nnot yet vested. In general, participants are entitled to immediate vesting if\nthey are at least age 60 and have less than 3 years of service at\ntermination.\nThe benefit enhancements provided under the corporate restructuring\nprogram were discontinued during 2012 for benefits accrued under the\nPharmacia Cash Balance formula.\nWarner Lambert Retirement Plan (WLRP) benefit formula\nFollowing is a summary of the major plan provisions for participants who accrued benefits under the\nLegacy Warner Lambert Retirement Plan.\nType of benefit formula Career Average (pay-related) defined benefit plan\nDefinitions\n(cid:127) Participation An employee joins the plan on the January 1st following employment date.\nNon-union employees hired on or after January 1, 2003 are not eligible to\nparticipate in the plan.\n(cid:127) Participant contributions No contributions were required after January 1, 1977.\n(cid:127) Compensation Employee base rate on January 1 plus incentive pay, overtime pay, sales\nbonuses and commissions\n(cid:127) Normal retirement age Age 65\n(cid:127) Early retirement age Eligibility for early retirement is age 55 with five years of service.\n(cid:127) Dollar Value of a Unit The Dollar Value of a Unit is determined by dividing the net market value of\nall assets in the Equity Fund by the present value of all credited units. The\nDollar Value of a Unit as of 12/1/2022 is $28.56808.\n(cid:127) Assumptions used to Interest rate \u2013 3.50%\ndetermine present value of\nMortality \u2013 1951 Group Annuity Table for males, set back five years for\nunits\nfemales\nWithdrawal \u2013 No withdrawal is assumed.\nDisability \u2013 No disability incidence is assumed.\nRetirement \u2013 60% are expected to retire at age 62; 100% are expected to\nretire at age 65. No retirement is assumed at any other age.\n(cid:127) Normal retirement benefit \u2013 The sum of the participant's Dollar Annuity Retirement Income and Equity\npay related Annuity Retirement Income\nDollar annuity retirement income\n1 1/2% of Compensation\nEquity annuity retirement income \u2014 assumed benefit and equity units\nFor employees who elected at January 1, 1977 to retain their Equity\nAnnuity Retirement Income, the Dollar Annuity benefit is half the amount\ndescribed above and the remaining half is the \"assumed benefit.\" Equity\n\n2024 Form 5500 \u2013 Schedule SB Plan: Pfizer Consolidated Pension Plan\nEIN/PN: 13-5315170/001\nSchedule SB, Part V \u2013 Summary of Plan Provisions\nAnnuity Units are credited to a participant each year by dividing that year\u2019s\nassumed benefit by the Dollar Value of a Unit at that time. Employees who\nelected to convert their Equity Annuity Retirement Income received\ncorresponding Dollar Annuity benefits equal to 1.88054 times their Equity\nunits. Equity Annuity Retirement Income to a retired participant is\ndetermined by multiplying the participant\u2019s number of Units by the Dollar\nValue of a Unit determined in the preceding calendar year.\nAdditional retirement income\nAdditional retirement income was also credited in 1964, 1969, 1973, 1977,\n1980, 1983, 1986, 1989, 1991, 1994, 1997,1999, 2005 and 2011 to those\nPlan members whose accrued benefits were less than certain retirement\nincome objectives.\nIn 2011, the objective was 1.2% of the average of the five highest year\u2019s\nearnings in the last 10 years, up to covered compensation, plus 1.5% of\nthese earnings in excess of covered compensation, multiplied by years of\ncredited service from age 21 and 1 year of service to December 31, 2011.\nThe update provided on December 31, 2011 is the final update.\nCost-of-living adjustments\nOn January 1, 2000, retirees who commenced benefits before July 1, 1999\nwere granted a 3% pension increase with a $200 maximum monthly\nincrease.\nBesides the benefits described above, participants who were members of a\nprior plan are credited with a benefit from that plan.\nEffective December 31, 1998 the Warner-Lambert Company Employees\u2019\nPension Plan for Members of Local No. 7-176, Oil Chemical and Atomic\nWorkers International Union (OCAW) was merged into the Warner-Lambert\nRetirement Plan. Retirement benefits paid by the OCAW plan are based on\na flat dollar multiplier. The effective multiplier is $34. There are no active\nparticipants.\nEffective January 1, 2007, the Employees\u2019 Pension Plan for Members of\nMechanics Motor City Lodge 698, International Association of Machinists\nand Aerospace Workers, A.F.L.-C.I.O. and the Employees\u2019 Pension Plan\nfor Members of Local 114, United Plant Guard Workers of America were\nmerged into the Warner-Lambert Retirement Plan. Refer to the\ncorresponding plans\u2019 provisions for additional details regarding benefits\npayable due to past service in these plans. There are no active participants.\nBenefit accruals under this formula ceased on December 31, 2011. Benefit\naccruals after January 1, 2012 will occur under the PRAP formula.\n(cid:127) Normal retirement benefit \u2013 For active employees retiring on or after January 1, 1992, an additional\nservice related benefit of $96 per year of service is provided. No service related benefit will\nbe earned for service after December 31, 2011.\n(cid:127) Early retirement eligibility Age 55 with five years of service\n(cid:127) Early retirement benefit For active employees on or after January 1, 1973 who retire prior to age 65\nbut not before age 62, no reduction in their pensions will be made on\naccount of immediate commencement. There is a reduction of 3% for each\nyear retirement precedes age 62 but after age 60 and 6% for each year\nunder age 60. The reductions do not apply to the service related benefits.\n(cid:127) Vesting eligibility Three years of vesting service\n(cid:127) Deferred vested benefit An employee is fully vested if he has completed three years of service. If\nthe employee is vested, they are entitled to the benefits described above\nincluding the provisions for early retirement.\n\n2024 Form 5500 \u2013 Schedule SB Plan: Pfizer Consolidated Pension Plan\nEIN/PN: 13-5315170/001\nSchedule SB, Part V \u2013 Summary of Plan Provisions\n(cid:127) Disability eligibility Three years of vesting service\n(cid:127) Disability benefit The plan provides continued accruals for disabled participants. Accruals\ncease if benefits are commenced. Pay is frozen as of the date of disability.\nParticipants who become disabled on or after January 1, 2012 do not\naccrue benefits while on disability.\n(cid:127) Death benefit \u2013 Automatic The Automatic Spouse\u2019s Pension is equal to 50% of the participant\u2019s\nSpouse\u2019s Pension Normal Retirement Benefit reduced for early retirement. The Automatic\nSpouse\u2019s Pension is payable as follows:\n(cid:127) If death occurs after August 23, 1984 but before age 55 and the active\nor terminated vested participant (who performed service after\nNovember 30, 1976) is vested in part or all of his retirement benefits\nand is survived by an eligible spouse, that spouse will receive the\nAutomatic Spouse's Pension commencing when the participant would\nhave reached age 55.\n(cid:127) If death occurs before the Normal Retirement Date and after age 55 (or\nbefore age 55 provided that the sum of the participant's years of plan\nparticipation and age equal 75 or more) and the active or terminated\nvested participant is survived by an eligible spouse, that spouse will\nreceive the Automatic Spouse's Pension; otherwise, a refund of\ncontributions with interest will be made.\n(cid:127) If death occurs after retirement or after Normal Retirement Date and\nthe participant is survived by an eligible spouse, such spouse will\nreceive the Automatic Spouse's Pension plus $2,500 if retirement\nincome commenced after January 1, 1965. Upon the death of a\nparticipant who is not survived by an eligible spouse and who dies after\nretirement, the larger of the following will be paid: the excess of\ncontributions with interest over benefits already paid, or $2,500. The\n$2,500 death benefit does not apply to participants that terminate after\nDecember 31, 2009.\nDeath benefit \u2013 Enhanced active death benefit (effective June 1, 2015)\n(cid:127) Eligibility Actively employed and eligible for early retirement on the date of death.\n(cid:127) Benefit An amount payable to the beneficiary equal to the greater of the present\nvalue of the Employee\u2019s age 62 single life annuity benefit and the present\nvalue of the Employee\u2019s single life annuity benefit immediately payable as\nof the first day of the month following the date of death.\nIf the participant is married on the date of death, the surviving spouse must\nwaive his/her rights to the Automatic Spouse\u2019s Pension described above to\nreceive this benefit.\nForm of benefits\n(cid:127) Automatic form for unmarried Single life annuity\nparticipants\n(cid:127) Automatic form for unmarried 50% joint & survivor annuity\nparticipants\n\n2024 Form 5500 \u2013 Schedule SB Plan: Pfizer Consolidated Pension Plan\nEIN/PN: 13-5315170/001\nSchedule SB, Part V \u2013 Summary of Plan Provisions\n(cid:127) Optional forms The following optional forms of payment are available instead of the Normal\nForm of Payment for all participants:\n(cid:127) Single life annuity\n(cid:127) 50% joint & survivor annuity\n(cid:127) 75% joint & survivor annuity\n(cid:127) 100% joint & survivor annuity\nLump Sums are converted using the applicable interest rate and applicable\nmortality table as defined in IRC Section 417(e)(3). All other forms of\npayment are converted using the GATT2003 mortality table and 7.50%\ninterest.\n(cid:127) Restructuring A corporate restructuring plan was implemented by Pfizer in 2005. Under\nthis program, individuals whose jobs are eliminated due to the restructuring\nmay be entitled to enhanced benefits from the Plan. Depending upon the\nparticipant\u2019s age and service at layoff, these enhancements may provide\nmore favorable early retirement reduction factors, unreduced benefits,\nand/or eligibility for alternative forms of payment.\nIn general, participants are entitled to unreduced pension benefits if they\nsatisfy the following conditions at termination: Age 60 (but less than 62) and\nage plus service greater than or equal to 65.\nThe benefit enhancements provided under the corporate restructuring\nprogram were discontinued during 2012 for benefits accrued under the\nWLRP formula.\n(cid:127) Enhanced Severance As a result of the April 2000 acquisition of Warner-Lambert by Pfizer,\nProgram participants subject to an involuntary termination within two years (senior\nmanagement within three years) after this Change in Control, for any\nreason other than death or Termination for Just Cause, are eligible for an\nadditional pay related and service related accrual for the period of\nseverance.\nThe additional pay and service accruals are based on the actual amount of\nseverance, respectively, as if the participant had remained employed during\nthe severance period.\nWLRP IAM Benefit Formula\n(cid:127) Type of benefit formula Flat dollar multiplier\n(cid:127) Employer Contributions The employer will make contributions in an amount no less than the\nminimum amount required under IRS regulations.\nNormal Retirement Benefit\n(cid:127) Eligibility The first day of the month coincident with or following attainment of age 65\n(cid:127) Benefit Monthly annuity equal to a dollar unit multiplied by credited service. The\ndollar unit in effect as of April 30, 1984 was $20.00.\nCost-of-living adjustments\nAs of July 1, 1995, retirees who commenced benefits before January 1,\n1995, were granted a 4% pension increase subject to a $150 maximum\nmonthly increase.\nOn January 1, 2000, retirees who commenced benefits before July 1, 1999\nwere granted a 3% pension increase with a $200 maximum monthly\nincrease.\nBenefit accruals under this formula will cease on December 31, 2011.\nBenefit accruals after January 1, 2012 will occur under the PRAP formula.\n\n2024 Form 5500 \u2013 Schedule SB Plan: Pfizer Consolidated Pension Plan\nEIN/PN: 13-5315170/001\nSchedule SB, Part V \u2013 Summary of Plan Provisions\nEarly Retirement Benefit\n(cid:127) Eligibility A member may retire on the first day of any month following his 57th\nbirthday and completion of 10 years of credited service.\n(cid:127) Benefit The pension amount is based on service to early retirement date, reduced\n5/8% for each month by which the annuity commencement date precedes\nage 62.\nDisability Benefit\n(cid:127) Eligibility A member who has 15 years of credited service and becomes totally and\npermanently disabled is eligible for a disability benefit.\n(cid:127) Benefit Monthly annuity equal to the amount determined by the regular normal\nretirement benefit formula based on service prior to the date of disability\nwithout any reduction for commencement of benefits prior to the normal\nretirement date. However, double this amount is payable for any month for\nwhich the disabled employee is not eligible for benefits payable under the\nSocial Security Act by reason of disability. The disability benefit does not\ncommence until disability has continued for at least 26 consecutive weeks\nand continues only to the normal retirement date when the retirement\nbenefit based on service prior to date of disability becomes payable.\nParticipants who become disabled on or after January 1, 2012 do not\naccrue benefits while on disability.\nVesting Eligibility Three years of vesting service\nDeferred Vested Benefit\n(cid:127) Eligibility A participant who has completed three or more years of Vesting Service is\nentitled to a deferred vested benefit equal to the Normal Retirement\nBenefit.\n(cid:127) Benefit Benefits which begin at an early retirement date are reduced 5/8% for each\nmonth by which the early retirement date precedes age 65.\nDeath Benefit \u2013 Preretirement The eligible spouse of certain vested members who worked after\nSurvivor Annuity January 1, 1976 shall receive a Preretirement Survivor Annuity in the event\nof the member\u2019s death before retirement.\nThe Preretirement Survivor Annuity benefit is the amount which would have\nbeen payable to the spouse had the member elected payment of benefits\nunder a Joint and 55% Survivor annuity form. If the participant is over\nage 57 at death, benefits commence immediately. If the participant is under\nage 57 at death, benefits commence when the participant would have\nattained age 57.\nDeath benefit \u2013 Enhanced active death benefit (effective June 1, 2015)\n(cid:127) Eligibility Actively employed and eligible for early retirement on the date of death.\n(cid:127) Benefit An amount payable to the beneficiary equal to the greater of the present\nvalue of the Employee\u2019s age 65 (age 62 if the Employee had reached age\n57 with 10 years of service) single life annuity benefit and the present value\nof the Employee\u2019s single life annuity benefit immediately payable as of the\nfirst day of the month following the date of death.\nIf the participant is married on the date of death, the surviving spouse must\nwaive his/her rights to the Preretirement Survivor Annuity described above\nto receive this benefit.\nWLRP \u2013 UPGWA benefit formula\n(cid:127) Type of benefit formula Flat dollar multiplier\n(cid:127) Participation No employees are eligible to become members after May 31, 1983.\n\n2024 Form 5500 \u2013 Schedule SB Plan: Pfizer Consolidated Pension Plan\nEIN/PN: 13-5315170/001\nSchedule SB, Part V \u2013 Summary of Plan Provisions\n(cid:127) Employer Contributions The employer will make contributions in an amount no less than the\nminimum amount required under IRS regulations.\nNormal Retirement Benefit\n(cid:127) Eligibility The first day of the month coincident with or following attainment of age 65\n(cid:127) Benefit Monthly annuity equal to a dollar unit multiplied by credited service. The\ndollar unit in effect as of January 1, 1982 was $18.50.\nCost-of-living adjustments\nAs of July 1, 1995, retirees who commenced benefits before January 1,\n1995, were granted a 4% pension increase subject to a $150 maximum\nmonthly increase. On January 1, 2000, retirees who commenced benefits\nbefore July 1, 1999 were granted a 3% pension increase with a $200\nmaximum monthly increase.\nBenefit accruals under this formula will cease on December 31, 2011.\nBenefit accruals after January 1, 2012 will occur under the PRAP formula\nEarly Retirement Benefit\n(cid:127) Eligibility A member may retire on the first day of any month following his 57th\nbirthday and completion of 10 years of credited service.\n(cid:127) Benefit The pension amount is based on service to early retirement date, reduced\n5/8% for each month by which the annuity commencement date precedes\nage 62.\nDeferred Vested Benefit\n(cid:127) Eligibility A participant who has completed three or more years of Vesting Service is\nentitled to a deferred vested benefit equal to the Normal Retirement\nBenefit.\n(cid:127) Benefit Benefits which begin at an early retirement date are reduced 5/8% for each\nmonth by which the early retirement date precedes age 65.\nDeath Benefit \u2013 Preretirement The eligible spouse of certain vested members who worked after\nSurvivor Annuity January 1, 1976, shall receive a Preretirement Survivor Annuity in the event\nof the member's death before retirement.\nThe Preretirement Survivor Annuity benefit is the amount which would have\nbeen payable to the spouse had the member elected payment of benefits\nunder a Joint and 50% Survivor annuity form. If the participant is over age\n57 at death, benefits commence immediately. If the participant is under\nage 57 at death, benefits commence when the participant would have\nattained age 57.\nDeath benefit \u2013 Enhanced active death benefit (effective June 1, 2015)\n(cid:127) Eligibility Actively employed and eligible for early retirement on the date of death.\n(cid:127) Benefit An amount payable to the beneficiary equal to the greater of the present\nvalue of the Employee\u2019s age 65 (age 62 if the Employee had reached age\n57 with 10 years of service) single life annuity benefit and the present value\nof the Employee\u2019s single life annuity benefit immediately payable as of the\nfirst day of the month following the date of death.\nIf the participant is married on the date of death, the surviving spouse must\nwaive his/her rights to the Preretirement Survivor Annuity described above\nto receive this benefit.\n\n2024 Form 5500 \u2013 Schedule SB Plan: Pfizer Consolidated Pension Plan\nEIN/PN: 13-5315170/001\nSchedule SB, Part V \u2013 Summary of Plan Provisions\nWyeth Retirement Plan (WRP) benefit formula\nFollowing is a summary of the major plan provisions for participants who accrued benefits under the\nLegacy Wyeth Retirement Plan.\nDefinitions\n(cid:127) Participation Nonunion salaried and hourly employees in most legacy Wyeth divisions\nand subsidiaries who have attained age 21 and completed one year of\nContinuous Service.\n(cid:127) Employee contributions None\n(cid:127) Continuous service3 Continuous employment since the later of date of hire or date of acquisition\nby Wyeth, until date of severance from service.\n(cid:127) Wyeth service Continuous service.\nWyeth service is frozen as of December 31, 2011. Service after January 1,\n2012 will be used towards determining the accrued benefit under the PRAP\nbenefit formula.\n(cid:127) Predecessor service Continuous employment rendered to a company before its date of\nacquisition by Wyeth, but only for those companies acquired before\nJanuary 1, 1956.\n(cid:127) Pensionable compensation Employees\u2019 scheduled salary as of April 1, bonuses from the current year,\nand overtime and commissions from the previous year. Any compensation\nthat is deferred is excluded from pensionable compensation.\nFor plan years prior to 2011, scheduled salary was determined as of\nJanuary 15.\n(cid:127) Final average compensation Average of the highest 5 calendar years of compensation of the final 10\nyears of a participant\u2019s career with Pfizer.\n(cid:127) Accrued benefit A monthly benefit equal to the greatest of (i), (ii), (iii), (iv), (v), and (vi).\n(i) One twelfth of:\n(a) 2% of 5 year final average pension earnings times the number of\nyears of a participant's Wyeth Service (up to a maximum of 30 years)\nafter age 21, minus\n(b) 1/60 of annual primary Social Security benefit times the number of\nyears of participation (up to a maximum of 30 years) after age 21.\n(ii) The sum of (a) and (b):\n(a) for service after age 25:\n$49.00 times years of Wyeth Service during 2011, plus\n$46.00 times years of Wyeth Service during 2010, plus\n$43.00 times years of Wyeth Service during 2009, plus\n$42.00 times years of Wyeth Service during 2008, plus\n$41.00 times years of Wyeth Service during 2007, plus\n$40.00 times years of Wyeth Service during 2006, plus\n$38.50 times years of Wyeth Service during 2005, plus\n$37.00 times years of Wyeth Service during 2004, plus\n3 Continuous employment prior to acquisition date is generally counted as Continuous Service for determining eligibility for benefits, but not\nfor accrual purposes. For participants who were employees of Chesebrough Pond\u2019s Inc as of October 31, 1986, and participants who were\nemployees of Genetics Institute as of January 1, 1992, pre-acquisition service is counted for accrual purposes.\nIn addition, employees of A.H. Robins who were hired before January 1, 1990 and actively at work July 1, 1990, will have their pre-\nacquisition service counted for benefit accrual purposes. Former employees of American Cyanamid will have their pre-acquisition service\ncounted for benefit accrual purposes to the extent permitted under Wyeth Retirement Plan provisions in effect as of December 31, 1995.\n\n2024 Form 5500 \u2013 Schedule SB Plan: Pfizer Consolidated Pension Plan\nEIN/PN: 13-5315170/001\nSchedule SB, Part V \u2013 Summary of Plan Provisions\n$36.00 times years of Wyeth Service during 2003, plus\n$35.00 times years of Wyeth Service during 2002, plus\n$34.00 times years of Wyeth Service during 2001, plus\n$33.00 times years of Wyeth Service prior to 2001\n(b) for service prior to age 25:\n$36.75 times years of Wyeth Service during 2011, plus\n$34.50 times years of Wyeth Service during 2010, plus\n$32.25 times years of Wyeth Service during 2009, plus\n$31.50 times years of Wyeth Service during 2008, plus\n$30.75 times years of Wyeth Service during 2007, plus\n$30.00 times years of Wyeth Service during 2006, plus\n$29.00 times years of Wyeth Service during 2005, plus\n$27.75 times years of Wyeth Service during 2004, plus\n$27.00 times years of Wyeth Service during 2003, plus\n$26.25 times years of Wyeth Service during 2002, plus\n$25.50 times years of Wyeth Service during 2001, plus\n$24.75 times years of Wyeth Service prior to 2001\n(iii) One twelfth of:\n(a) 0.8% of the first $3,000, plus\n(b) 1.5% of a participant's earnings in excess of $3,000 for each year of\nWyeth Service after age 35. (This formula applies only to\nemployees hired by Wyeth on or before 9/1/74.)\nMaximum of 30 years of service applies.\n\n2024 Form 5500 \u2013 Schedule SB Plan: Pfizer Consolidated Pension Plan\nEIN/PN: 13-5315170/001\nSchedule SB, Part V \u2013 Summary of Plan Provisions\n(cid:127) Accrued benefit (continued) (iv) One twelfth of:\n(a) 2% of average of annual pension earnings received from 1/1/68 to\n1/1/78 after attaining age 35, times number of years of a\nparticipant's Wyeth Service (after age 35 and prior to 1/1/78), plus\n(b) 2.67% times total annual pension earnings received after 1/1/78\nafter attaining age 35, minus\n(c) 1/60 of annual primary Social Security benefit times total number\nof years of participation after age 35. (This formula applies only to\nemployees hired by Wyeth prior to 10/1/81.)\nMaximum of 30 years of service applies.\n(v) One twelfth of:\n(a) 0.6% of the first $3,000, plus\n(b) 1.125% of a participant's earnings in excess of $3,000 for each\nyear of Wyeth Service after age 25 and after 1/1/76. (This formula\napplies only to employees hired by Wyeth on or before 9/1/74.)\nMaximum of 40 years of service applies.\n(vi) One twelfth of:\n(a) 1.5% of average of annual pension earnings received prior to\n1/1/78 and after the later of 1/1/76 or the date of attainment of age\n25, times number of years of a participant's Wyeth Service prior to\n1/1/78 and after the later of 1/1/76 or the date of attainment of age\n25, plus\n(b) 2% times total annual pension earnings received after the later of\n1/1/78 or the date of attainment of age 25, minus\n(c) 1/80 of annual primary Social Security benefit times total number\nof years of participation after the later of 1/1/76 or the date of\nattainment of age 25. (This formula applies only to employees\nhired by Wyeth prior to 10/1/81.)\nMaximum of 40 years of service applies.\nNormal retirement\n(cid:127) Eligibility Age 65\n(cid:127) Benefit Accrued benefit\nEarly retirement\n(cid:127) Eligibility Age 55 with three years of Continuous Service\n(cid:127) Benefit Age 55 with 10 years of Continuous Service:\nA monthly benefit equal to the Accrued Benefit, reduced by 3% for each\nyear by which payments commence prior to age 65. If the Accrued Benefit\nis calculated under the flat rate Minimum Formula, no reduction is applied\nfor retirement at age 62 or later.\nAge 55 and vested with less than 10 years of Continuous Service:\nAccrued Benefit, but reduced actuarially if payments commence prior to\nage 65, using the GATT2003 mortality table with 7.50% interest\nLate retirement\n(cid:127) Eligibility A participant who continues to be employed by the Company after his\nNormal Retirement Date shall continue to accrue benefits for Wyeth\nService rendered until his actual retirement date.\n(cid:127) Benefit The monthly amount of a participant's postponed retirement income is\ncomputed in the same manner as his Normal Retirement income.\nVesting eligibility 3 years of vesting service\n\n2024 Form 5500 \u2013 Schedule SB Plan: Pfizer Consolidated Pension Plan\nEIN/PN: 13-5315170/001\nSchedule SB, Part V \u2013 Summary of Plan Provisions\nDeferred vested\n(cid:127) Eligibility Termination prior to age 55 with three years of Continuous Service\n(cid:127) Benefit Accrued Benefit, but reduced actuarially if payments commence prior to\nage 65, using the GATT2003 mortality table with 7.50% interest\nDisability\n(cid:127) Eligibility Total disability at any age after 10 years of Continuous Service and\ndisabled before January 1, 2008\n(cid:127) Benefit A monthly benefit, payable until age 65 (at which point the Normal\nRetirement Benefit is payable), equal to the greatest of (i), (ii), and (iii).\n(i) $375, if disability commences during 2008\n$365, if disability commences during 2007\n$355, if disability commences during 2006\n$350, if disability commences during 2005\n$345, if disability commences during 2004\n$340, if disability commences during 2003\n$335, if disability commences during 2002\n$330, if disability commences prior to 2002\n(ii) $42.00 times years of Wyeth Service during 2008, plus\n$41.00 times years of Wyeth Service during 2007, plus\n$40.00 times years of Wyeth Service during 2006, plus\n$38.50 times years of Wyeth Service during 2005, plus\n$37.00 times years of Wyeth Service during 2004, plus\n$36.00 times years of Wyeth Service during 2003, plus\n$35.00 times years of Wyeth Service during 2002, plus\n$34.00 times years of Wyeth Service during 2001, plus\n$33.00 times years of Wyeth Service prior to 2001\n(iii) Accrued Benefit, without regard to the pay related formulas.\nParticipants who become disabled on or after January 1, 2012, are not\neligible for the above disability benefit and do not accrue benefits while on\ndisability\nPre-retirement death\n(cid:127) Death prior to early Death in active employment with Wyeth after vesting but before becoming\nretirement eligible for Early Retirement:\nA monthly benefit, payable to the surviving spouse or estate of unmarried\nparticipant and commencing on the first of the month coincident with or\nnext following the date the employee would have reached his 55th birthday;\nequal to 50% of the Vested Termination Benefit that would have been paid\nto the employee, assuming he had terminated employment on the day of\nhis death, survived to age 55 and had elected a 50% Contingent Annuitant\nOption (paid as a lump sum to estate of unmarried participant).\n(cid:127) Death after early retirement Death in active employment with Wyeth after becoming eligible for Early\nRetirement:\nA monthly benefit, payable to the surviving spouse or estate of unmarried\nparticipant, equal to 50% of the Early Retirement Benefit that would have\nbeen paid to the employee, assuming he had retired on the day prior to his\ndeath and had elected a 50% Contingent Annuitant Option (paid as a lump\nsum to estate of unmarried participant).\n\n2024 Form 5500 \u2013 Schedule SB Plan: Pfizer Consolidated Pension Plan\nEIN/PN: 13-5315170/001\nSchedule SB, Part V \u2013 Summary of Plan Provisions\n(cid:127) Death after termination of Death after termination of employment with vesting before commencement\nof Vested Termination Benefit (also applies to employees who terminated\nemployment\nwith vested rights on and after January 1, 1976 and prior to January 1,\n1985, where death occurs on or after August 23, 1984):\nA monthly benefit, payable to the surviving spouse or estate of unmarried\nparticipant and commencing on the first of the month coincident with or\nnext following the later of the employee's (i) 55th birthday or (ii) date of\ndeath; equal to 50% of the Vested Termination Benefit that would have\nbeen paid to the employee, assuming he had elected to commence\nbenefits on such date and elected a 50% Contingent Annuitant Option (paid\nas a lump sum to estate of unmarried participant).\nPre-retirement death \u2013 Enhanced active death benefit (effective June 1, 2015)\n(cid:127) Eligibility Actively employed and eligible for early retirement on the date of death.\n(cid:127) Benefit An amount payable to the beneficiary equal to the lump sum that would\nhave been payable to the participant if the participant had retired on his\ndate of death with a benefit commencement date on the first day of the\nmonth following date of death and survived to that date.\nIf the participant is married on the date of death, the surviving spouse must\nwaive his/her rights to the QJSA described above to receive this benefit.\nThis benefit is paid in lieu of any other death benefits described above.\nContingent event benefits\n(cid:127) Eligibility Participants terminated due to the Pfizer acquisition prior to October 15,\n2011, as well as those terminated involuntarily following Pfizer\u2019s\nacquisition, with at least 70 points (age plus service) at termination and\nwhose base compensation is less than $155,000.\nThe benefit enhancements provided under the corporate restructuring\nprogram were primarily discontinued during 2012 with the exception of\nindividuals who are terminated as part of the Plant Network Strategy or\nEngine for Sustainable Innovation (ESI).\n(cid:127) Enhanced benefit Eligible participants receive subsidized early retirement benefits as if the\nparticipant was at least age 55 with 10 years of service at termination. Note\nthat accrued benefits are not increased, nor are participants entitled to\ncommence benefits prior to 55 due to this enhancement.\nForm of benefits\n(cid:127) Automatic form for unmarried Single Life Annuity\nparticipants\n(cid:127) Automatic form for married 50% Joint and Survivor Annuity\nparticipants\n(cid:127) Optional forms 10 Year Certain, Level Income, Lump Sum, Guaranteed Death Benefit, 66\n2/3%, 75% And 100% Joint And Survivor Annuity\n(cid:127) Optional conversion factors (cid:127) Optional form benefits (other than a lump sum) are converted using the\nGATT2003 mortality table with 7.50% interest.\n(cid:127) Lump sum benefits for benefits accrued before January 1, 2012, are\nconverted using whichever basis provides the higher present value: a)\nthe applicable interest rate and applicable mortality table as defined in\nIRC Section 417(e)(3) or b) the applicable PBGC interest rate and\napplicable mortality table assumptions as of the valuation date.\n(cid:127) Lump sum benefits for benefits accrued on or after January 1, 2012,\nare converted using the applicable interest rate and mortality table as\ndefined in IRC Section 417(e)(3).\n\n2024 Form 5500 \u2013 Schedule SB Plan: Pfizer Consolidated Pension Plan\nEIN/PN: 13-5315170/001\nSchedule SB, Part V \u2013 Summary of Plan Provisions\nFormer Employees of A.H. On December 15, 1989, Wyeth completed its acquisition of A.H. Robins\nRobins provisions Company, Incorporated. Wyeth provided for the continuation of the\nfollowing four U.S. defined benefit pension plans of A.H. Robins through\nJune 30, 1990.\n(cid:127) Employees' Retirement Plan of A.H. Robins Company, Inc and\nAffiliated Companies\n(cid:127) Employees' Retirement Plan of Eurand America, Inc\n(cid:127) Employees' Retirement Plan of Agri-Bio Corp.\n(cid:127) Employees' Retirement Plan of Viobin Corporation\nEffective July 1, 1990, the above four A.H. Robins' Plans were merged with\nthe Wyeth Retirement Plan - U.S. Employees hired by A.H. Robins before\nJanuary 1, 1990 and actively at work on July 1, 1990 will have their\nretirement benefits calculated under the formulas of both the Wyeth\nRetirement Plan and the prior A.H. Robins' Plans. The employee will\nreceive the greater benefit, based upon his combined service with A.H.\nRobins and Wyeth.\nUnder this \"umbrella\" approach, Robins employees will accrue retirement\nbenefits under the Wyeth final 5-year average pay formulas, the Wyeth flat-\nrate minimum formula and the Wyeth disability formula.\nAlthough Wyeth will grandfather the normal and early retirement provisions\nof the A.H. Robins Retirement Plans, all ancillary benefits and provisions,\nsuch as disability benefits, death benefits and actuarial equivalent factors,\nunder the Robins' Plans were frozen as of July 1, 1990, the merger date.\nA.H. Robins Normal Retirement\n(cid:127) Eligibility First of the month coincident with or next following the later of age 65 and\nthe fifth anniversary of participation\n(cid:127) Benefit A monthly benefit equal to the greater of (i) or (ii), but not less than the\naccrued benefit under the Wyeth formula.\n(i) The sum of (a) and (b):\n(a) The excess of 50% of final five-year average monthly\ncompensation over 50% of participant's monthly Primary Social\nSecurity Benefit with the result reduced proportionately for benefit\naccrual service less than twenty;\n(b) 1/4% of final five-year average monthly compensation multiplied\nby years of benefit accrual service in excess of twenty.\n(ii) The minimum monthly normal retirement allowance for participants as\nof December 31, 1982, is the benefit which would have been payable\nat age 65 under the plan in effect on December 31, 1982 assuming the\n1982 compensation remains constant until age 65.\n(cid:127) Accrued benefit Same as Normal Retirement Benefit based upon Final Average\nCompensation as of the determination date and service as of the Normal\nRetirement Date and assuming constant future earnings in calculating\nSocial Security. This amount is then multiplied by the ratio of credited\nservice as of the determination date to credited service as of the Normal\nRetirement Date.\nA.H. Robins Late Retirement The amount of monthly delayed retirement allowance computed as the\nlarger of the normal retirement allowance actuarially increased to reflect its\nlater commencement or the normal retirement benefit using benefit accrual\nservice, final average compensation and Primary Social Security Benefit\ncalculated at delayed retirement date.\nA.H. Robins Early Retirement\n\n2024 Form 5500 \u2013 Schedule SB Plan: Pfizer Consolidated Pension Plan\nEIN/PN: 13-5315170/001\nSchedule SB, Part V \u2013 Summary of Plan Provisions\n(cid:127) Eligibility First of any month after attainment of age 55 and the completion of at least\nten years of vesting service\n(cid:127) Benefit The amount of early retirement allowance is based on the participant's\nAccrued Benefit at the date of early retirement.\nUnless the participant has attained age 62 and completed ten years of\nvesting service, the Accrued Benefit is subject to a reduction to reflect its\nearlier commencement. The Accrued Benefit is reduced by 6 2/3% per\nyear between ages 60 and 65 and by 3 1/3% per year between ages 55\nand 60.\nA.H. Robins Deferred Vested\n(cid:127) Eligibility First of any month after attainment of age 55 and the completion of at least\nfive years of vesting service\n(cid:127) Benefit The Accrued Benefit is reduced by 6 2/3% per year between ages 60 and\n65 and by 3 1/3% per year between ages 55 and 60.\nFormer Employees of On November 21, 1994, Wyeth acquired American Cyanamid Company.\nAmerican Cyanamid On December 31, 1994, the American Cyanamid Company Employees\nRetirement Plan was merged with and into the Wyeth Retirement Plan -\nU.S. Former nonunion employees of American Cyanamid will have their\nretirement benefits calculated under the ACY Retirement Plan formulas\nthrough December 31, 1995. Any former ACY nonunion employee who\nretires or is terminated prior to January 1, 1996 will receive a benefit under\nthe American Cyanamid formula.\nAs of January 1, 1996, all former nonunion American Cyanamid employees\nwill have their benefits determined under the Wyeth formula. All service\nwith American Cyanamid will be included when computing benefits under\nthe Wyeth formula to the extent permitted under Wyeth Retirement Plan\nprovisions in effect as of December 31, 1995.\nBenefit accruals under American Cyanamid ceased as of December 31,\n1995 for nonunion employees, and each nonunion American Cyanamid\nemployee's frozen benefit as of that date would serve as a minimum\nbenefit, as required by ERISA.\nAll former American Cyanamid union employees will have their benefits\ndetermined under the applicable coordinated bargaining agreement. The\nAmerican Cyanamid union employees were transferred to the Wyeth Non-\nCoordinated Bargaining Retirement Plan - U.S. effective January 1, 1996.\nRestructuring enhancement Participants who have 70 points at date of termination, but are not age 55\nwith 10 years of service (within 2 years of the sale for Fort Dodge\nparticipants) will receive the retiree enhanced early retirement factors.\nAlpharma Inc. Pension Plan (Alpharma) benefit formula\nFollowing is a summary of the major plan provisions for participants who accrued benefits under the\nLegacy Alpharma Inc. Pension Plan formula.\n\n2024 Form 5500 \u2013 Schedule SB Plan: Pfizer Consolidated Pension Plan\nEIN/PN: 13-5315170/001\nSchedule SB, Part V \u2013 Summary of Plan Provisions\nDefinitions\n(cid:127) Participating employees All employees who meet the following:\n(cid:127) Employee of the former Alpharma Specialty Pharma Inc company\nunder Pfizer\n(cid:127) Employees over age 18 (age 21, prior to October 1, 2001) following six\nmonths of service\n(cid:127) Was a participant as of December 31, 2006\nParticipation was frozen effective December 31, 2006.\n(cid:127) Vesting service 1 year of service for each year an employee worked at least 1,000 hours or\nservice in a plan year, from the later of date of hire or acquisition/transfer\ndate\n(cid:127) Credited service 1 year of service for each year an employee completed at least 1,000 hours\nof service as a participant in a plan year in a plan year, from the later of\ndate of hire or acquisition/transfer date.\nNo additional Credited Service is credited after December 31, 2006.\n(cid:127) Compensation Base salary plus overtime, limited to 20% of base earnings. Commissions\nare included for participants whose annualized rate of base pay is less than\nor equal to two times the federal minimum wage. No compensation on or\nafter December 31, 2006 is included.\n(cid:127) Final Average Compensation The annual average of the highest 5 consecutive years of pensionable pay\nduring the last 10 years of pension service ending on the earlier of the\nparticipant\u2019s termination date or retirement date. A participant\u2019s earnings\nafter December 31, 2006, shall not be taken into account for purposes of\ndetermining his or her Accrued Benefit.\n(cid:127) Accrued Benefit The annual accrued benefit is the sum of:\n(cid:127) 0.80% of Final Average Compensation times years of Credited Service,\nup to 30 years\n(cid:127) 1.45% of Final Average Compensation in excess of Covered\nCompensation times years of Credited service, up to 30 years\nThe accrued benefit shall be reduced by the pension under the Solvay U.S.\nGroup Pension Plan and its successors, but the benefit shall never be less\nthan zero.\nFor participants with an hour of service prior to January 1, 1994, the\nparticipant shall have an accrued benefit equal to the greater of the benefit\nlisted above and the sum of (i) the Participant\u2019s accrued benefit as of\nJune 30, 1994, based on the plan provisions at that date and (ii) the\nParticipant\u2019s accrued benefit under the formula listed above applied to\nyears of credited service on and after January 1, 1994.\nAll benefits were frozen as of December 31, 2006.\nNormal retirement\n(cid:127) Eligibility First of the month coinciding with or next following the attainment of age 65\n(cid:127) Benefit Accrued benefit as of December 31, 2006\nEarly retirement\n(cid:127) Eligibility Age 55 and 5 years of Vesting Service\n\n2024 Form 5500 \u2013 Schedule SB Plan: Pfizer Consolidated Pension Plan\nEIN/PN: 13-5315170/001\nSchedule SB, Part V \u2013 Summary of Plan Provisions\n(cid:127) Benefit Monthly pension benefit determined as of early retirement date, reduced by\n7% for each year of payment after age 60 but before age 65, and 4% for\neach year of payment after age 55 but before age 60.\nFor Barre-National benefits, reduced by 3/5% for each month after age 60\nbut before age 65, and 3/10% for each year of payment after age 55 but\nbefore age 60.\nFor Prior Plan benefits, reduced by 4/10% for each month before 65.\nLate retirement\n(cid:127) Eligibility Retirement after NRD\n(cid:127) Benefit Greater of monthly pension benefit determined as of NRD, actuarially\nincreased to actual retirement date, and monthly pension benefit\ndetermined as of actual retirement date.\nDeferred vested\n(cid:127) Eligibility Termination for reasons other than death or retirement with a vested\nbenefit\n(cid:127) Benefit Monthly pension benefit determined as of termination date, payable as\nearly as age 55 with 5 years of Vesting Service and reduced to be\nactuarially equivalent to Normal Retirement Benefit\nDisability\n(cid:127) Disability Eligibility None provided\nPre-retirement death\n(cid:127) Eligibility Death while eligible for normal, early, postponed, or deferred\nvested retirement benefits\n(cid:127) Benefit (cid:127) Single: Survivor portion of 50% J&S payable at participant\u2019s earliest\ncommencement date.\n(cid:127) Married: Survivor portion of 50% J&S payable (or 75% J&S if elected\nby participant) payable at participant\u2019s earliest commencement date.\nForm of benefits\n(cid:127) Normal Form of Payment Life annuity if single; 50% J&S if married.\nFor prior plan accrued, life annuity with 10 years certain if single, 50% J&S\nwith 10 years certain if married.\n(cid:127) Automatic form for unmarried Single Life Annuity\nparticipants\nFor Prior Plan Accrued benefit, Single Life Annuity with 10 Years Certain\n(cid:127) Automatic form for married 50% Joint and Survivor Annuity\nparticipants\nFor Prior Plan Accrued benefit, 50% Joint and Survivor Annuity\nwith 10 Years Certain\n\n2024 Form 5500 \u2013 Schedule SB Plan: Pfizer Consolidated Pension Plan\nEIN/PN: 13-5315170/001\nSchedule SB, Part V \u2013 Summary of Plan Provisions\n(cid:127) Optional forms of payment (cid:127) Single life annuity\n(cid:127) 50% Joint and survivor annuity\n(cid:127) 75% Joint & survivor annuity\n(cid:127) 100% Joint & survivor annuity\n(cid:127) 10-Year certain and life annuity\nFor participants with a Prior Plan Benefit:\n(cid:127) Period and certain life annuity\n(cid:127) Equal installments over a 5 or 10 year period\n(cid:127) Lump sum\nFor Participants with benefits under the Barre-National Plan\n(cid:127) 50% Joint and survivor annuity with a 10-year certain period\n(cid:127) 66 2/3% Joint and survivor annuity with a 10-year certain period\n(cid:127) Actuarial Basis for Optional For all forms other than a lump sum, 1971 Group Annual Mortality Table for\nForms Males and 8.00%.\nFor Prior Plan benefit, 1951 Unisex Group Mortality Table projected to\n1970 Male Mortality Table and 8.00%.\nFor Barre-National benefit, pre-retirement: 1971 Group Annual Mortality\nTable for Males and 8%. For post-retirement, 1971 Group Annual Mortality\nTable sex distinct, set back one year.\nFor lump sums, the applicable interest rate and mortality table as defined in\nIRC Section 417(e)(3).\n(cid:127) Plan participants\u2019 None\ncontributions\nFaulding Inc. Pension Plan (Faulding) benefit formula\nFollowing is a summary of the major plan provisions for participants who accrued benefits under the\nLegacy Faulding Inc. Pension Plan formula.\nDefinitions\n(cid:127) Participating employees All employees who meet the following:\n(cid:127) Employee of the former Alpharma Specialty Pharma Inc Company\nunder Pfizer\n(cid:127) Not a member of a collective bargaining unit\n(cid:127) Was a participant as of December 31, 2007\nParticipation was frozen effective March 31, 2002.\n(cid:127) Vesting service 1 year of service for each year an employee worked at least\n1,000 hours or service in a plan year, including years of service with\nKalipharma, Inc., Kalidupher, Inc. and Dupont Merck after January 1976.\n(cid:127) Credited service 1 year of service for each year an employee completed at least\n1,000 hours of service as a participant in a plan year, including years of\nservice with Kalipharma, Inc., Kalidupher, Inc. and Dupont Merck after\nJanuary 1976.\nNo additional Credited Service is credited after March 31, 2002.\n\n2024 Form 5500 \u2013 Schedule SB Plan: Pfizer Consolidated Pension Plan\nEIN/PN: 13-5315170/001\nSchedule SB, Part V \u2013 Summary of Plan Provisions\n(cid:127) Compensation W-2 compensation, no greater than the IRS Code Section 401(a)(17)(B)\nmaximum compensation limit. No compensation on or after March 31, 2002\nis included.\n(cid:127) Final Average Compensation Highest 5 consecutive plan years of Compensation out of the last 10 plan\nyears as an active participant.\n(cid:127) Accrued Benefit The annual accrued benefit is the sum of:\n(cid:127) 0.91% of Final Average Compensation times years of Credited Service,\nup to 35 years\n(cid:127) 0.52% of Final Average Compensation is excess of Covered\nCompensation times years of Credited service, up to 35 years\nThe accrued benefit shall be reduced by the pension under the Solvay U.S.\nGroup Pension Plan and its successors, but the benefit shall never be less\nthan zero.\nFor participants with an hour of service prior to July 1, 1994, the participant\nshall have an accrued benefit equal to the greater of the benefit listed\nabove and the sum of (i) the Participant\u2019s accrued benefit as of June 30,\n1994, based on the plan provisions at that date and (ii) the Participant\u2019s\naccrued benefit under the formula listed above applied to years of credited\nservice on and after July 1, 1994.\nAll benefits were frozen as of March 31, 2002.\nNormal retirement\n(cid:127) Eligibility First of the month coinciding with or next following the attainment of age 65\n(cid:127) Benefit Accrued benefit as of March 31, 2002\nEarly retirement\n(cid:127) Eligibility Age 55 and 5 years of Vesting Service. No service requirement if plan\nparticipation commenced prior to July 1, 2000\n(cid:127) Benefit Monthly pension benefit determined as of early retirement date,\nreduced by 1/3% for each month early retirement precedes NRD\nLate retirement\n(cid:127) Eligibility Retirement after NRD\n(cid:127) Benefit Greater of monthly pension benefit determined as of NRD,\nactuarially increased to actual retirement date, and monthly\npension benefit determined as of actual retirement date\nDeferred vested\n(cid:127) Eligibility Termination for reasons other than death or retirement after the\nearliest of completing five years of vesting service or attaining\nage 55\n(cid:127) Benefit Monthly pension benefit determined as of termination date,\npayable as early as age 55 and reduced to be actuarially\nequivalent to Normal Retirement Benefit\nDisability\n(cid:127) Eligibility Total and Permanently Disabled (T&PD) for 6 months, where T&PD is\ndefined as a physical or mental condition preventing a participant from\ncontinuing any gainful occupation and which constitutes total disability\nunder Social Security\n\n2024 Form 5500 \u2013 Schedule SB Plan: Pfizer Consolidated Pension Plan\nEIN/PN: 13-5315170/001\nSchedule SB, Part V \u2013 Summary of Plan Provisions\n(cid:127) Benefit Monthly pension benefit determined as of disability date, payable\nbeginning in any month following 6 months of T&PD, and reduced as for\nearly retirement\nPre-retirement death\n(cid:127) Eligibility Death while eligible for normal, early, postponed, or deferred\nvested retirement benefits\n(cid:127) Benefit Survivor portion of 50% J&S benefit determined at participant's death.\nBenefit is payable at the later of first of the month after the date of death\nand the first date the participant would have been eligible to commence\npayment.\nForm of benefits\n(cid:127) Automatic form for unmarried Single life annuity\nparticipants\n(cid:127) Automatic form for married 50% joint & survivor (J&S)\nparticipants\n(cid:127) Optional forms of payment Life annuity with 5, 10, or 15 years certain; certain only in monthly\nquarterly, semi-annual, or annual installments (only a 10-year certain only\nannuity will be available after 12/31/2025); 75%, or 100% J&S annuity; and\nlump sum.\n(cid:127) Actuarial Basis for Optional For all forms other than a lump sum, 1984 Unisex Pension Mortality and\nForms 8.00%.\nFor lump sums, the applicable interest rate and mortality table as defined in\nIRC Section 417(e)(3).\n(cid:127) Plan participants\u2019 None\ncontributions\nBenefits included or excluded\nUnless noted below, all benefits provided by the plan, as restated and amended through\nJanuary 1, 2024, are included in this valuation.\n(cid:127) Most recent plan amendments included: Plan Amendment No. 16 was adopted in December\n2023 to allow active participants who are eligible for a full unreduced pension benefit (with certain\nexclusions), to make a one-time election to commence pension benefits as of August 1, 2023. This\namendment also provided a terminated vested lump sum window with a benefit commencement\ndate of November 1, 2023.\n(cid:127) Plan amendments excluded: None.\n(cid:127) Late retirement increases:\n\u2500 Active participants (PRAP and WLRP benefit formulas): These portions of the plan provide\nbenefit suspension notices to participants who work beyond normal retirement; therefore, late\nretirement actuarial increases only apply to participants who defer retirement beyond age 70\u00bd.\nThis valuation includes increases for current participants over age 70.\n\u2500 Actives participants (PPP benefit formula): This portion of the plan does not provide benefit\nsuspension notices to participants who work beyond normal retirement; therefore, late\nretirement actuarial increases apply to participants who defer retirement beyond normal\nretirement age. This valuation includes increases for current participants over age 65.\n\n2024 Form 5500 \u2013 Schedule SB Plan: Pfizer Consolidated Pension Plan\nEIN/PN: 13-5315170/001\nSchedule SB, Part V \u2013 Summary of Plan Provisions\n\u2500 Active participants (WRP and Alpharma benefit formula): The plan applies late retirement\nactuarial increases for all participants who defer retirement beyond their normal retirement date\nand this valuation includes those increases.\n\u2500 Deferred vested participants: Current deferred vested participants over normal retirement age\nare valued including the late retirement actuarial increase.\n(cid:127) Internal Revenue Code limitations: The limitations of Internal Revenue Code Section 415(b) and\n401(a)(17) have been incorporated into our calculations.\n(cid:127) IRC Section 416 rules for top-heavy plans: We did not test whether this plan is top-heavy (when\nthe present value of benefits for key employees equals or exceeds 60% of the present value for all\nparticipants). However, we expect that the plan is not top-heavy due to the large number of rank-\nand-file participants; therefore, the funding target and target normal cost do not reflect any liability\nfor top-heavy benefit accruals.\n(cid:127) IRC Section 436 benefit restrictions:\n\u2500 Unpredictable contingent event benefits: This valuation excludes restricted contingent event\nbenefits that occurred before the valuation date but includes contingent event benefits which are\nexpected to occur on or after the valuation date regardless of anticipated funding-based\nlimitations.\n\u2500 Plan amendments: See above.\n\u2500 Prohibited payments: Limitations on prohibited benefits (if any) are reflected for annuity starting\ndates before the valuation date but are ignored for annuity starting dates on or after the\nvaluation date.\n\u2500 Benefit accruals: The plan\u2019s funding target does not reflect any limitation on benefit accruals.\nThe target normal cost does not reflect any limitation on benefit accruals.\n(cid:127) Scheduled benefit increases: There are no scheduled benefit increases as the plan is frozen.\n(cid:127) Unpredictable contingent event benefits: The plan\u2019s unpredictable contingent event benefits are\nvalued based on the assumptions described in the Actuarial Assumptions section.\nPlan provision changes since prior valuation\nThe following changes were first reflected in the January 1, 2024 valuation:\n(cid:127) Effective August 1, 2023, the Plan provided a one-time opportunity for active participants who had\nattained an unreduced benefit milestone with respect to their PRAP, Warner-Lambert and/or Wyeth\nbenefits to voluntarily elect to commence that(those) legacy benefit(s) through an in-service\ndistribution window.\n(cid:127) The Plan provided a terminated vested lump sum window with a benefit commencement date of\nNovember 1, 2023.\n\nPFIZER CONSOLIDATED PENSION PLAN\nSCHEDULE H, LINE 4i - SCHEDULE OF ASSETS (HELD AT END OF YEAR)\nAs of December 31, 2024\n(DOLLARS IN THOUSANDS)\n(a) (b) (c) (d) (e)\nIdentity of issue, borrower, lessor, Description of investment, including maturity\nCost Current Value\nor similar party date, rate of interest, collateral, par, or maturity\nPercentage of Pfizer Master Trust \u2013 Cash, Debt\nSecurities, Corporate Equities and Other\n* Northern Trust $ 9,860,749 $ 9,733,376\nInvestments\nBlackRock Equity Index A Fund Equity Commingled Fund 11,440 75,461\nJP Morgan Real Estate Funds 49,903 68,738\nMorgan Stanley Real Estate Fund 39,693 46,693\nTotal investment assets $ 9,961,785 $ 9,924,269\n* Represents a party-in-interest as defined by ERISA.\nAmounts may not add due to rounding.\nSee accompanying Independent Auditors\u2019 Report.\n20\n\n2024 Form 5500 \u2013 Schedule R Plan: Pfizer Consolidated Pension Plan\nEIN/PN: 13-5315170/001\nSchedule R, line 18 \u2014 Funded Percentage of Plans Contributing to the Liabilities of Plan\nParticipants\nEffective December 31, 2024, the Wyeth Coordinated Bargaining Retirement Plan-US was merged into\nthe Pfizer Consolidated Pension Plan. As a result, there are liabilities to participants or their\nbeneficiaries under the plan at the end of the plan year, which consisted of liabilities under both plans\nas of the last day of the 2023 plan year.\nFunding Target\nEmployer\nPlan Plan Attainment\nIdentification\nName Number Percentage as\nNumber\nof 12/31/2023\nPfizer Consolidated Pension Plan 13-5315170 001 96.65%\nWyeth Coordinated Bargaining Retirement Plan-US 13-5315170 019 97.08%\n\n2024 Form 5500 \u2013 Schedule SB Plan: Pfizer Consolidated Pension Plan\nEIN/PN: 13-5315170/001\nSchedule SB, Line 32 \u2014 Schedule of Amortization Bases\nThe total shortfall amortization charge is the sum of the individual shortfall amortization installment for\neach plan year since the IRC Section 430 changes made by ARPA took effect for the plan. Although an\nindividual shortfall amortization installment can be negative, the combined shortfall amortization charge\ncannot be less than $0.\nShortfall Bases\nYear Outstanding Years 2024\nEstablished Balance Remaining Installment\n2023 884,498,608 14 85,235,379\n2024 (547,996,793) 15 (50,427,791)\nTotal $ 336,501,815 $ 34,807,588\n\n2024 Form 5500 \u2013 Schedule SB Plan: Pfizer Consolidated Pension Plan\nEIN/PN: 13-5315170/001\nSchedule SB, Line 24 \u2013 Change in Actuarial Assumptions\n(cid:127) The expected investment return was updated from 5.55% for 2022 to 7.05% for 2023 to reflect\nfuture expectations.\n(cid:127) For the Wyeth pre-2012 benefit, the PBGC lump sum interest rate in each future year was\ncalculated using the formula described in PBGC guidance issued September 9, 2020 using the 12-\nyear spot rate from implied forward rates developed from the November 2023 full yield curve\npublished by the IRS in December 2023 for PPA funding calculation purposes, and adjusted to\nreflect changes in the spot rates of the Mercer Yield Curve from the November 30, 2023 to\nDecember 31, 2023 curves.\n(cid:127) The cash balance interest accumulation rate was updated to 5.00% through 2024 and 5.35%\nthereafter, in order to reflect future expectations, while taking into account the fact that 30-year\nTreasury yields are currently below the 5.00% floor.\n(cid:127) The administrative expense component of the normal cost decreased from $23,200,000 to\n$17,150,000 to reflect our expectations for the current year, based on the prior year\u2019s actual\nadministrative expenses adjusted for the expected change in PBGC premiums, rounded to the\nnearest $50,000.",
    "char_count": 142605
  }
]